Evaluation of the antioxidant and anti-diabesity potential of cyclopia maculata using in vitro non-cell based screening models by Matrose, Albertina Neliswa
EVALUATION OF THE ANTIOXIDANT AND ANTI-DIABESITY POTENTIAL OF 
CYCLOPIA MACULATA USING IN VITRO NON-CELL BASED SCREENING 
MODELS 
 
 
 
ALBERTINA NELISWA MATROSE 
 
 
A thesis submitted in partial fulfillment of the requirements for the degree of 
Masters in Herbal Science in the South African Herbal Science and Medical 
Institute, University of Western Cape, Bellville, South Africa 
 
 
 
 
 
 
 
 
 
 
 
 
Study leader: Prof J.A. Syce 
Co-study leader: Prof E. Joubert 
Co-study leader: Dr C.J. Malherbe 
 
 
September 2014 
 
 
 
 
 
II 
 
 
EVALUATION OF THE ANTIOXIDANT AND ANTI-DIABESITY POTENTIAL OF 
CYCLOPIA MACULATA USING IN VITRO NON-CELL BASED SCREENING 
MODELS 
 
 
 
 
 
 
ALBERTINA NELISWA MATROSE  
 
 
 
 
 
 
 
KEY WORDS:  
Obesity,  
Diabetes,  
Oxidative stress, 
Cyclopia maculata, 
Antioxidant capacity, 
DPPH, ABTS, ORAC and FRAP  
Total polyphenol content, 
Lipase inhibition, 
α-Glucosidase inhibition, 
Effect of fermentation,  
HPLC-DAD-BCD. 
 
 
 
 
 
III 
 
Declaration  
 
 
 
 
 
 
I declare that the thesis EVALUATION OF THE ANTIOXIDANT AND ANTI-
DIABESITY POTENTIAL OF CYCLOPIA MACULATA USING IN VITRO NON-CELL 
BASED SCREENING MODELS is my own work, that it has not been submitted 
before for any degree or examination in any other university, and that all the 
sources I have used or quoted have been indicated and acknowledged by 
complete references.  
 
 
 
 
 
A.N MATROSE        September 2014 
 
 
 
Signed …………………….      UWC Bellville 
 
 
 
 
 
 
 
 
 
 
IV 
 
Abstract  
 
 
The simultaneous increase in obesity and type 2 diabetes has resulted in a new term, 
‘diabesity’, to describe individuals suffering from both diseases.  Adverse effects 
associated with the use of the anti-obesity drug, OrlistatTM, and the anti-diabetic drug, 
AcarboseTM, both enzyme inhibitors, necessitate the search for alternative              
anti-diabesity therapeutics with less or no side effects. Furthermore, oxidative stress 
plays a major role in the pathogenesis of these diseases. The aim of this study was 
therefore to evaluate the antioxidant and anti-diabesity potential of a hot water extract 
of C. maculata in non-cell based assays and correlate the activities with phenolic 
composition.   
 
Total antioxidant capacity (TAC) was assessed in terms of free radical scavenging and 
iron reducing ability. The DPPH, ABTS, ORAC and FRAP assays were employed. 
Anti-diabesity potential was assessed in terms of the inhibition of the digestive 
enzymes, α-glucosidase and pancreatic lipase. The effect of fermentation was also 
determined by analyzing aqueous extracts of unfermented C. maculata plant material 
(n = 9) and their fermented counterparts (n =9). Extraction simulated the industrial 
scale process used for preparation of food-grade extracts.  
 
Total polyphenol content of C. maculata extracts was measured in gallic acid 
equivalence (GAE) and the unfermented batch of extracts contained an average of 
24 g GAE/100 g. This was significantly higher than that of the fermented batch of 
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extracts (16 g GAE/100 g). HPLC analysis showed highest quantities for mangiferin and 
isomangiferin. Other compounds in relatively high concentrations were iriflophenone-3-
C-β-D-glucoside, hesperidin and eriocitrin. The compounds differed in the extent of 
degradation upon fermentation. Most affected were mangiferin and iriflophenone-3-C-β-
D-glucoside, i.e. 70 % decrease compared to ≤ 40 % for the other compounds.  
 
Different TAC values were obtained with different assays used, as expected due to 
different mechanisms and rate of reaction, with the highest TAC value obtained for the 
ORAC assay in the relative order TACORAC>TACABTS >TACDPPH>TACFRAP, irrespective 
of state of fermentation. Fermentation decreased TAC values obtained in all assays. 
The individual polyphenol compound content correlated significantly (P < 0.0001) with 
the TAC of extracts, however, the flavanone glycoside hesperidin showed no 
detectable antioxidant activity in the on-line HPLC antioxidant assays.  
 
A positive inhibitory activity was obtained against α-glucosidase. The extracts 
however, were more effective against mammalian α-glucosidase than yeast               
α-glucosidase. In the respective assays the extracts were, however, significantly 
weaker α-glucosidase inhibitors than Acarbose™ and (+)-catechin. Fermentation also 
decreased the activity of α-glucosidase. The lipase inhibitory activity of the extracts 
was compared with Orlistat™. This drug proved to be highly effective while the C. 
maculata extracts only showed weak inhibition of the enzyme. Once again the extracts 
of unfermented plant material were more effective than their fermented counterparts. 
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Based on multiple biological activities of the phenolic compounds in C. maculata, this 
plant might be a useful source of compounds that could provide a lead structure for 
the development of multiple target-oriented therapeutic modalities for the treatment of 
diabesity. The major compounds in C. maculata extracts, i.e. mangiferin, isomangiferin 
and iriflophenone-3-C-β-D-glucoside, could be used as chemical markers to obtain a 
standardized antioxidant nutraceutical. The anti-diabesity activity of these compounds, 
however, needs further exploration before they can be used as bioactive markers for a 
nutraceutical product aimed at the anti-diabesity market. 
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Chapter 1 
Introduction 
 
Obesity is a direct result of an imbalance between energy intake and energy 
expenditure, which results in excess energy stored in fat cells (Goedecke et al., 
2006). It is an increasing medical problem globally (Melnikova and Wages, 
2006; Birari and Bhutani, 2007), with 1.46 billion adults worldwide estimated to 
have a body mass index (BMI) of greater than25 kg/m2 in 2008 and of these 205 
million men and 297 million women were obese (Finucane et al., 2011). South 
Africa’s overweight and obesity prevalence has also increased alarmingly among 
all its citizens, following the global trend of obesity (Mollentze, 2006). Moreover, 
insulin resistance, type 2 diabetes, dyslipidaemia, hypertension and coronary 
heart disease have been reported to be adverse health consequences 
associated with obesity (Mollentze, 2006). 
 
Obesity elevates the incidence of insulin resistance which leads to development 
of diabetes (Hollander, 2007). Shaw et al. (2010) estimated a global prevalence 
of 285 million diabetic cases in 2010, and this figure is predicted to reach 439 
million by 2030. Obesity and diabetes often occur simultaneously and therefore 
are termed diabesity. Diabesity is a common term that reflects both diseases 
aetiological and clinical presentation and or also defined as a combination of type 
2 diabetes mellitus (T2MD) and obesity (Astrup and Finer, 2000; Tharakan et 
al., 2011). 
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According to Fernandez-Sanchez et al. (2011), obesity, inflammation, increased 
cellular oxidative stress and diabetes are directly linked. Furthermore, a 
significant correlation between lipid peroxidation (a marker of oxidative injury) 
and body mass index (BMI) of obese subjects, suggests a direct link 
betweenobesity and increased oxidative stress (Furukawa et al., 2004).  
Increasing experimental and clinical evidences suggest that oxidative stress may 
also play a major role in the pathogenesis of both type 1 and type 2 diabetes 
(Maritim et al., 2003). 
 
The most appropriate approach for prevention of obesity is with lifestyle 
modifications but therapeutic strategies include anti-obesity agents and surgery 
(Sergent et al., 2012). Various drugs with different mechanism of action for 
treatment of obesity are on the market or in development, and one of the 
mechanisms of action is through the inhibition of the nutrient digestive enzyme, 
pancreatic lipase (Adan, 2013), a dietary enzyme responsible for digestion of 
approximately 50-70 % of dietary triglycerides into monoacylglycerides and free 
fatty acids which are absorbed by enterocytes (Sergent et al., 2012). The ability 
of any compound/substance to inhibit pancreatic lipase is a widely employed 
mechanism to determine its anti-obesity potential (Birari and Bhutani, 2007). 
For instance OrlistatTM, a clinically approved drug for the treatment of obesity, 
inhibits pancreatic lipase (Khedidja and Abderrahman, 2011). The mechanism 
by which this drug exerts its effect is by inactivating the hydrolysis of dietary fat 
and preventing the absorption of dietaryfats by approximately 30 %, thus 
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reducing the calorie intake of an obese patient (Li et al., 2009). However, side 
effects associated with the use of OrlistatTM have been reported which include 
amongst others oily stools, faecal incontinence and flatulence, (Melnikova and 
Wages, 2006; Birari and Bhutani, 2007).Therefore pancreatic lipase inhibitors 
with less or no side effects are needed. As reviewed by Birari and Bhutani 
(2007) phytochemicals of plant origin such as saponins and polyphenolics were 
found to inhibit pancreatic lipase, rendering them as alternative strategies for the 
development of anti-obesity therapeutics. However, these strategies may also 
exhibit adverse effects on cell survival parameters as compounds such as 
saponins have been reported to induce cell apoptosis (Li et al., 2013) and would 
therefore require toxicology studies before further development.  
 
Similarly, treatment of diabetes type 2 can be achieved through inhibition of       
α-glucosidase (a digestive enzyme responsible for breaking down of complex 
carbohydrates thus leading to increased blood glucose levels) (Hollander, 2007). 
Therefore, inhibition of this enzyme prevents postprandial increase in blood 
glucose levels (Hollander, 2007). AcarboseTM is the clinically approved            
anti-diabetic drug that inhibits α-glucosidase to exert its therapeutic effects 
(Silvio and Inzucchi, 2002). However, adverse effects such as flatulence and 
diarrhea (both resulting from increased bacterial fermentation as a result of a 
delayed carbohydrates uptake in the gut) and abdominal discomfort have been 
reported with the use of AcarboseTM (Silvio and Inzucchi, 2002; Hollander, 
2007). Therefore, new α-glucosidase inhibitors with less/no side effects are 
needed (Birari and Bhutani, 2007). The potential of natural products is 
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unexplored and might be an alternative strategy for development of anti-diabetic 
therapeutics (Sergent et al., 2012). Furthermore, Prabhakar and Doble (2011) 
noted that, apart from the currently available anti-diabetic treatments, herbal 
medicines have also been recommended as therapeutics due to their 
effectiveness, fewer side effects and low costs. A review by Pandey and Rizvi 
(2009) on plant polyphenols as dietary antioxidants in human health and disease 
has revealed that these compounds provide a significant protection against 
diabetes through inhibition of glucose absorption in the gut.  
 
Apart from their potential role as lipase and α-glucosidase inhibitors in vivo 
(Birari and Bhutani, 2007; Pandey and Rizvi, 2009), polyphenols have the 
ability to modulate oxidative stress, one of the underlying factors contributing to 
obesity and diabetes (Fernandez-Sanchezet al., 2011). These compounds 
reduce oxidative stress through their free radical scavenging ability and, in so 
doing also protect the cells from oxidative damage (Soobratteeet al., 2005). 
Moreover, Bagchi et al. (1997) discovered that flavonoids such as 
proanthocyanidins provide a significant protection against free radical cellular 
damage and free radical induced peroxidation. 
 
The current study investigated the anti-diabesity potential of Cyclopia maculata, a 
Cyclopia species that grows naturally in the Overberg, and specifically in the 
Genadendal area, where it is locally consumed as a herbal infusion. Honeybush 
(Cyclopia species) is one of South Africa’s commercialized herbal teas, with C. 
subternata, C. intermedia and C. genistoides comprising most of the annual 
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production (Joubert et al., 2011).Growing demand for this herbal tea, to some 
extent as a result of its healthy image, has raised interest for other species such 
as C. maculata. However, the commercial potential of C. maculata is still 
unexploited and as a result investigation of its phenolic composition is limited to 
date. Joubert et al. (2003) showed that C. maculata contains high levels of the 
xanthones such as mangiferin and isomangiferin, and the flavanone, hesperidin. 
Their study reported that the plant material of C. maculata (on drymass basis) 
contained 1.63 %, 0.32 % and 0.72 % of mangiferin, isomangiferin and 
hesperidin, respectively. However, other compounds such as vicenin-2, 
scolymoside, iriflophenone-3-C-β-D-glucoside, and phloretin-3ɂ,5ɂ-di-C-β-D-
glucoside have also recently been identified in this species (Schulze, 2013).  
 
Several studies have demonstrated a number of bioactivities associated with 
mangiferin and/or hesperidin, amongst which are, antioxidant, 
immunomodulatory, anti-allergic, anti-inflammatory and anti-diabetic properties 
(Garg et al., 2001; Wauthoz et al., 2007). Furthermore, an animal model study 
conducted by Mahmoud et al. (2012) has shown hesperidin to attenuate 
hyperglycemia-mediated oxidative stress and pro-inflammatory cytokine 
production in type 2 diabetes. This flavanone has been reported to have lipase 
inhibitory effects (Kawaguchi et al., 1997). Mangiferin has shown to attenuate 
oxidative stress induced cellular damage (Marquez et al., 2012). Moreover, as 
evaluated by Pardo-Andreu et al. (2008), in atherosclerosis-prone 
hypercholesterolemic mouse, it also prevents mitochondrial oxidative stress. A 
study by Muruganandan et al. (2005) showed that mangiferin exhibited         
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anti-diabetic activity by significantly lowering fasting plasma glucose levels at 
different time intervals in streptozotocin (STZ) diabetic rats. Phoboo et al. (2013) 
demonstrated α-glucosidase inhibitory effects of mangiferin, however, it was less 
effective than the clinical drug AcarboseTM, a known α-glucosidase inhibitor 
(Phoboo et al., 2013). Mangiferin also exhibit lipase inhibitory effects as 
determined by Yoshikawa et al. (2002). It is well established that mangiferin, 
isomangiferin and to a lesser extent hesperidin are also potent free radial 
scavengers (Leiro et al., 2003; Hubbe, 2000). 
 
Commercially, the honeybush herbal tea is available on local and international 
markets in both fermented (oxidized) and unfermented (green; unoxidised) form. 
A study by Joubertet al. (2008b) determined that fermentation (i.e. high 
temperature oxidation processing mainly employed to develop and improve 
quality and colour of the tea) caused a decrease in total polyphenol content 
(particularly xanthones) in Cyclopia plant material. A decrease in free radical 
scavenging ability of honeybush aqueous extracts resulting from the oxidation of 
phenolic compound during fermentation has also been observed (Hubbe, 2000; 
Joubert et al.,  2008a,b). 
 
The present study investigated the antioxidant and anti-diabesity potential of 
Cyclopia maculata using in vitro non-cell based screening models. The focus fell 
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on hot water extracts as this type of extract is produced for the food and 
nutraceutical industries as food ingredient and supplement, respectively.  
 
The specific objectives of the study were:  
 
· To characterise the phenolic composition of C. maculata extracts through 
total polyphenol and HPLC analysis of individual compounds; 
· To determine anti-oxidant capacity of C. maculata extracts using different 
antioxidant assays (DPPH●, ABTS●+, FRAP and ORAC); 
· To determine anti-diabesity activity of C. maculata extracts through 
inhibition of pancreatic lipase and α-glucosidase; 
· To determine the effect of fermentation on C. maculata extracts on its 
phenolic composition, antioxidant activity and anti-diabesity activity; and 
finally; 
· To identify antioxidant and anti-diabesity bioactives in C. maculata 
extracts using high performance liquid chromatography diode-array 
detection coupled with (bio)chemical detection (HPLC-DAD-BCD).  
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CHAPTER 2 
 
Literature review 
 
 
 
 
2.1  Introduction  
 
This chapter provides an overview of the prevalence of diabesity, risk factors, 
and commercially available therapeutic agents (OrlistatTM and AcarboseTM) for 
treatment of obesity and diabetes. The mechanism of action, advantages and 
disadvantages of these drugs are discussed as background to a general 
overview of natural products used for treatment of diabesity. The emphasis will 
be on polyphenols as this diverse group of plant constituents are increasingly 
investigated for anti-diabetic and anti-obesity effects. Of importance, in the 
context of the study, is their ability to inhibit intestinal α-glucosidase and 
pancreatic lipase. Oxidative stress, one of the health conditions associated with 
diabesity, and the potential of polyphenols through their antioxidant activity to 
modulate oxidative stress, will also be discussed. The focus of this study will fall 
on Cyclopia maculata. The phenolic composition of Cyclopia species investigated 
to date will be reviewed as species contain similar chemical composition (and 
since little information on the composition of C. maculata is available). This will 
serve to provide insight into the type of compounds that could potentially 
contribute to bioactivity of C. maculata extracts. The effect of “fermentation” 
(oxidation) on the phenolic composition of Cyclopia species and subsequently 
their bioactivities such as antioxidant, anti-obesity and anti-diabetic effects, will 
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also be discussed. Principles of the different methods employed in the study will 
be discussed and limitations highlighted.  
 
2.2  Obesity 
 
Obesity is a growing epidemic globally (Melnikova and Wages, 2006;Birari and 
Bhutani, 2007), with 1.46 billion adults worldwide estimated to be overweight  in 
2008, and  of these, 205 million men and 297 million women were obese 
(Finucane et al., 2011). According to the World Health Organisation (WHO) 
standards, a body-mass index (BMI) of 25.0 kg/m2 or higher is categorized as 
overweight and a BMI of 30.0 kg/m2 or more as obese (WHO, 2013). BMI is 
defined as a person’s weight in kilograms divided by the square of the height in 
meters (kg/m2) (Baboota et al., 2013). Obesity is defined as excessive fat build-
up in the body that may impair health and decrease life expectancy (WHO, 2013; 
Savini et al., 2013). This disease occurs as a result ofan imbalance between 
energy intake and energy expenditure (Goedecke et al., 2006). Consumption of 
energy dense, nutrient-poor foods that are high in saturated fats and sugars, and 
lack of exercise are the key risk factors contributing to the obesity epidemic 
(Cooke and Bloom, 2006).  
 
The amount of fat stored in the liver is determined by the balance in fatty acid 
uptake, fatty acid synthesis, triglyceride synthesis, fatty acid oxidation and 
triglyceride export. Changes in these conditions could result in excessive fat 
accumulation (increased levels of adipose tissue), which therefore increases 
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morbidity risks, causing metabolic abnormalities such as obesity which is often 
accompanied by hypertension, impaired glucose tolerance and insulin resistance. 
Moreover, major complications associated with obesity are insulin resistance and 
diabetes type 2 (Keller, 2006). Therefore the incidence of obesity is intimately 
linked to diabetes as well as other side effects, such as oxidative stress and 
inflammation (Stienstra et al., 2006).The presence of excessive adipose tissue 
has been identified as a source of pro-inflammatory cytokines, tumor necrosis 
factor alpha (TNF-α), interleukin 6 (IL-6) and interleukin 1 (IL-1).  These cytokines 
are potent stimulators of the production of reactive oxygen species (ROS) so that 
high levels of cytokines could be the reason for increased oxidative stress in 
obese individuals (Fernandez-Sanchez et al., 2011).The excessive adipose 
tissue also results in elevated levels of plasma free fatty acids (FFAs), which 
decrease insulin stimulated glucose uptake, leading to insulin resistance 
(Guenther et al., 2011). The direct link between obesity and diabetes has led to 
the collective term, “diabesity” (a common term that reflects both their etiological 
and clinical presentation, also defined as a combination of type 2 diabetes (T2D) 
mellitus and obesity) (Astrup and Finer, 2000; Tharakan et al., 2011).  
 
Even though life style interventions are the recommended approach for treatment 
of obesity (Sergent et al., 2012; Adan, 2013), targeting specific enzymes or 
brain circuits that are implicated in obesity with pharmaceutical drugs has been 
proven to be efficient treatments (Adan, 2013). High levels of FFAs in the plasma 
can, amongst others, be regulated by inhibiting fat digestion in the small 
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intestine, thereby reducing body fat accumulation. This can be achieved by 
inhibiting pancreatic lipase, which is a key enzyme in lipid metabolism as it is 
responsible for the absorption of dietary triglycerides and phospholipids (Slanc et 
al., 2009).  This enzyme hydrolyses 50-70 % of dietary fats into fatty acids and 
monoglycerides. Inhibition of pancreatic lipase results in inefficient triglyceride 
digestion and subsequently their excretion in the faeces (Birari and Bhutani, 
2007). Therefore, pancreatic lipase inhibitors are potential anti-obesity agents 
(Birari and Bhutani, 2007). OrlistatTM (Xenical™), a saturated derivatives of 
lipstatin, a natural product (Figure 1) isolated from the bacterium Streptomyces 
toxytricini, is a clinically approved pharmaceutical drug for the treatment of 
obesity. 
 
 
 
 
Figure 1.  Chemical structure of Orlistat™ 
[http://pubchem.ncbi.nlm.nih.gov/summary/summary.c
gi?cid=3034010].  
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The mechanism of action of Orlistat™(Figure 2) is inhibition of pancreatic lipase, 
which prevents breaking down of ingested fats (Barbier et al., 2004; Patel, 
2011),thus blocking the absorption of about 25 % of dietary fat (Hill et al., 1999). 
OrlistatTM binds to the active site of pancreatic lipase through its reactive            
β-lactone ring, leading to an ester bond with the serine hydroxyl group of the 
catalytic triad of pancreatic lipase. It forms an enzyme inhibitor complex of an 
acyl-enzyme type resulting in irreversible inhibition of the enzyme (Tsujita et al., 
2006). As a result, approximately one-quarter of consumed fat passes through 
the gastrointestinal tract and is eliminated.  
 
 
 
 
Figure 2.  Pancreatic lipase inhibition by Orlistat™ (Xenical™: trade name for Orlistat™ by 
Roche): A unique mechanism for treatment of obesity [Patel, 2011]. Orlistat™ 
binds to active site of lipase thus blocking the cleavage of triglycerides.  
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The use of Orlistat™ has been associated with a number of adverse effects, 
such as oily stool, oily spotting, faecal urgency, increased defecation, flatulence 
and faecal incontinence (mostly resulting from the unabsorbed fats that are 
excreted in the faeces) (Barbier et al., 2004; Birari and Bhutani, 2007). In 
addition to that an in vivo study by Ellrichman et al. (2008) in 
humansdemonstrated changes in gastrointestinal hormone concentrations (such 
as glucagon-like peptide-1-(7-36)-amide, cholecystokinin and peptide YY) which 
may raise appetite sensations and increase food consumption. This should 
therefore also be considered as potential side effects in the use of Orlistat™ for 
the treatment of obesity. However, its success as a potent pancreatic lipase 
inhibitor has prompted research for the identification of new pancreatic lipase 
inhibitors that lack or prevent some of these side effects (Barbier et al., 2004; 
Birari and Bhutani, 2007; Martins et al., 2010). At present, natural products are 
being explored for their potential as anti-obesity drugs (Yun, 2010). 
 
2.2.1 Phytochemicals evaluated for anti-obesity potential  
 
Natural products provide a vast pool of pancreatic lipase inhibitors with potential 
of being developed into anti-obesity agents, as reviewed by Cavaliere et al. 
(2001) and Birari and Bhutani (2007). Table 1 summarises information of a 
selection of plants of which their extracts and secondary metabolites (some of 
which are polyphenolic compounds) have been shown to have potential as lipase 
inhibitors. Several of the compounds resemble OrlistatTM in that they irreversibly 
bind to lipase and inactivate it through formation of a stable covalent intermediate 
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with serine, in the active site of lipase (Yun, 2010), whereas some plant 
metabolites such as crocin (a glycosylated carotenoid and the major active 
constituent of Gardenia jasminoids) bind covalently, but reversibly modify serine 
(Birari and Bhutani, 2007).   
 
Table 1  Plants, extracts and constituents with lipase inhibitory activity  
Genus/ 
species  
Common 
name 
Type of 
compounds 
Active 
component  
Activity 
relative to 
Orlistat™ 
References  
Panax 
japonicus 
rhizomes 
 Saponin Chikusetsusaponin < Han et al., 
2005 
Salix 
matsudana 
Corkscrew 
willow 
Polyphenols Crude extract Not compared Han et al., 
1999 
Rosmarinus 
officinalis 
Rosemary  Methanolic extract 
(IC50 = 13.8 µg/mL) 
 
> Bustanji et al., 
2010 
Glycyrrhize 
urolensis 
Sweet root Aromatic 
ketones (forms 
flavonoid) 
Licocholcone A < Won et al., 
2007; Zheng et 
al., 2010 
Citrus unshiu Naartjie Flavonoid Hesperidin Not compared Kawaguchi et 
al., 1997  
Rosmarinus 
officinalis 
Rosemary Phenolic  acids  Chlorogenic acid 
(IC50 = 96.5 
µg/mL); caffeic 
acid (IC50 = 32.5 
µg/mL) 
< Bustanji et al., 
2010 
Mangifera 
Indica 
Mango Polyphenols  Crude extract Not compared Moreno et al., 
2006 
Filipendula 
kamtschatica 
Giant 
meadowsweet 
Flavonoid 
(flavanone) 
3-O-β-
Xylopyranosyl-(1-
2)-O- β-
galactopyranoside 
Quercetin  ( IC50 = 
300 µM) 
< Kato et al., 
2012 
Filipendula 
kamtschatica 
Giant 
meadowsweet 
Chlorogenic 
acid 
2-O-Caffeoyl- 
4-O-galloyl-L-
threonic acid ( IC50 
= 246 µM) 
< Kato et al., 
2012 
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Genus/ 
species  
Common 
name 
Type of 
compounds 
Active 
component  
Activity 
relative to 
Orlistat™ 
References  
Filipendula 
kamtschatica 
Giant 
meadowsweet 
Chlorogenic 
acid  
3-O-Caffeoyl-4-O-
galloyl-L-threonic 
acid ( IC50 = 26 
µM) 
< Kato et al., 
2012 
Ilex 
paraguariensis 
Yerba mate Polyphenols Crude extract Not compared Martins et al., 
2010 
Camellia 
sinensis 
Green tea  Catechins 
(flavanol) 
EGCG and ECG Not compared Koo and Noh, 
2007 
Platycodon 
grandiflorum 
Hakone white  Saponin  Platycodin D < Zheng et al., 
2010 
Prunella 
vulgaris 
  Crude extract < Zheng et al., 
2010 
Rheum 
palmatum 
  Crude extract < Zheng et al., 
2010 
Dioscorea 
nipponica 
Chuan long 
shu yu 
Saponin Dioscin Not compared Zheng et al., 
2010 
Nelumbo 
nucifera 
Lotus Phenolic 
constituents  
Crude extract Not compared Zheng et al., 
2010 
Pure 
compound  
 Flavonoid Luteolin  < Zheng et al., 
2010 
Arachis 
hypogaea 
Peanut shell Flavonoid  Luteolin  < Yamamoto et 
al., 2000 
> and < indicate more and less effective than Orlistat™ 
 
The inhibitory potency of the extracts is generally significantly weaker than that of 
OrlistatTM, since the extracts do not contain only active but also inactive 
substances (Yun, 2010). An in vitro study by Zheng et al. (2010) showed that 
crude extracts of Prunella vulgaris and Rheum palmatum exhibited a significantly 
low percentage inhibition (<10 %) at a concentration of 10 µg/mL when evaluated 
for their pancreatic inhibition, whereas OrlistatTM showed approximately 65 % 
inhibition at the same concentration. Their findings were in agreement with the 
report by Yun (2010) and other authorswith regards to the potency of plant 
Table 1 (continued) Plants, extracts and constituents with lipase inhibitory 
activity  
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extracts. However, purified fractions and compounds from crude extracts can 
also be less potent than OrlistatTM. Zheng et al. (2010) demonstrated that the 
flavonoid, luteolin (isolated from promising Chinese herbs), exhibited weaker 
lipase inhibition activity (17 % inhibition) than OrlistatTM (87 % inhibition) at the 
same concentration (25 µg/mL). On the other hand, some crude plant extracts 
have been shown to possess higher lipase inhibitory activity than their isolated 
compounds. For instance, a methanolic extract from Rosmarinus officinalis 
(rosemary) showed higher lipase inhibitory activity than its phenolic acids, 
chlorogenic acid and caffeic acid (IC50 values of 13.8, 96.5 and 32.6 µg/mL, 
respectively) (Bustanji et al., 2010). In the same assay OrlistatTM was shown to 
have an IC50 value of 0.65 µg/mL. Thus both crude extracts and isolated 
compounds were much less effective than OrlistatTM.  
 
In nature, there is a vast of number of phenolic compounds, ranging from 
relatively simple compounds, such as phenolic acids to complex polymers such 
as tannins. Flavonoids are the major phenolic compounds of plant extracts and 
generally the most active constituents as their structures allow binding to 
enzymes and scavenging of radicals, amongst others (Fraga et al., 2010; Xiao 
et al., 2013a, b). They are represented by a benzene ring (A) in their structure, 
condensed with a heterocyclic six-membered pyran or pyrone ring (C), which is 
in 2 or 3 position and carries a phenyl ring (B) as a substituent (Figure 4). 
Structurally flavonoids can differ greatly or in many cases slightly, however, these 
differences have a huge impact on the potency of the active compounds.  
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A study by You et al. (2012) comparing the lipase inhibitory activity of the 
flavanol catechin and the flavonol quercetin showed the latter compound to be ca 
30 times more effective in inhibiting lipase (IC50 = 83.66 µg/mL vs 2500.98 µg/mL, 
respectively). These compounds are structurally similar except for the C2-C3 
double bond and C4 keto group present in quercetin.  Nakai et al. (2005) showed 
that flavanols require galloyl moieties within their chemical structures and/or 
polymerization for enhanced pancreatic lipase inhibition. A study by Wu et al. 
(2013) investigating the binding interactions of the flavanol (-)-epigallocatechin-3-
gallate (EGCG) with lipase, revealed non-covalent binding of EGCG to lipase, 
which alters the molecular conformation of the enzyme, resulting in a decreased 
enzyme catalytic activity.  
 
Compounds with similar chemical structure, except for the presence and/or 
positioning of moieties, may have varied inhibitory potencies. Such a case was 
demonstrated by Lee at al. (2010) for the aglycone luteolin and its glycosides, 
orientin and isoorientin. The inhibitory activity of luteolin against pancreatic lipase 
was much weaker than those of its C-glycosylated derivatives, orientin and 
isoorientin. Furthermore, C-glycosylation of luteolin at position C-6 (isoorientin) 
resulted in a more potent compound than when glycosylated at position C-8 
(orientin). The type of glycoside moiety could also play a role. Luteolin 6-C-β-D-
boivinopyranoside was shown to be less effective than the 6-C-β-D-
glucopyranoside, isoorientin (Lee et al., 2010). 
 
 
 
 
 24 
Kato et al. (2012) demonstrated that the position of the moiety is also important 
for other type of phenolic compounds. The IC50 values of the threonic acids, 2-O-
caffeoyl-4-O-galloyl-L-threonic acid and its isomer 3-O-caffeoyl-4-O-galloyl-L-
threonic acid were respectively 246 µM and 26 µM (Table 1). These compounds 
are regio-isomers containing a diacylglycerol-like structure. In addition to this 
keto structural feature being important for activity, the position of the caffeoyl 
groups greatly affects the potency of these compounds, with the 3-O-caffeoyl 
isomer having ca 10 fold higher potency than the 2-O-caffeoyl isomer. Even 
though the inhibitory effect of 3-O-caffeoyl-4-O-galloyl-L-threonic acid was 
significantly higher than that of its regio-isomer, it showed a significantly weaker 
lipase activity than that of Orlistat™ (IC50 = 0.22 µM).  
 
 In conclusion structural features of compounds are important for activity, and 
even for the same type of compound, minor modifications can have a major 
effect on their lipase inhibitory activity 
 
2.3 Diabetes 
 
Diabetes, as is the case for obesity, is a seriously increasing medical problem 
globally (Larsen et al., 2010). Obesity and/or lack of physical activity were 
identified as two of the main determining factors in the development of insulin 
resistance that precede the diagnosis of type 2 diabetes (T2D) (Astrup, 2001; 
Hamilton et al., 2007). More than 90 % of diabetes cases are T2D (Larsen et 
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al., 2010). In 2010, the estimated number of adults affected by T2D worldwide 
was 285 million. By 2030 it was predicted to affect 439 million people globally 
(Shaw et al., 2010), but in 2006, T2D was already projected to rank as 9th 
leading cause of death in low-income countries (Mathers and Loncar, 2006). 
This can be attributed to growth and ageing of the population as well as 
urbanisation associated with increasing trends towards unhealthy diets, obesity 
and sedentary lifestyles (Green et al., 2003).  
 
Diabetes is defined as a health condition that is generally characterised by 
metabolic defects in production and utilisation of glucose by the body which 
result in elevated blood glucose (Larsen et al., 2010). According to Schinner et 
al. (2005) the major pathophysiological event contributing to the development of 
T2D, besides β-cell failure, is the resistance of target cells to insulin (a hormone 
responsible for metabolism of carbohydrates, lipids, and proteins). Insulin 
resistance is a physiological condition in which cells fail to respond to the normal 
actions of the hormone, therefore leading to insufficient insulin-stimulated 
glucose uptake (Reaven, 1988). The inadequate use of insulin by the cells leads 
to postprandialhyperglycemia (Larsen et al., 2010), which is defined as a rapid 
increase of blood glucose level after food consumption (Sakulnarmrat and 
Konczak, 2012).  
 
The increase in blood glucose can be reduced through inhibition of enzymes 
involved in carbohydrate digestion, specifically intestinal α-glucosidase, as this is 
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the main enzyme responsible for the release of glucose from foods (Boath et al., 
2012). Inhibition of α-glucosidase is thus considered as one of the main 
approaches underlying management of T2D (Van de Laar, 2008). Inhibitors of 
intestinal α-glucosidase may be effective in retarding carbohydrate digestion, 
thus preventing excess glucose absorption in the small intestine (Tadera et al., 
2006).  
α-Glucosidase is targeted by proprietary drugs such as AcarboseTM ( Figure 3), 
which are prescribed to control blood glucose levels in T2D after ingestion of 
starch containing meals (Boath et al., 2012). 
 
 
 
AcarboseTM reduces postprandial hyperglycemia by interfering with the digestion 
of dietary carbohydrates (De Melo et al., 2006). In the small intestine, starch is 
digested to oligosaccharides by amylase, and further digested to glucose by 
membrane-bound α-glucosidase. AcarboseTM competitively binds to the 
oligosaccharide binding site of α-glucosidase, thus preventing binding and 
enzymatic hydrolysis of the oligosaccharide substrate (Figure 4). α-Glucosidase 
inhibition therefore represents a pharmacologic approach for modifying the 
Figure 3.  Chemical structure of Acarbose TM [De Melo et al., 2006].   
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digestion and absorption of dietary carbohydrates as an adjunct to dietary 
changes (Bischoff, 1994).  
 
 
 
α-Glucosidase inhibitors, VogliboseTM and MiglitolTM, are also clinically used for 
treatment of diabetes, but AcarboseTM,due to its efficacy, is the most widely used 
anti-diabetes drug of this type (Van de Laar et al., 2005; Ismail and Deshmukh, 
2012). Since it delays carbohydrate uptake, bacterial fermentation in the gut is 
increased, resulting in flatulence, diarrhea and abdominal discomfort (Silvio and 
Inzucchi, 2002; Hollander, 2007). Therefore, new α-glucosidase inhibitors with 
Figure 4.  α-Glucosidase inhibition by Acarbose TM [Bischoff H, 1994]. 
 
 
 
 
 
 28 
less or no side effects are needed (Birari and Bhutani, 2007). Natural and 
synthesized α-glucosidase inhibitors have become an attractive therapeutic 
approach for treatment of postprandial hyperglycemia (Garlapati et al., 2013).  
 
2.3.1 Phytochemicals evaluated for anti-diabetes potential 
 
A wide array of medicinal plants and their active constituents play a role in the 
prevention and treatment of diabetes (Prabhakar and Doble, 2008). Many plants 
extracts and secondary metabolites have been reported as potential α-
glucosidase inhibitors. Several examples are presented in Table 2. The source of 
the enzyme used to evaluate this activity is also indicated in the same table as 
the activity depends on the source of enzyme used the in vitro assay (Kim et al., 
2008a; Hogan et al., 2010). The mechanism of action through which crude plant 
extracts or in some cases purified compounds exerts their anti-diabetic effects 
has been revealed to be same as that of Acarbose™ (Yoshikawa et al., 1997; 
Chen, 2007). For the purpose of this discussion, the activity of a number of plant 
extracts in comparison to the anti-diabetic drug, Acarbose™ will be highlighted.  
 
Gynura medica, a species belonging to the Compositae family, has been found 
(amongst other medicinal plants) to show good hypoglycemic activity in diabetic 
animal models. Its ethyl acetate extract inhibits yeast α-glucosidase more 
effectively than AcarboseTM. This drug is not very effective against yeast            
α-glucosidase, but very effective against mammalian α-glucosidase 
 
 
 
 
 29 
(Uddin et al., 2012). Many other plants of this genus were also found to inhibit 
the key enzymes relevant to T2D, including α-glucosidase and α-amylase 
(Tan et al., 2013). The inhibitory activity of a methanol extract of Cassia 
auriculata against α-glucosidase was reported to be relatively comparable to that 
of AcarboseTM, showing ED50values of 4.9 mg/kg and 3.1 mg/kg, respectively 
(Abesundara et al., 2004). Comparison of different extracts of Gynura 
divaricata (L.) DC, a traditional Chinese herb used in folk medicine for treatment 
of diabetes, showed them to inhibit yeast α-glucosidase in a dose-dependent 
manner. All extracts were less effective than AcarboseTM. The drug at 0.2 mg/mL 
inhibited 47 % of the enzyme activity whereas the water extract at 1.25 mg/mL 
inhibited of 39 % (Wu et al., 2011).   
 
Jo et al. (2011) evaluated the in vitro mammalian α-glucosidase inhibitory activity 
of skin/pulp and seed extracts of Schizandra chinensis fruit. On the basis of the 
results their postprandial blood glucose lowering effect was subsequently 
compared to AcarboseTM in vivo, showing significantly reduction in postprandial 
hyperglycemia caused by sucrose loading for the pulp/skin extract, but to a 
lesser extent than that observed for the Acarbose™ administered group. 
 
Despite their resemblance to AcarboseTM in their mode of action, purified 
compounds of plant extracts have a greater potential as anti-diabetes agents 
than AcarboseTM, since many are stronger α-glucosidase inhibitors. 
Yoshikawaet al. (1997) demonstrated that salacinol (a compound isolated from 
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Salacia reticulata) competitively inhibited intestinal α-glucosidase (Table 2). The 
inhibitory activity of salacinol against maltase (IC50 = 3.2 µg/mL) and sucrase 
(IC50 = 0.84 µg/mL) was found to be nearly equal to that of Acarbose™          
(IC50 value not presented), while its activity was more potent against isomaltase 
(IC50 = 0.59 µg/mL). It was later determined that salacinol showed an even 
stronger inhibition of the increase in serum glucose levels in rats fed high 
sucrose diet than the drug (Yoshikawa et al., 1997). 
 
Prabhakar and Doble (2008) and other authors noted that active constituents of 
plant extracts include various types of constituents, including flavonoids, 
alkaloids, glycosides, polysaccharides, steroids, carbohydrates, glycopeptides, 
terpenoids, amino acids and inorganic ions. Phenolic acids, flavonoids and 
polysaccharides were identified as the major hypoglycaemic active components 
of the Gynura genus (Tan et al., 2013). Sakulnarmrat and Konczak (2012) 
demonstrated that flavonoid-rich fractions of Australian herbs (Anise myrtle, 
Lemon myrtle and Tasmania pepper leaf) exhibited pronounced yeast                
α-glucosidase inhibitory activities in vitro (Table 2). Luteolin, the flavone 
aglycone, was reported to be more potent than Acarbose™ (Kim et al., 2000; 
Nicolle et al., 2011).  
 
According to Gunawan-Puteri et al. (2011), Wu et al. (2011), Tan et al. (2013) 
and others, flavonoids are the major compounds found in many medicinal plants 
and are reported as the main compounds responsible for the activities against 
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the key enzymes relevant to T2D such as α-glucosidase and α-amylase. The 
following discussion will therefore focus on flavonoids and their structural 
configuration in relation to their α-glucosidase inhibitory activity. As previously 
indicated, many different flavonoids are present in plants. Certain structural 
features are important for α-glucosidase inhibitory activity as reviewed by Xiao et 
al. (2013a). The main structural features and their effect are summarized in 
Figure 5 and 6. The number of hydrogen bonds and glycosylation, amongst 
others, play an important role in the binding of flavonoids to the active sites of 
digestion enzymes such as α- amylase and α- glucosidase (Xiao et al., 2013a, 
b). 
 
A hydroxyl group on the A ring enhances the α-glucosidase inhibitory effects of 
flavonoids. Gao et al. (2004) observed a dramatic loss in activity due to removal 
of a hydroxyl group at positions of 5, 6, or 7 of baicalein (5, 6, 7-
trihydroxyflavone). Hydroxylation of the B-ring is also important with compounds 
Figure 5. The potential sites of the flavonoids affecting the inhibitory effects against α-glucosidase are 
schematically illustrated. The up and down arrows represent increasing and decreasing 
inhibition, respectively [Xiao et al., 2013b]. 
 
A 
B 
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containing a catechol group being more effective than their 3'-deoxy 
counterparts. Luteolin was demonstrated to be more effective than apigenin, 
orientin more effective than vitexin, and isoorientin more effective than isovitexin 
(Li et al., 2009). Furthermore, as for lipase inhibition, the presence and position 
of the sugar moiety affect activity. In this case the aglycone was shown to be 
more effective than the glycosides, opposite to the effect demonstrated for lipase 
inhibition (as previously discussed in section 2.2.1). Glycosylation at the C-8 
position (orientin and vitexin) also had a greater impact on activity than 
glycosylation at C-6 (isoorientin and isovitexin) with the C-6 glycosides thus 
being more effective (Li et al., 2009). However, another study, using                  
α-glucosidase from rat intestine instead of yeast α-glucosidase showed vitexin to 
be more effective than isovitexin (Shibano et al., 2008). 
 
 
 
Figure 6. Chemical structures of flavonoids representing structural features enhancing the      
 α- glucosidase inhibitory activity [Xiao et al., 2013a].   
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The presence and number of moieties such as methoxy groups also determine 
activity. 5, 7, 3’, 4’-Tetramethoxyflavone was shown to be less effective than 
5, 7, 4’-trimethoxyflavone, due to the presence of the additional methoxy group at 
the 3-position (Azuma et al., 2011). Saturation of the 2, 3-double bond of the    
C-ring of flavones lowered α-glucosidase inhibition (Tadera et al., 2006). It is 
postulated that loss of planarity plays a role (Xiao et al., 2013b). Conflicting 
results for the effect of hydroxylation of the C-ring have been noted (Xiao et al., 
2013b).  
 
In conclusion, structural configuration plays a major role in the α-glucosidase 
inhibitory activity of flavonoids. Despite their specificity in compound-enzyme 
interaction, polyphenols have high efficacy for α-glucosidase inhibition. It is thus 
evident that polyphenol-rich plant extracts have potential as α-glucosidase 
inhibitors. Knowledge of their phenolic composition would aid in identifying 
potential candidates. 
 
Table 2 Plants, extracts and constituents with α-glucosidase inhibitory activity 
Genus/ 
species  
Common name Phenolic compounds Active component  Source of 
enzyme 
Activity 
relative to 
Acarbose TM 
References  
Gynura 
medica 
 Flavonoids, phenolic 
acids, cerebrosides, 
polysaccharides, 
alkaloids, terpenoids 
and sterols 
3,5-Dicaffeoylquinic 
acid methyl 
Ester 
Yeast > Tan et al., 2013 
Gynura 
medica 
 Flavonols and 
phenolic acids   
Ethyl acetate extract Yeast > Tan et al., 2013 
Lonicera 
japonica 
Japanese 
honeysuckle 
Flavonoid  Luteolin Yeast > 
 
Kim et al., 2000 
Anemarrhena 
asphodeloide
s Bunge   
 Saponin, xanthone,  Sarsasapogenin, 
mangiferin,  
neomangifrin. 
Not 
specified; 
Rice ( Ichiki 
et al., 2007) 
Not compared Ichiki et al., 2007 
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Genus/ 
species 
Common name Phenolic compounds Active component  Source of 
enzyme 
Activity 
relative to 
Acarbose TM 
References  
Salacia 
reticulata 
Wight  
Kotalahimbatu Xanthone,  
glycoside with a 
sulphate group, ester 
 
Mangiferin, salacinol, 
kotalanol, 
epigallocatechin 
Yeast > 
 
Yoshikawa et al., 
2002 
Salacia 
reticulata 
Saptarangi Xanthone 
glycoside with a 
sulphate group, ester 
Mangiferin, salacinol, 
kotalanol, 
epigallocatechin 
Yeast > 
 
Yoshikawa et al., 
2002 
Salacia 
reticulata 
Kotalahimbutu Glycoside with a 
sulphate group  
Salacinol Rat (In vivo) > Yoshikawa et al., 
1997 
Anetholea 
anisata 
Anise myrtle Polyphenolic rich 
fractions 
Ellagic acid, ellagic 
acid derivatives 
quercetin, hesperetin  
Rat intestinal 
acetone 
powder  
Not compared Sakulnarmrat et 
al., 2012 
Backhousia 
citriodora 
Lemon myrtle Polyphenolic rich 
fractions 
 Ellagic acid, ellagic 
acid derivatives 
quercetin, hesperetin 
Rat intestinal 
acetone 
powder 
Not compared Sakulnarmrat et 
al., 2012 
Tasmannia 
lanceolata 
Tasmannia 
pepper leaf 
Mountain pepper/ 
Tasmannia pepper 
leaf 
Polyphenolic rich 
fractions  
Chlorogenic acid, 
quercetin 3-rutinoside 
(rutin) 
Rat intestinal 
acetone 
powder 
Not compared Sakulnarmrat et 
al., 2012 
Kaempferia 
parviflora 
Black galingale  Flavones  5,7,3',4'- 
Tetramethoxyflavone 
(IC50 = 20.4 µM),  
5,7,4'-
Trimethoxyflavone 
(IC50 = 54.3 µM), 
3,5,7,3',4'-
pentamethoxyflavone 
(IC50 = 64.3 µM) 
Rat intestinal 
acetone 
powder 
Not compared Azuma et al., 
2011  
Gynura 
divaricata 
Vary across 
regions as well as 
languages. 
Ref:eol.org/pages/
6242973/ 
 Water extract and 
organic  solvent 
fractions 
Yeast α-
glucosidase 
< Wu et al., 2011 
> and < indicate more and less effective than Acarbose™ 
 
 
2.4 Oxidative stress – link to diabesity 
 
Oxidative stress reflects an imbalance between the systemic manifestation of 
reactive oxygen species (ROS) and the ability of a biological system to readily 
detoxify the reactive intermediates or to repair the resulting cellular damage 
(Sies, 1997). ROS are molecules or atoms possessing an unpaired electron 
Table 2 (continued) Plants, extracts and constituents with α-glucosidase inhibitory activity  
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which is free to react with other molecules thus causing cellular injury or cell 
death (Wong et al., 2006; Bisbal et al., 2010). ROS, produced during normal 
aerobic respiration, glucose and lipid metabolism, cellular stress and immune 
responses (Halliwell, 1991; Kim et al., 2008b), are an important part of the 
normal physiological functions of the body. Disturbance in the normal redox state 
of cells can cause toxic effects through the production of high levels of peroxides 
and free radicals (Maritim et al., 2003; Dudonne et al., 2009). An imbalance of 
the antioxidant defence system of the body and free radical formation may lead 
to the development of chronic diseases such as cancers, cardiovascular 
diseases, diabetes, neurodegenerative diseases, rheumatoid arthritis and 
increased oxidative stress (Wong et al., 2006; Kajaria et al ., 2012). Maritim et 
al. (2003) noted that free radicals are formed disproportionately in diabetes by 
glucose oxidation, non-enzymatic glycation of proteins, and the subsequent 
oxidative degradation of glycated proteins. Moreover, it has been recognized that 
there is direct association between obesity and increased oxidative stress 
(Keaney et al., 2003; Higdon and Frei, 2003). Therefore, antioxidants are also 
important in treatment of diabesity.  
 
Halliwell and Gutteridge (1989) stated that an antioxidant is any substance that 
when present at low concentrations, compared with that of an oxidizable 
substrate, significantly delays or inhibits oxidation of that substrate. This 
definition includes compounds of a non-enzymatic as well as an enzymatic 
nature (Sies, 1997). Numerous medicinal plants have been exploited for their 
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antioxidant activity and polyphenols (flavonoids) have been identified as major 
constituents of plant extracts (Liu, 2004). This class of phytochemicals is well-
known for their free radical scavenging properties (Xiao et al., 2013a, b).   
 
2.4.1 Structure-activity relationship of antioxidants 
 
Polyphenols are the most abundant antioxidants in human diet and are the most 
common and widespread constituents in the plant kingdom 
(Xiao et al., 2013 a, b). Flavonoids are the most potent antioxidants of the 
polyphenol sub groups (Nijveldt et al., 2001).This group of compounds is 
characterised by aromatic rings in their chemical structure, consisting of one or 
more hydroxyl groups attached to the aromatic rings (Liu, 2004). The C2=C3 
bond on the C-ring, a dihydroxylgroup (catechol-type) or three adjacent hydroxyl 
group (pyrogallol-type) on the B-ring, and the presence of C-5, and C-7 hydroxyl 
groups on the A-ring are listed as the main requirements for antioxidant and 
antiradical activity of flavonoids (Nijveldt et al., 2001; Woodman et al., 2005; 
Xiao et al., 2013a, b). The presence of a catechol group on the B-ring is reported 
to be a major determinant for high radical scavenging activity of many 
compounds and an additional OH at C-5 results in even higher activity (Cos et 
al., 1998; Woodman et al., 2005). These structural features (Figure 3) enable 
easy electron donation, thus breaking the free radical chain reactions (Fraga et 
al., 2010), rendering more stable and less-reactive radicals and therefore prevent 
cellular injury caused by free radicals (Figure 5)  (Nijveldt et al., 2001). 
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The flavonol quercetin, amongst others, is an example of a good antioxidant, 
owing its potency to fulfilling the general structural requirements for a potential 
antioxidant (Figure 7) (Woodman et al., 2005).  
 
 
 
 
Therefore polyphenol-rich plant extracts or regular consumption of a polyphenol 
rich diet could contribute a major improvement to human health (Liu, 2004). In 
addition to their lower cost, fewer side effects and effectiveness, interests in 
using natural products as starting materials for drug discovery has benefitted 
many therapeutic areas (Hashim et al., 2012).  Phytochemicals have been 
proven to contribute a variety of health promoting effects to human diet, such as 
antioxidant, anti-inflammatory, anti-cancer, anti-diabetic, anti-viral, anti-bacterial 
properties (Liu, 2004; Mckay and Blumberg, 2007). In addition to that, Liu 
(2004) further noted that the additive and synergistic effects of phytochemicals in 
Figure 7.  Chemical structures of quercetin and its glycosides [Xiao et al., 2013a]. 
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fruits and vegetables are responsible for their antioxidant potency. Moreover, 
honeybush extracts and individual compounds that were identified as major 
constituents in C. maculata, have been reported as good antioxidants (Sato et 
al., 1992; Joubert et al., 2008b). This aspect will be discussed under section 2.5 
as the current study will also focus on the health modulating properties of a 
honeybush species (C. maculata), with regards to its antioxidant activity.    
 
2.5 Cyclopia species (honeybush tea) 
 
Cyclopia (Fabaceae) is a genus consisting of more than 20 species of woody 
legumes endemic to the fynbos region of South Africa 
(De Nysschen et al., 1996), growing in the coastal districts of the Western and 
Eastern Cape provinces (Du Toit et al., 1998; Joubert et al., 2011). The species 
are characterised by their woody stems and hard-shelled seeds. The different 
species have different leaf shapes and sizes (Figure 8), but all have trifoliate 
leaves and indented calyx single-flowered inflorescences and sweet scented 
bright yellow flowers (Bond and Goldblatt, 1984; Schutte et al., 1995).  
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The most commonly used and currently also the major commercialised species 
are C. intermedia, C. subternata and C. genistoides (Joubert et al., 2011). 
Concerted efforts to cultivate and establish a honeybush industry started during 
the mid-1990s so that production is still small. Most of the annual production is 
exported to countries in Europe. Other countries importing large quantities are 
United States of America and Japan (Joubert et al., 2011). Currently demand 
exceeds production (Erasmus, 2012).Growing demand for this herbal tea, to 
some extent as a result of its healthy image, has raised commercial interest for 
other species (Joubert et al., 2011). One of these is C. maculata, a lesser 
known species of which the commercial potential has not yet been developed. 
Figure 8.  Cyclopia species (A) C. genistoides, (B) C. subternata, (C) C. intermedia, (D) C. 
maculata. Species A, B and C are commercially available and species D is still 
under development (photos supplied by E. Joubert, ARC Infruitec-Nietvoorbij, 
Stellenbosch).  
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Cyclopia maculatagrows naturally in the Overberg, amongst others in the 
Genadendal area, where it is locally consumed as herbal infusion. 
 
Traditionally the leaves of several Cyclopia species were used to brew 
honeybush tea (De Nysschen et al., 1996). Anecdotal evidence suggested that 
regular consumption of the tea could have health benefiting effects (Du Toit and 
Joubert, 1998; Joubert et al., 2008). Joubert et al. (2011) noted that the first 
mention of the use of a Cyclopia species as a herbal tea was by Green (1881), 
who referred to “Cape tea”. The leafy shoots and flowers of Cyclopia species 
were fermented and dried to prepare a tea that was traditionally used as a 
restorative and an expectorant in chronic catarrh, pulmonary tuberculosis, as well 
as a health drink for digestive and stomach ailments (Joubert et al., 2011). With 
a history of medicinal use evident, interest in their phenolic composition led to 
investigations, starting with fermented C. intermedia and unfermented C. 
subternata, due to their commercial prominence at the time (Ferreira et al., 
1998; Kamara et al., 2003, 2004). 
 
2.5.1 Chemical composition of Cyclopia species 
 
In-depth studies on the phenolic composition of Cyclopia species have been 
carried out on C. intermedia, C. subternata and C. genistoides (Ferreira et al., 
1998; Kamara et al., 2003 and 2004; De Beer et al., 2012; Kokotkiewicz et al., 
2012and 2013), revealing qualitative differences. Several classes of compounds 
have been identified, i.e. flavanones, flavonols, flavones, isoflavones, 
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coumestans, benzophenones, dihydrochalcones and xanthones. A number of 
common compounds are listed in Table 3.  
 
Table 3 Chemical compounds previously detected in Cyclopia species 
 C. genistoides C. subternata C. intermedia C. maculata References 
Mangiferin √ √ √ √ 
Ferreira et al. (1998), Kamara et al. (2004, 
Joubert et al.  (2003; 2008), Kokotkiewiczet al. 
(2013) 
Isomangiferin √ √ Nd √ Ferreira et al. (1998), Joubert et al. (2008b), De 
Beer et al. (2009), Kokotkiewiczet al. (2013) 
Eriocitrin √ √ Nd √ Joubert. et al (2008b) 
Luteolin √ √ Nd √ Joubert et al. (2003; 2008b) 
Naringenin Nd Nd √ Nd Ferreira et al. (1998) 
Eriodictyol Nd Nd √ √ Ferreira et al. (1998) 
Narirutin √ √ √ Nd Ferreira et al. (1998), Joubert et al.  (2008) 
Hesperidin √ √ √ √ Ferreira et al. (1998), Joubert et al.  (2008), 
Kokotkiewiczet al. (2013) 
Hesperetin √ √ √ Nd Ferreira et al. (1998), Joubert et al. (2008) 
 
 
Quantitative analysis performed on Cyclopia species (C. intermedia, C. 
genistoides, C. subternata and C. sessiliflora) identified the xanthones, 
mangiferin and isomangiferin, and the flavanone, hesperidin as the major 
polyphenols present in honeybush (Joubert et al., 2003; Joubert et al., 2008b; 
De Beer and Joubert, 2010). Even though little information on the composition 
of Cyclopia maculata is available, the plant material (on dry mass basis) has 
been reported to contain 1.63 %, 0.32 % and 0.72 % of mangiferin, isomangiferin 
and hesperidin, respectively (Joubert et al., 2003). 
√: detected, Nd: not detected 
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Quantitative analysis of hot water extracts of several Cyclopia species showed 
large variation in the content of the active compounds between and within 
species (Joubert et al., 2008b; De Beer and Joubert, 2010).  Table 4 
summarises data of individual constituents and total polyphenol content as 
determined by Joubert et al. (2008b). Given the qualitative and quantitative 
differences in phenolic composition, differences in biological activities between 
Cyclopia species can be expected.  
 
Table 4 Variation in phenolic content of Cyclopia species  
 
Compounds Cyclopia 
intermedia 
Cyclopia 
subternata 
Cyclopia 
genistoides 
Cyclopia 
sessiliflora 
Mangiferin 0.23±0.05 0.08±0.02 4.29±1.20 0.19±0.04 
Isomangiferin nd nd 0.94±0.15 nd 
Eriocitrin nd 0.26±0.07 nd 0.13±0.04 
Narirutin 0.02±0.00 0.04±0.01 0.20±0.06 nd 
Hesperidin 0.45±0.08 0.27±0.08 0.47±0.01 0.45±0.03 
Hesperetin 0.06±0.03 nd nd nd 
Luteolin nd 0.01 0.01 nd 
Total polyphenols 16.26±1.39 17.49±1.54 22.01±0.92 17.10±1.44 
 
 
 
2.5.2 Potential of Cyclopia species as anti-diabesity agent  
 
Generally, many of the compounds present in the leaves of Cyclopia species are 
known to have various health promoting properties. Several of the compounds 
Joubert et al. (2008b); values as percentage of dried extract; nd: not detected. Total polyphenol content 
expressed as gram gallic acid equivalents/100g dried extract as determined with the Folin-Ciocalteu reagent. 
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contain one or more of the structural features (discussed in sections 2.2, 2.3 and 
2.4) required for inhibition of the enzymes, pancreatic lipase and α-glucosidase, 
and antioxidant activity, indicating the potential of honeybush as anti-diabesity 
nutraceutical.  
 
The xanthones are of interest as they are the major class of compounds detected 
in Cyclopia species (De Beer et al., 2010). Xanthones comprise an important 
class of oxygenated heterocycles whose role is well-known in medicinal 
chemistry. The biological activities of this class of compounds are associated 
with their tricyclic scaffold but vary depending on the nature and/or position of the 
different substituents (Pinto et al., 2005). The chemical structure of xanthones is 
based on a C6-C3-C6 skeleton, where two phenyl rings are connected via a unit 
composed of three carbons (Figures 9) and two or more hydroxyl groups 
attached to each phenyl ring (Liu et al., 2006). Even though little is known about 
the mechanism of action of xanthones for α-glucosidase inhibition, it has been 
demonstrated that three or more phenolic hydroxyl groups are fundamental for 
significant inhibitory effects. The position of the hydroxyl groups are also 
important, with the hydroxyl group at C-7 more active than that at C-6, which was 
more active than that at C-8 (Liu et al., 2006).The inhibitory activity is 
significantly enhanced by the conjugated π-system (Liu et al., 2007). For 
example, Liu et al. (2007) showed that a compound having one more conjugated 
aromatic ring was at least 17-fold more effective than the compound having a 
smaller d π-system. 
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Mangiferin is known to be associated with a vast diversity of pharmacological 
properties, including antioxidant, anti-allergic anti-tumour, immunomodulatory, 
anti-inflammatory, anti-diabetic, lipolytic, antibone resorption, monoamine 
oxidase-inhibiting and anti-parasitic properties (Bhattacharya et al., 1997; 
Liu et al., 2007; Wauthoz et al., 2007; Vyas et al., 2012). Moreover, mangiferin 
is known to be a potent free radical scavenger (Sato et al., 1992; 
Joubert et al., 2008b). Inhibitory effects against pancreatic lipase and               
α-glucosidase have been reported for mangiferin (Yoshikawa et al., 2002; 
Liu et al., 2006), supporting its potential as treatment for diabetes mellitus 
(Ichiki et al., 1998) and for lowering body weight (Yoshimi et al., 2001). 
Moreover, a decrease in blood glucose and decreased insulin resistance were 
exhibited after oral administration of mangiferin in an in vivo mouse T2D model, 
providing further evidence of its anti-diabetic effect (Muira et al., 2001). 
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Figure 9. Structures of mangiferin (major honeybush xanthone) and isomangiferin (minor 
honeybush xanthone) 
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Hesperidin, another major constituent of honeybush, has been recognised for its 
antioxidant properties. This flavanone has been found to reduce superoxide in 
electron transfer plus concerted proton transfer reaction in vitro 
(Jovanovic et al., 1994). Wilmsen et al. (2005) evaluated this activity in both 
chemical (using DPPH) and biological (using methylviologen; 1,1'-dimethyl-4-4'-
bipyridinium dichloride) systems and the antioxidant activity of hesperidin was 
shown to be similar to that of Trolox. This activity was also exhibited in an in vivo 
study by Fraga et al. (1987) in liver homogenates for hydroperoxide-induced 
chemiluminescence. 
 
 Furthermore, porcine pancreatic lipase inhibitory effects (IC50=32 µg/mL) have 
been reported for hesperidin (Kawaguchi et al., 1997), suggesting that the 
compound possesses anti-obesity properties. Moreover, a study by Zhang et 
al. (2012) revealed that a hesperidin derivative exhibited anti-hyperglycemic 
activity through inhibition of the enzyme α-glucosidase (55.02 % inhibition at     
10 mM hesperidin). Hesperidin and naringinin have been reported to attenuate 
hyperglycemia-mediated oxidative stress and pro-inflammatory cytokine 
production in high fat fed/streptozotocin-induced type 2 diabetic rats (Mahmoud 
et al., 2012).  
 
Eriocitrin (another flavanone present in substantial amounts in some Cyclopia 
species) has been shown to suppress oxidative stress (Minato et al., 2003) and 
compounds such as luteolin, eriodictyol, hesperetin and naringinin have shown 
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antioxidant and antiradical potential in various in vitro and in vivo studies (Sato et 
al., 1992; Joyeux et al., 1995; Haraguchi et al., 1996). These findings suggest 
that the presence of these flavonoids in Cyclopia extracts could contribute 
therapeutic effects in management of diabesity by this herbal tea as the link 
between oxidative stress, inflammation and diabesity has been noted (Furukawa 
et al., 2004; Maritim et al., 2003; Fernandez-Sanchez et al., 2011).  
 
The success of herbal teas such as honeybush relies on the fermented form   
(Du Toit et al., 1998; Joubert et al., 2011). The plant material, comprising 
leaves and stems, and sometimes flowers as well, were traditionally fermented (a 
key step in the production of tea, whereby the plant material undergoes high 
temperature oxidation) for colour, flavour and taste development. However, a 
study conducted by Joubert et al. (2008b) found that the extracts of fermented 
Cyclopia species contained lower quantities of total polyphenols and had 
significantly lower anti-oxidant capacities than extracts of unfermented plant 
material. Their study also showed a significant decrease in the content of the 
individual phenolic compounds, thus rendering the extracts less potent in the 
fermented state with regards to antioxidant activity. Like many medicinal plants, 
the therapeutic effects of Cyclopia are attributed to the presence of polyphenols, 
which are known to be susceptible to oxidation and degradation at high 
temperatures. Hence the current study will also investigate the effect of 
fermentation on the anti-diabesity potential of C. maculata. 
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2.6 Principles of laboratory assays employed in investigation of            
anti-diabesity and antioxidant potential of plant products   
 
2.6.1 Anti-diabesity assays  
 
2.6.1.1 Pancreatic lipase inhibition assay  
 
Lipases, are secreted by the pancreas in the presence of fat, hydrolyses dietary 
triglycerides into monoglycerides and fatty acids. Lipase inhibitors covalently bind 
to the active site of lipase (serine), preventing the enzyme from binding to the 
said substrate (triglycerides) (Margesin et al., 2002). Chromogenic substrates of 
the p-nitrophenyl ester type such as p-nitrophenyl palmitate (pNPP) 
(Kanwar et al., 2005), p-nitrophenyl butyrate (pNPB) (Kim et al., 2012),             
p-nitrophenyl acetate (pNPA), p-nitrophenyl caprylate (pNPC), p-nitrophenyl 
laurate (pNPL) and p-nitrophenyl propionate (pNPRP) are widely used for 
determination of lipase activity (Margesin et al., 2002).  Other probes such as 
the micellar solutions of triolein and 4-methylumbelliferyl oleate (4-MUO), 
fluorescent probes are also used for determination of lipase activity 
(Margesin et al., 2002).  Due to their ease of use, pNPB and 4-MUO are 
commonly used substrates (Kato et al., 2012). Moreover, the assay methods 
that employ these two substrates (pNPB and 4-MUO) have been reported to 
show three to four order or even higher activity compared to the assays that use 
the micellar solution of triolein as a substrate (Ikeda et al., 2005; Kusano et al., 
2008).The principle of the assay is based on the hydrolysis of the substrate such 
as pNPB to release  p-nitrophenol as an end product which is detected through 
 
 
 
 
 48 
subsequent measurement of absorbance at 405 nm (Figure 10) (Kanwar et al., 
2005; Slanc et al., 2009; Kim et al., 2010a). One unit of the enzyme is defined 
as micromole(s) of p-nitrophenol released by hydrolysis of the substrate by one 
milliliters of enzyme under assay conditions (Kanwar et al., 2005). In any assay 
that involves the use of a chromogenic substrate blocking of 
residual/unquenched enzymatic activity is essential to avoid the false increase in 
colour intensity and for maintaining reproducibility of the results. Appropriate 
methods to block lipase activity are lacking (Kanwar et al., 2005). However, a 
number of studies have reported the use of either, sodium carbonate (Rapp and 
Backaus, 1992; Dosanjh and Kaur, 2002), acetone, ethanol oracetone: 
methanol mixture for the above-mentioned purpose (Kanwar et al., 2005). 
 
Colorimetric methods are easy and the quickest assays that can be employed to 
determine lipase inhibition activity of plant extracts (Margesin et al., 2002), 
however, a disadvantage associated with this type of assay is the colour 
interference by plant extracts. Fluorimetric methods that involve the use of 
butyrylesters of 7-hydroxy-4-methylcoumarin or 4-methylumbelliferyl butyrate 
(MUB) as substrates (Andlauer et al., 2009) are alternative methods for 
determination of lipase inhibitory activity of plant extracts to account for any 
colour interference. The enzyme converts the substrate to a reaction product 
(Figure 10) that fluoresces when excited by light of a particular wavelength 
(excitation 365 nm and emission 460 nm). However, as the same as the 
colorimetric substrates, these types of substrates are also insoluble in water, thus 
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requiring the use of a minimum portion of organic solvent such as dimethyl 
sulphoxide (DMSO) in water to dissolve, which in turn could affect the activity of 
the enzyme. Despite the above mentioned limitation, the fluorescent method is 
reported to be more sensitive and specific than the colorimetric methods 
(Cooper and Morgan, 1981; Margesin et al., 2002).  
 
2.6.1.2 α-Glucosidase inhibition assay 
 
The α-glucosidase inhibition assay is carried out using enzymes from different 
sources such as yeast α-glucosidase (Liu et al., 2007) or rat intestinal acetone 
powder (Boath et al., 2012), and in some cases microbial α-glucosidases from 
other sources than yeast are used (Kim et al., 2008a). Due to its accessibility 
and low cost, yeast α-glucosidase is the most widely used enzyme (Liu et al., 
2007). However, it has been reported that most yeast α-glucosidase inhibitors did 
not show inhibitory activity against mammalian α-glucosidase due to the 
difference in molecular recognition of the binding site of the enzymes (Gao and 
Kawabata, 2004; Jo et al., 2011).p-Nitrophenyl α-D-glucopyranoside (pNPG) is 
the most widely used substrate for colorimetric detection (Figure 10) at 405 nm 
(Liu et al., 2007; Boath et al., 2012). To block the residual/unquenched 
enzymatic activity sodium carbonate can be used (Kim et al., 2010b). For the 
same reason(s) stated in 2.6.1.1, fluorimetric methods are preferred for 
determination of α-glucosidase inhibitory effects of plant extracts. In this case 
(Figure 10), 4-methylumbelliferyl α-D-glucopyranoside (4-MUG) is a suitable 
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substrate for this type of assay (Azuma et al., 2011) and the principle of the 
method is similar to the one discussed in 2.6.1.1.  
 
 
Figure 10. Enzyme reacts with substrate to release probe. The probe could be chromogenic 
or fluorescent, depending on the assay (supplied by CJ Malherbe, ARC Infruitec-
Nietvoorbij, Stellenbosch). 
 
 
2.6.2 Folin–Ciocalteau Reagent (FCR) method for total polyphenol 
determination   
 
The literature describes a number of methods for determination of total 
phenolics, including the Prussian Blue assay by Price and Butler (1977) and the 
Folin-Denis method by Folin and Denis (1912), which was later modified in 1927 
by Folin and Ciocalteu (Schofield et al., 2001). Subsequently, these methods 
have been modified numerous times and the version of the Folin-Ciocalteu 
method adapted by Singleton and Rossi (1965) is the most commonly used 
method for determination of the total polyphenol content of plant extracts. The 
Folin-Ciocalteu assay is based on the oxidation of phenolic compounds in 
Substrate+ Probe Substrate       Probe  
Enzyme  
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alkaline medium by molybdenum and tungsten to form a blue-coloured complex. 
The intensity of the complex is measured spectrophotometrically at 765 nm 
(Arthur et al., 2011; Bajcan et al., 2013), and the total polyphenol content of 
analysed samples is calculated as the amount of gallic acid equivalents (Bajcan 
et al., 2013).  
 
This method offers several advantages. Firstly, the FCR can be purchased 
readily mixed. Secondly, the assay is quick and easy as the visual colour 
changes from intense yellow to blue in the presence of phenols in the reaction 
mixture. Thirdly, even though the initial methods were described using test tubes 
or cuvettes (Singleton and Rossi, 1965), the method has been adapted for use 
in 96-well micro-plates (Zhang et al., 2006). Therefore, many samples could be 
tested simultaneously. Lastly, the total polyphenol content of the tested plant 
extracts could be expressed in terms of gallic acid equivalence. The historical 
use of gallic acid is owed to its affordability, water solubility, easy crystallization 
from water and stability in dry from (Singleton et al., 1999).  
 
2.6.3 Antioxidant assays  
 
Antioxidants act by several mechanisms and no one assay can capture the 
different modes of action of an antioxidant (Niki and Noguchi, 2000; Badarinath 
et al., 2010).The use of multiple assays could help compare antioxidants from 
different food products since different assays act on different principles (Prior et 
al., 2005). Moreover, various antioxidants with different reactivity and selectivity 
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towards substrates are involved in oxidative stress in vivo (Niki and Noguchi, 
2000). The current study will employ four of the antioxidant methods (ferric 
reducing/antioxidant power (FRAP), 2,2-azino-bis(3-ethylbenz-thiazoline-6-
sulfonic acid) (ABTS●+), 2,2-diphenyl-1-picrylhydrazyl (DPPH●) and the oxygen 
radical absorbance capacity (ORAC) assay) to determine the antioxidant 
potential of C. maculata. The following section describes the principles, strengths 
and limitations of the individual methods that are commonly used to determine 
the antioxidant activity of plants extracts and constituents.  
 
2.6.3.1 DPPH radical scavenging method  
 
The DPPH● scavenging assay was first described by Blois in 1958 and was later 
modified slightly by numerous researchers (Brand-Williams et al., 1995; Li et 
al., 2007; Chan et al., 2007; Tirzitis and Bartosz, 2010; Krishnaiah et al., 
2010). It is one of the most extensively used antioxidant assays for plant 
samples. DPPH● is a stable free radical that reacts with compounds that can 
donate a hydrogen atom (Tirzitis and Bartosz, 2010). This method is based on 
the measurement of the reducing ability of antioxidants towards DPPH● 
(Prior et al., 2005).  This ability can be evaluated by electron spin resonance or 
by colour change from purple to yellow if/when an extract/antioxidant is able to 
reduce DPPH● (Brand-Williams et al., 1995; Li et al., 2007; Tirzitis and 
Bartosz, 2010) leading to a decrease in absorbance which is measured 
spectrophotometrically at 515 nm (Bondet et al., 1997; Krishnaiah et al., 2010). 
The assay is known to be sensitive enough to detect active ingredients at low 
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concentration (Hsu et al., 2005). The visual colour change also serves as an 
advantage in that one can easily see when the reaction has occurred. This stable 
free radical is commercially available and therefore it does not have to be 
generated before the assay like other radicals such as ABTS●+ (Prior et al., 
2005; Tirzitis and Bartosz, 2010). In spite of the wide use of this method, 
complications, which may cause incorrect results, have been reported. The 
DPPH● scavenging assay is pH-dependant. Therefore, partial ionization of the 
tested compounds can affect the rate of their reaction with the free radical 
(Musialik and Litwinienko, 2005). In addition to that this method requires the 
use of organic solvents as DPPH● is insoluble in water. Moreover, DPPH● is an 
organic nitrogenous radical, which bears no similarity to the highly reactive and 
transient peroxyl radicals involved in lipid peroxidation (Huang et al., 2005).  
 
2.6.3.2 ABTS radical cation scavenging method  
 
This method was first developed by Rice-Evans and Miller (1994) and was then 
modified by Re et al. (1999). Originally, ABTS●+ was generated by the activation 
of metmyoglobin with hydrogen peroxide. The method was improved by reacting 
ABTS with potassium persulfate to generate ABTS●+ (Re et al., 1999). The 
blue/green pre-formed ABTS●+ is reduced in the presence of hydrogen donating 
antioxidants. ABTS●+ is reported to have absorption maxima at wavelengths   
645 nm, 734 nm and 918 nm, however, the decrease in this radical absorbance 
is commonly measured spectrophotometrically at 415 nm (Re et al., 1999; 
Krishnaiah et al., 2010). At this wavelength coloured plant extracts can interfere 
 
 
 
 
 54 
with measurement. Thermodynamically a compound requires a redox potential 
lower than that of ABTS●+ in order to reduce it, and many phenolic compounds 
meet this requirement and can thus react with ABTS●+ (Van den Berg et al., 
1999). The effect of antioxidant concentration and duration of the inhibition of the 
radical absorption of the cation are taken into account when the antioxidant 
activity is determined. ABTS●+ is soluble in both aqueous and organic solvents, 
and it is not affected by ionic strength, therefore, this decolourisation assay can 
be used to measures total antioxidant capacity of both lipophilic and hydrophilic 
substances (Re et al., 1999; Pellegrini et al., 1999). Moreover, ABTS●+ can also 
be used to determine the effects of pH on antioxidant mechanisms, as it is can 
be used over a wide pH range. Cano et al. (1998) demonstrated that ABTS●+ 
was stable from pH 3.0 to pH 6.5 but optimal at pH 4.5. However, even though 
frequently used, the radical is noted to be unstable at pH values of above 7.5 
(Cano et al., 1998). In addition to that, like DPPH●, ABTS●+ is not found in 
mammalian biology and thus represents a non-physiological radical source 
(Prior et al., 2005; Tirzitis and Bartosz, 2010).  
 
2.6.3.3 Ferric Reducing Antioxidant Power (FRAP) 
 
The original FRAP method was developed to measure reducing power in plasma 
(Benzi and Strain, 1996), but the assay has been adapted to determine 
antioxidants in plant extracts (Benzi and Szeto, 1999). The principle of this 
assay is based on the reduction of a ferric-tripyridyl triazine (Fe3+-TPTZ) complex 
to its ferrous coloured form in the presence of antioxidants (Benzie and Strain, 
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1996). The Fe3+-TPTZ complex is reduced to an intense blue ferrous under acidic 
conditions. FRAP values are obtained by comparing the absorbance change at 
593 nm in test reaction mixtures with those containing ferrous ions in known 
concentrations. The activity can also be expressed in either ascorbic acid 
equivalence (Aparadh et al., 2012) or Trolox equivalence (Benzie and Strain, 
1996; Arthur et al. 2011). Moreover, the reaction is reported to be non-specific, 
therefore, any half-reaction which has a less-positive redox potential under the 
same reaction conditions than Fe3+ /Fe2+-TPTZ will influence the reduction of the 
complex (Benzie and Strain, 1996). The FRAP assay is simple, speedy, 
inexpensive and reagents are simple to prepare, giving highly reproducible 
results with no specialized equipment required. Moreover, in contrast to other 
tests for antioxidant power, the FRAP assay is reported to be robust and does 
not require specialised equipment, thus can be performed using automated, 
semi-automatic or manual methods (Benzie and Strain, 1996; Prior et 
al., 2005). Pulido et al. (2000) showed that reaction time is important and the 
use of 4 and 30 min reaction times could be applied to differentiate between 
active and less active antioxidants. As for other antioxidant methods, the 
antioxidant efficiency of polyphenols seems to depend on the extent of 
hydroxylation and conjugation (Pulido et al., 2000).   
 
2.6.3.4 Oxygen Reduced Absorbance Capacity (ORAC) 
 
The original work on the development of the ORAC assay was by Glazer (1990), 
and the method was further developed by numerous researchers (Cao et al., 
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1993; Ghiselli et al., 1995; Huang et al., 2002) and others. ORAC is a 
“biological” assay based on the inhibition of peroxyl-radical-induced oxidation that 
is initiated by decomposition of azo-compounds at high temperatures (Ou et al., 
2001; Ganske and Dell, 2006). It presents a hydrogen atom transfer reaction 
mechanism, which is most relevant to human biology (Prior et al., 2005). The 
antioxidant scavenges the peroxy radical thus delaying decay in fluorescence 
(Figure 11) (Prior et al., 2005). ORAC values are usually reported as Trolox 
equivalents (Prior et al., 2005). The earlier version(s) of the method which 
involve the use of B-phycoerythrin (a protein isolated from Porphyridium 
cruentum) (Prior et al., 2005) as a probe are reported to be associated with a 
number of drawbacks. They are noted to be time-consuming and labour-intensive 
(Cao et al., 1993). The improved assay that employs fluorescein as a probe was 
demonstrated to be robust and compatible with lipid soluble antioxidants (Huang 
et al., 2002). 
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Figure 11.  Diagram illustrating the delay in fluorescence decay over  
time due to antioxidant activity tested by the ORAC method [Prioret 
al., 2005]. 
 
 
 
 
2.6.4 On-line HPLC (bio)chemical detection assays  
 
In the search for bioactive compounds from plant products, several attempts 
have been made to accelerate the isolation, identification and bioactivity 
evaluation process. Coupling of an HPLC system with on-line post-column 
detection (Figure 12) of radical scavenging compounds or other bioactive 
compounds such as enzyme inhibitors (Figure 13) has emerged as an 
appropriate approach to achieve this objective (Malherbe et al., 2012). These 
(bio)chemical detection (BCD) assays can be defined as the detection of 
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bioactives based on (bio)chemical reactions or simulated (bio)chemical reactions 
(Malherbe et al., 2012). Moreover, the system provides both the 
chromatographic profile and corresponding fingerprint of bioactive compound(s) 
that may not have been previously identified (unknown compounds) in a 
particular extract (Kusznierewicz et al., 2011). 
 
 
Figure 12. HPLC system coupled with chemical detection (free radical scavenging)  
(supplied by CJ Malherbe, ARC Infruitec-Nietvoorbij, Stellenbosch). 
 
 
Figure 13. HPLC system coupled with (bio)chemical detection (enzyme inhibition). HPLC effluant combined with make-up 
buffer, usimg dual syringe pump for enzyme and substrate addition (supplied by CJ Malherbe, ARC 
Infruitec-Nietvoorbij, Stellenbosch). 
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Several HPLC-on-line BCD methods (based on various assay models) have 
been studied and developed (Malherbe et al., 2012; Glod et al., 2014). Amongst 
these are the antioxidant assays, i.e. luminol-chemiluminescence inhibition, 
DPPH● and ABTS●+ reduction (Dapkevicius et al., 1999; Koleva et al., 2001; 
Nuengchamnon get al., 2005). HPLC on-line DPPH● and ABTS●+ assays have 
been selected for the current study due to their high popularity and other 
advantages, such as relatively simple set-up and ease of control (Koleva et al., 
2001; Niederlander et al., 2008), and therefore, will be discussed in section 
2.6.4.1.  
 
HPLC on-line post-column detection is not only applicable to radical scavenging, 
but also to enzyme inhibition (Malherbe et al., 2012). An on-line method for α-
glucosidase inhibition has been developed by adapting the microplate 
colorimetric assay to on-line format (Li et al., 2010). In many cases, the 
bioactives can be identified by comparison with standard compounds. By 
combining the HLPC on-line system with mass spectrometry (MS), the molecular 
weight of the separated compound(s) can be obtained to aid identification 
(Nuengchamnong and Ingkaninan, 2009). These methods aim at rapid 
pinpointing of bioactives in complex mixtures without the need for lengthy 
isolation procedures. It is therefore a useful de-replication tool when screening 
for new bioactive compounds in plant extracts.  
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2.6.4.1 On-line HPLC radical scavenging assays  
 
A basic instrumental configuration is required for all on-line HPLC-BCD methods. 
However, it can be optimised to suit a particular assay type (Malherbe et al., 
2012). Reduction of DPPH● and ABTS●+ by the antioxidant, either through 
hydrogen transfer or electron transfer, leads to a significant change in the UV-Vis 
absorption of the compound (Niederlander et al., 2008). These methods are 
usually used in a qualitative approach, thus they are suitable for screening of 
antioxidants (Arthur et al., 2011).  
 
For the HPLC on-line DPPH● method, the HPLC separated analytes react with 
DPPH● post-column and the reduction is detected as a negative peak by a      
UV-Visdetector at 515 nm (Figure 14). The method is suitable for both isocratic 
and gradient HPLC analyses with mobile phase compositions ranging from 10 to     
90 % organic solvent in water or buffer (pH 3 - 6). The method is simple, has a 
broad applicability, and uses common but optimized instruments, inexpensive 
and stable reagents, and a time-saving and non-laborious experimental protocol. 
It can also be used for quantitative analysis to identify compounds with highest or 
low antioxidant activity (Koleva et al., 2000; Niederlander et al., 2008; Arthur 
et al., 2011; De Beer et al., 2011). Arthur et al. (2011) used a quantitative 
approach to determine the antioxidant activity of four phenylethanoid glycosides 
of similar structure, differing in the position of the caffeoyl group and type of 
sugar.  
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Figure 14. HPLC-DAD-BCD chromatogram of an Athrixia phylicoides extract showing the     
UV-vis chromatogram at the top and the radical scavenging chromatogram as 
negative peaks at the bottom [De Beer et al., 2011]. 
 
For the HPLC on-line ABTS●+ method the HPLC-separated analytes react post-
column with the preformed ABTS●+, and the induced bleaching is also detected 
as a negative peak, either at 414, 600 or 734 nm(Koleva et al., 2001; 
Niederlander et al., 2008; Lee et al., 2012). The HPLC-ABTS●+method is also 
reported to be suitable for both isocratic and gradient HPLC runs using mobile 
phases containing 100 % organic solvent or its solution in water, weak acids, or 
buffers (pH 3-7.4) (Koleva et al., 2001). Moreover, the poor stability of the 
radical at higher pH can be avoided due to the short reaction time of the assay. 
The method can be used to identify compounds with the highest antioxidant 
potency in a complex mixture (De Beer et al., 2011).  
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The HPLC-ABTS●+ assay is more sensitive than the HPLC-DPPH● assay as the 
ABTS●+ is more water-soluble than DPPH●. As a result it is the most widely used 
for the evaluation of water-soluble antioxidants (Niederlander et al., 2008). 
Moreover, this method is described as a complimentary extension of the     
HPLC-DPPH● on-line assay (Koleva et al., 2001). De Beer et al. (2011) 
demonstrated that the negative peak areas obtained with the two methods are 
not the same, indicating difference in reactivity of the compounds towards the 
two radicals. 
 
Like any other scientific method, HPLC-ABTS●+ assay has its strengths and 
limitations. Even though it provides a fast screening tool, it provides only       
time-dependent stoichiometry of reaction (moles ABTS●+quenched per OH group 
over a given time), and therefore it does not measure reaction rate, as it misses 
the critical initial fast reaction and eliminates distinction between fast and slower 
reacting antioxidants (Tian et al., 2013). In addition to that, for both HPLC on-line 
assays, the reaction temperature and mobile phase pH caused dramatic changes 
to the activity of antioxidants. Koleva et al. (2000) demonstrated that a highly 
acidic system (pH 2.2) caused a drastic reduction in DPPH● absorbance. 
Different peak areas were observed by Kusznierewicz et al. (2011) when 
investigating phenolic compounds, which were analysed at different reaction 
temperatures 30 °C-130 °C (post-column derivatisation carried out with ABTS●+ 
and DPPH●).  
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2.6.4.2  Enzyme inhibition HPLC on-line assays  
 
There are no on-line methods that have been published to date for lipase 
inhibition. However, a HPLC-BCD method, adapted from the micro-plate assay, 
is available for α-glucosidase inhibition, using of yeast α-glucosidase and the 
probe, p-nitrophenyl-α-D-glucopyranoside (PNPG) (Li et al., 2010). The assay 
was developed for screening of α-glucosidase inhibitors in plant extracts. HPLC 
separation of complex mixtures usually requires a gradient of organic solvents 
such as methanol or acetonitrile, but high concentrations of organic solvents 
could lower enzyme activity or could cause a complete inactivation of the 
enzyme. Therefore, 30 % methanol is reported to be the optimal concentration 
for the assay conditions. Moreover, volatile acid can be added to the mobile 
phase to improve separation (Li et al., 2010). Acarbose™ has been reported to 
show a definite negative peak with (bio)chemical detection (at 1 mg/mL). It is 
however not visible on the UV-vis chromatogram. Plant extracts that were 
evaluated for α-glucosidase inhibitory effects using the method of Li et al. (2010) 
showed negative peaks for some compounds. Recently Li et al. (2014) 
demonstrated inhibitory activity for tannins such as ellagic acid.  Furthermore, the 
same method mentioned was adapted by Muller et al. (2012). Their modification 
of the assay included replacing 2 % acetic acid with 1 % formic acid to account 
for enzyme sensitivity to high acids. Since Acarbose™ was shown not to be 
detectable by HPLC-DAD (not UV-visible), catechin, a flavanol, was used as a 
positive control and to align chromatograms taking into account the delay in  
post-column reaction (Muller et al., 2012). The method was applied to a rooibos 
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extract and negative peaks were obtained (Figure 15), indicating α-glucosidase 
inhibitory effects for some compounds. The optimal pH for this assay is reported 
as pH 6.8 (Li et al., 2010b; Muller et al., 2012).  Peaks observed for enzyme 
inhibition are not sharp as for free radical scavenging due to the longer reaction 
times causing peak broadening (Figures 14 and 15). Poor separation of 
compounds could therefore lead to incorrect identification of an active compound.  
 
 
 
Figure 15. HPLC-DAD-BCD chromatogram of α-glucosidase inhibition by rooibos extract 
showing the UV-Vis chromatogram at the top and chromatogram depicting enzyme 
inhibition as negative peaks at the bottom [Muller et al., 2011]. 
 
In conclusion, due to multiple reaction characteristic and mechanisms, as well as 
different phase localizations that are involved in an oxidant-antioxidant reaction, 
no single assay can accurately reflect all radical sources or all antioxidants in a 
mixed or complex system (Prior et al., 2005). More than one assay should thus 
be used. HPLC-BCD on-line assays could provide additional information as 
 
 
 
 
 65 
individual compounds, contributing to the activity of an extract, could be 
identified. Due to fast reaction times not all active compounds will be identified. 
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Chapter 3 
Research outlay  
 
3.1 Introduction          
  
This chapter provides the objectives and approach used in this study to evaluate 
the antioxidant and anti-diabesity potential of Cyclopia maculata, using in vitro 
non-cell (chemical) based screening assays. The principles of the individual 
assays employed are reviewed in Chapter 2.    
3.2  Study objectives   
 
The overall aims of this study were to determine the potential of Cyclopia 
maculata aqueous extracts as antioxidant, anti-diabetic and anti-obesity agents 
and to determine the effect of fermentation of the plant material, prior to 
extraction, on these potential health-promoting properties. 
 
The specific objectives were: 
 
· To characterise the phenolic composition of C.maculataextractsthrough 
total polyphenol and HPLC analysis of individual compounds; 
· To determine anti-oxidant capacity of C.maculataextracts using different 
antioxidant assays (DPPH●, ABTS●+, FRAP and ORAC); 
· To determine anti-diabesity activity of C.maculataextracts through 
inhibition of pancreatic lipase and α-glucosidase; 
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· To determine the effect of fermentation on C.maculata extracts on its 
phenolic composition, antioxidant activity and anti-diabesity activity; and 
finally; 
· To identify antioxidant and anti-diabesity bioactives in C. maculata 
extracts using high performance liquid chromatography diode-array 
detection coupled with (bio)chemical detection (HPLC-DAD-BCD).     
           
3.3 Study approach 
 
In order to reach the set objectives, procedures as described in the subsequent 
sections were followed. 
 
3.3.1 Sample preparation 
 
Preparation of plant extracts (from harvest to freeze-dried aqueous extracts) is 
illustrated in Figure 16. Briefly, shoots from plant seedlings, selected from a 
natural population in the wild, were harvested to allow for natural variation 
(n = 9). After cutting into small pieces each batch was divided into two             
sub-batches (n = 9 per treatment), with one sub-batch subjected to high 
temperature oxidation (“fermentation”) before drying (n = 9) and the other dried 
without fermentation (n = 9). This allowed for direct comparison of the effect of 
fermentation on each batch. 
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Figure 16. Preparation of extracts (from harvest to freeze-drying). Drying: The cut plant material 
dried on a forced circulation dring tunnel before divided to sub-batches.  
 
Aqueous extraction of the leaves was performed simulating the industrial scale 
process used when preparing food-grade extracts. The extracts were then 
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subjected to freeze-drying and stored at 4 ºC in the dark under desiccation to 
prevent chemical changes. All analyses were performed on the reconstituted 
freeze-dried aqueous extracts. 
 
3.3.2 Characterisation of C. maculata in terms of composition and activity 
 
For bioactivity characterisation of C. maculata extracts, different micro-plate 
assays (unless otherwise specified) were used, thus enabling end-point or kinetic 
measurements of multiple samples per experiment. A schematic diagram of 
different assays employed in this regard is illustrated in Figure 17.  Absorbance 
or fluorescence intensity were used as detection modes depending on which 
mode was more sensitive for each assay. 
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Figure 17. Characterisation of C. maculata samples using a battery of assays  
 
 
3.3.2.1 Phenolic composition   
 
Cyclopia, like most plant species, are rich in polyphenols, which are known to be 
associated with a number of biological effects. It is thus important to characterise 
the phenolic composition of the extracts under investigation in this study. The 
total polyphenol content (TPC) was determined to provide an indication of 
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differences between samples. For this reason the most commonly used method, 
incorporating the Folin-Ciocalteu reagent (Singleton et al., 1999), was used for 
determination of TP of C. maculata extracts. The TPC was quantified in gallic 
acid equivalence (GAE). However, TP does not provide information on individual 
phenolic compounds, and non-phenolic compounds can also react with the Folin-
Ciocalteu reagent (Sanchez-Rangel et al., 2013). Therefore, the plant extracts 
were also subjected to HPLC analysis for separation and quantification of 
individual compounds. The method used was developed for C. subternata (De 
Beer et al., 2009) so that the quantification focused only on the major 
compounds, which were adequately separated.   
 
3.3.2.2 Antioxidant activity  
 
Different chemical antioxidant assays are normally used to characterise the 
antioxidant activity of plant extracts to allow for different mechanisms of action 
(Prior et al., 2005). A number of antioxidant assays (DPPH●, ABTS●+, FRAP and 
ORAC) were performed for a meaningful comparison of the antioxidant capacity 
of C. maculata extracts. The principles of these methods and their relative merits 
were discussed in section 2.6.3.  
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3.3.2.3 Determination of anti-diabetic potential  
 
One of the therapeutic approaches to treatment of type 2 diabetes (T2D) is to 
decrease the postprandial hyperglycemia by retarding absorption of glucose. 
This can be achieved through inhibition of carbohydrate-hydrolyzing enzymes, 
such as α-glucosidase, as this enzyme plays a key role in digestion of 
carbohydrates (disaccharides and oligosaccharides), into monosaccharides 
(Krentz and Bailey 2005). Therefore, the anti-diabetic potential of C. maculata 
extracts was assessed in terms of their ability to inhibit the activity of this 
enzyme. Two enzyme sources were used for the anti-diabetic assay. Due to its 
popularity and accessibility (Hu et al., 2013), α-glucosidase from Saccharomyces 
cerevisiae was used to evaluate this bioactivity. Thereafter, rat intestinal acetone 
powder as source of mammalian α-glucosidase was used to determine the 
physiological relevance of the findings, relative to anti-diabetic effect of the 
extracts in humans (Hu et al., 2013; Misbah et al., 2013). 
 
Acarbose™ is the most widely used positive control in α-glucosidase  inhibition 
assays (Van de Laar et al., 2005), however, many studies have shown the drug 
to be a weak microbial α-glucosidase inhibitor (Table 2 : chapter 2), but strong 
activity against mammalian α-glucosidase has been reported (Uddin et al., 
2012). Thus (+)-catechin, a known microbial α-glucosidase inhibitor, (Muller et 
al., 2012), or Acarbose™ (for intestinal α-glucosidase) (Kim et al., 2010) were 
used as positive controls for the respective assays. These inhibitors were also 
used to normalize activity between different plates and experimental days. 
 
 
 
 
 100 
 
3.3.2.4 Determination of anti-obesity potential 
 
The anti-obesity potential of the extracts was assessed in terms of their ability to 
inhibit porcine pancreatic lipase (PPL), as it is the key enzyme in absorption of 
dietary triacylglycerol through lipid metabolism (Slanc et al., 2009). Amongst the 
different sources of lipases (such as animal, plant or microbial cells), PPL was 
selected for the current study as this mammalian enzyme has relevance to 
human digestive system (Luthi-Peng et al., 1992; Tokdar et al., 2011).  
Orlistat™ a known potent lipase inhibitor (Barbier et al., 2004) was used as a 
positive control and to normalise activity between different plates and 
experimental days. 
 
3.3.2.5 Substrates used for fluorescence intensity of anti-diabesity 
methods  
 
The background absorbance of the plant extracts affected the sensitivity of the 
colorimetric methods that were initially used to evaluate the above mentioned 
bioactivities, thus necessitating the use of fluorescent probes. To obtain sensitive 
and specific fluorescent methods (Cooper and Morgan, 1981; Margesin et al., 
2002), 4-Methylumbelliferyl butyrate (MUB) and 4-methylumbelliferyl                   
α-D-glucopyranoside (MUG) (Andlauer et al., 2009; Azuma et al., 2011) were 
chosen as substrates for PPL and α-glucosidase, respectively.  
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3.3.3 Identification of bioactives of C. maculata extracts 
 
From the data obtained from the respective micro-plate assays, samples that 
showed the highest activity in each assay (from both fermented and unfermented 
sub-batches) were selected for on-line HPLC-DAD-BCD analysis (Figure 14: 
chapter 2). Counter partners (lowest activity) of each sample were also subjected 
to on-line HPLC-DAD-BCD analysis, thus giving obtaining a sample size n = 8 
(Figure 18). These methods indicate which peaks on chromatographic 
fingerprints contribute to the activity of the extracts as observed in the micro-plate 
assays. 
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Figure 18. Identification of active constituents for antioxidant activity, lipase and α-glucosidase 
inhibition from C. maculata extracts using the on-line HPLC-DAD-BCD assays. 
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Chapter 4 
Methods and Materials 
 
4.1 Introduction  
 
This chapter describes the equipment, materials and methods used to evaluate 
the antioxidant, anti-diabetes and anti-obesity potential of Cyclopia maculata. 
The information is arranged under the following sub-headings:   
i) Equipment and material, ii) Reagents and chemicals, and  iii) Methods; 
harvesting and preparation of plant material and preparation of plant extracts, 
phenolic analysis (total polyphenol and HPL-DAD analysis), determination of 
antioxidant activity (different micro-plate assays and on-line HPLC-BCD), 
enzyme assays for determination of anti-diabesity activity of C. maculata (micro-
plate and on-line HPLC-BCD assays) and iv) data analysis.     
     
4.2 Equipment and materials   
 
4.2.1 Equipment - including consumables  
 
The following equipment and chemicals were used in this study:  
· BioTek Synergy HT multiplate reader (BioTek Instruments, Winooski, 
USA), 
· Blue, clearand yellow pipette tips (1000, (300 and 10) and 200 µL) 
(Greiner bio-one, Germany),  
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· Eppendorf MixMate (Merck Millipore, Merck KGaA, Darmstadt, Germany), 
· Gilson single channel pipettes (Gilson, France), 
· Gilson 20-300 µL multi-channel pipette (Gilson, France), 
· Glassware (Various suppliers), 
· Hettich Universal centrifuge (Andreas Hettich GmbH and Co.KG, 
Germany), 
· High performance liquid chromatograph (HPLC-DAD) with diode-array 
detector (Agilent 1200 series HPLC  consisting of quaternary pump 
(G1311A), degassing system (G1379B), diode-array detector (G1315A), 
auto-sampler (G1329A), controlled by (chemstation software (Rev. 
B.02.01) (Agilent Technologies, Waldbronn, Germany). A Zorbax Eclipse 
XDB C18 column (150 x 4.6 mm; 5 µm particle size) (Agilent Technologies, 
Waldbronn, Germany) was used in the analysis, 
· High performance liquid chromatograph (HPLC-DAD-BCD) with 
diode-array detector and on-line (bio)chemical detection system 
(Agilent 1200 series HPLC  consisting of quaternary pump (G1311A), 
degassing system (G1379B), diode-array detector (G1315A), autosampler 
(G1329A), controlled by (chemstation software (Rev. B.02.01) (Agilent 
Technologies, Waldbronn, Germany). A Zorbax Eclipse XDB C18 column 
(150 x 4.6 mm; 5 µm particle size) (Agilent Technologies, Waldbronn, 
Germany) was used. HPLC effluent and post-detector reagents were 
combined through a high pressure mixing tee (U-466) and for enzyme 
based assays a further micro-splitter (P-470) was used before enzyme and 
 
 
 
 
 108 
substrate were added (Idex Health and science, LLC, Oakharbor, 
Washington, USA). For the antioxidant assays, a 15 m poly-ether ketone 
(PEEK) reaction coil (0.25 mm i.d) was used, while enzyme assays used a 
2 m pre-coil followed by 4 m reaction coil of polytetrafluoroethylene (PTFE) 
(0.3 mm i.d). Absorbance based assays were monitored using a variable 
wavelength detector (VWD) (1314B) while a fluorescence detector 
(FLD) (G1321A) was used for fluorimetric assays. The enzyme and 
substrate were added with a Harvard PHD 200 Programmable syringe 
pump (Harvard Apparatus, Holliston, Massachusetts, USA) and reaction 
coils for enzyme based assays were incubated in a column heater,   
 
· HR73 Halogen moisture analyzer (Mettler Toledo, Greifensee, 
Switzerland), 
· 4 mm Millex-HV 0.45 µm PVDF syringe filters (Merck Millipore, Merck 
KGaA, Darmstadt, Germany), 
· 33 mm Millex-HV 0.45 µm PVDF syringe filters (Merck Millipore, Merck 
KGaA, Darmstadt, Germany), 
· Mini-sifter (Scientific Manufacturing Company, JM Quality Services, Cape 
Town, South Africa), 
· Parafilm: DEMIS flexible packaging (Demis, USA), 
· Polypropylene 96-Deep well plate (Axygen Scientific Inc, USA), 
· Polypropylene 2 mL reaction tubes (Greiner bio-one, Germany),  
· Reagent reservoir for different reagents (Axygen Scientific Inc, USA), 
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· Ultrasonic processor: 400/600-watt (Sonics and Materials, Newtown, 
Connecticut, USA), 
· Virtis Genesis 35ES Freeze-dryer (Virtis-SP, SP Industries, 
Pennsylvania, USA),  
· Polystyrene flat bottom 96-well plate (Greiner bio-one, Germany),  
· Whatman filter paper (Whatman International, Ltd. Maidstone, U K). 
 
4.2.2 Reagents and chemicals  
 
Analytical grade reagents and chemicals were used, except when noted 
otherwise. HPLC-grade phenolic standards and solvents, as well as enzymes, 
substrates and standards (positive controls), are listed separately. 
 
General reagents and chemicals  
· Ascorbic Acid (Sigma-Aldrich, USA),  
· 2,2ɂ-Azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) di-
ammonium(ABTS) (Roche, Switzerland), 
· 2,2' -Azobis(2-methylpropanimidamide) dihydrochloride (AAPH) 
(Sigma-Aldrich, USA), 
· Dimethyl sulphoxide (Fluka, Sigma-Aldrich, USA),  
· 2,2–Diphenyl-2-picrylhydrazyl radical (DPPH●) (Sigma-Aldrich, USA), 
· Di-Sodium hydrogen phosphate (May & Baker, England), 
· (±)-6-Hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid (Trolox) 
(Sigma-Aldrich, USA), 
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· Ethanol (99 %) (Servochem, South Africa),  
· Fluorescein disodium (Fluka, Sigma-Aldrich, USA), 
· Folin-Ciocalteu’s phenol reagent (Merck Millipore, Merck KGaA, 
Darmstadt, Germany),  
· Gallic acid (Sigma-Aldrich, USA), 
· Hydrochloric Acid (37 %) (Merck Millipore, Merck KGaA, Darmstadt, 
Germany),  
· Iron(III) chloride anhydrous (Riedel-de Haen, Sigma-Aldrich, USA), 
· Methanol (Merck Millipore, Merck KGaA, Darmstadt, Germany),  
· Phosphate Buffered saline tablets (Sigma-Aldrich, USA),  
· Potassium dihydrogen phosphate (Merck Millipore, Merck KGaA, 
Darmstadt, Germany), 
· Potassium persulphate (Sigma-Aldrich, USA), 
· Sodium carbonate (Merck Millipore, Merck KGaA, Darmstadt, Germany), 
· Tris(hydroxymethyl)aminomethane hydrochloride (Sigma-Aldrich, 
USA), 
· 2,4,6-Tris(2-pyridyl)-s-triazine (TPTZ) (Merck Millipore, Merck KGaA, 
Darmstadt, Germany). 
 
HPLC-gradient grade solvents and calibration standards  
· Acetic acid glacial (>99.85 %) (Fluka, Sigma-Aldrich, South Africa, Cat. 
Nr: 33209-2.5L), 
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· Acetonitrile-CHROMASOLV™ gradient grade for HPLC                 
(>99.9 %) (Sigma-Aldrich, USA, Cat. Nr: 34851-2.5L),  
· Citric acid (>99.5 %) (Sigma-Aldrich, USA, Cat. Nr: CO7598009),  
· Eriocitrin (>98 %) (Extrasynthese, Genay, France, Cat. Nr: 1110 S), 
· Eriodictyol (>99 %) (Extrasynthese, Genay, France, Cat. Nr: 1111 S), 
· Formic acid (>98-100 %) (Merck Millipore, Merck KGaA, Darmstadt, 
Germany, Cat. Nr: 1.00263.2500), 
· Hesperetin (>99 %) (Extrasynthese, Genay, France, Cat. Nr: 1115 S), 
· Hesperidin (>98.5 %) (Sigma-Aldrich, USA, Cat. Nr: 1116 S), 
· Luteolin (>99 %) (Extrasynthese, Genay, France, Cat. Nr: 1125 S),  
· Mangiferin (100 %) (Sigma-Aldrich, USA, Cat. Nr: M3547), 
· Methanol–Lichro Solv, Gradient grade for liquid chromatography 
(Merck Millipore, Merck KGaA, Darmstadt, Germany, Cat. Nr: 106007 ),  
· Narirutin (>99 %) (Extrasynthese, Genay, France, Cat. Nr: 1130 S), 
· Naringenin (>99 %) (Extrasynthese, Genay, France, Cat. Nr: 1128 S). 
 
 
Enzymes, substrates and inhibitors 
· Acarbose (>95 %) (Sigma-Aldrich, USA, Cat. Nr: A8980),  
· (+)-Catechin (>98 %) (Sigma-Aldrich, USA, Cat. Nr: C-1251),  
· α–Glucosidase from Saccharomyces cerevisiae (215 or 120 units/mg 
protein tested with p-NPG or maltose, respectively, 23 % protein) 
(Sigma-Aldrich, USA, Cat. Nr: G0660-750UN), 
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· 4-Methylumbelliferyl-α-D-glucopyranoside (4MUG) (>99 %) (Sigma-
Aldrich, USA, Cat. Nr: M9766), 
· 4-Methylumbelliferyl butyrate (MUB) (>95 %) (Sigma-Aldrich, USA, Cat. 
Nr: 19362), 
· para-Nitrophenyl butyrate (pNPB) (>98 %) (Sigma-Aldrich, USA, Cat. Nr: 
N9876 ), 
· 4-Nitrophenyl α-D-glucopyranoside (pNPG) (>99 %) (Sigma-Aldrich, 
USA, Cat. Nr: N1377),  
· Orlistat (>98 %) (Sigma-Aldrich, USA, Cat. Nr: O4139 ),  
· Rat intestinal acetone powder (Sigma-Aldrich, USA, Cat. Nr: I1630),  
· Type II crude porcine pancreatic lipase: (42 or 133 units/mg protein 
tested with triacetin or olive oil, respectively, 56 % protein) (Sigma-
Aldrich, USA, Cat. Nr: L3126). 
 
· Abbreviations  of enzyme assays, controls and concentrations used: 
 
Ø AGLC = α-Glucosidase with colorimetric probe; (+)-Catechin (control: 
17.2 µg/mL). 
Ø AGCF = α-Glucosidase with fluorimetric probe; (+)-Catechin (control:     
200 µg/mL). 
Ø RATG = Rat intestinal acetone powder; Acarbose™ (control: 202 µg/mL). 
Ø LPC = Lipase with colorimetric probe; Orlistat™ (control: 25 µg/mL). 
Ø LPF = Lipase with fluorimetric probe; Orlistat™ (control: 25 µg/mL). 
Ø pNPB = para-Nitrophenyl butyrate. 
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Ø MUB = 4-Methylumbelliferyl butyrate. 
Ø pNPG = 4-Nitrophenyl α-D-glucopyranoside. 
Ø 4-MUG = 4-Methylumbelliferyl-α-D-glucopyranoside.  
 
 
4.3 Methods  
 
4.3.1 Harvesting and preparation of plant material 
 
Nine batches of C. maculata shoots (needlelike leaves and stems) (approximately
5 - 8 kg/batch) were harvested from a wild population on the farm Welgedacht, 
near Riversdale in the Southern Cape region of South Africa. Shoots from more 
than one bush comprised a batch. The thick stems were removed and the shoots 
from each batch were cut into small pieces (< 3 mm) with a mechanised fodder 
cutter, mixed thoroughly and split into two sub batches. These were respectively 
subjected to controlled drying in a forced circulation drying tunnel at 40 °C  for 6 
hours to a moisture content less than 10 % directly after cutting to obtain 
unfermented plant material and to high temperature fermentation (oxidation). For 
fermentation, the cut plant material (1 kg; 53.9 - 56.4 % moisture content) was 
moistened with water (1 part water to 4 parts plant material), mixed, placed in a 
stainless steel container, that was then covered with aluminium foil and placed in a 
laboratory oven at 90 °C for 16 hours. Following fermentation, the plant material 
was spread out on a drying rack and dried as described for the unfermented plant 
material. The moisture content of the plant material was determined, using a 
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Mettler Toledo HR73 Halogen moisture analyzer. The dried plant material 
(fermented and unfermented) was passed through a 1.4 mm sieve for 1.5 minutes 
at 190 rpm using a SMC-Mini-sifter to remove coarse pieces of stem. 
 
4.3.2 Preparation of plant extracts 
 
 Hot water extracts of the unfermented and fermented sieved plant material were 
prepared by extracting 40 g of plant material with 400 mL (1:10 m/v) of freshly 
boiled deionised water. The mixture was placed in the water bath at 93 °C for 
30 minutes with mixing every 5 minutes. The extracts were decanted through a 
tea strainer into a clean Schott bottle and filtered through Whatman #4 filter 
paper thereafter. The filtrate was to cool down to room temperature in a water 
bath and the volume was measured. Thereafter, soluble solids content of the 
infusions was gravimetrically determined by evaporating duplicate aliquots (5 mL) 
of each filtrate to dryness in the pre-weighed nickel moisture dishes on a steam 
bath. The moisture dishes were thereafter dried using a laboratory convection 
oven at 100 °C for 60 minutes.  The moisture dishes were cooled to room 
temperature in a desiccator, weighed and the soluble solid (SS) content 
calculated thereafter. The remaining filtrate of each sample was freeze-dried in 
Virtis Genesis 35ES, with condenser set at-45 °C and a vacuum of 100 mTorr. 
The freeze-dried filtrates were transferred into labelled 24 mL screw cap amber 
vials, sealed with parafilm and stored in5 litter jars with silica gel added. The 
freeze-dried powder samples were stored at 4 °C until analysis. 
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4.3.3 Preparation of stock solutions 
 
For HPLC analysis (DAD and BCD) and all enzyme assays, stock solutions of 
the samples at 6 mg/mL concentration were used. These were prepared by 
dissolving 120 mg of the freeze-dried filtrate with 20 mL of deionised water. For 
total polyphenol and all antioxidant micro-plate assays, (1 mg/mL) stock solutions 
were used. These were prepared by dissolving 20 mg of the freeze-dried filtrate 
with 20 mL of deionised water.  All aliquots of stock solutions of C. maculata 
samples were stored at -20 °C in 2 mL reaction tubes and defrosted at room 
temperature on the day of analysis. All assays were performed in triplicate and 
results were presented as an average with a percentage error less than 5 %. A 
Biotek Synergy HT micro-plate reader, equipped with Gen5 Secure software, 
was used for all micro-plate assays. In the following sections the term ‘extracts’ 
will be used although it will refer to filtered extracts. Taking the volume of filtrate 
recovered into account, the extract yield was calculated (g SS/100g leaves).  
4.3.4 Phenolic analysis  
 
4.3.4.1    Total polyphenol analysis 
 
The Folin-Ciocalteu method of Singleton and Rossi (1965) adapted for micro-
palate reader format by Arthur et al. (2011) was used for determination of total 
polyphenol content (TPC) of C. maculata extracts. Gallic acid was used to 
prepare a calibration curve ranging in concentration from 1 mg/L to 10 mg/L. The 
samples stock solutions (1 mg/mL) were diluted (300 µL sample diluted to a final 
volume of 1000 µL deionised water solution) to obtain absorbance values within 
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the range of the calibration curve. Twenty microliters each of the gallic acid 
standards, samples and the assay control (deionised water) were transferred in 
triplicate into a 96-well polystyrene flat bottomed micro-plate. Folin-Ciocalteu’s 
reagent (10 x diluted; 100 µL) and sodium carbonate solution (7.5 % w/v; 80 µL) 
were added into the reaction mixture, followed by mixing of the well contents 
using an Eppendorf MixMate micro-plate shaker. The micro-plates were 
incubated at 30 °C for 2 hours to allow for development of a blue-color complex 
resulting from oxidation of the phenolic compounds. The absorbance was 
measured at 765 nm and the TPC expressed as mg Gallic Acid Equivalents 
(GAE) per 100 mL extracts.  
 
4.3.4.2 High performance liquid chromatography-diode-array (HPLC-DAD) 
analysis  
 
To characterise the phenolic composition of the extracts the HPLC-DAD method 
of De Beer and Joubert (2010) was used to quantify major phenolic compounds 
in the extracts. An aliquot of each sample was defrosted on the day of analysis. 
One milliliter of each stock solution (6 mg/mL) was mixed with 100 µL of 10 % 
(w/v) ascorbic acid. Ascorbic acid was added to the calibration standards and 
defrosted reconstituted extracts to prevent oxidative degradation of the phenolic 
compounds. Millipore Millex-HV syringe filters (0.45 µm pore-size) with 4 mm and 
33 mm diameter were used to filter calibration standards and plant extracts, 
respectively, before HPLC-DAD analysis. Gradient elution with acetonitrile 
(solvent A) and 2 % acetic acid (solvent B) at a flow rate of 0.8 ml/min was as 
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follows: 0-5 min, 20 % A isocratic;5 - 9 min, 20 – 22 % A; 9 - 10 min, 22 % A 
isocratic; 10 - 15 min, 22 - 23 A; 15 - 18 min, 23 – 60 % A isocratic; 18 - 20 min, 
60 – 20 % A; and 20 - 30 min, 20 % A isocratic. The injection volume for extracts 
was 10 µL and for standards 10 - 20 µL. The concentration range for calibration 
standards are presented in Table 5. UV-Vis spectra were recorded for all 
samples from 200 nm to 550 nm. 
 
 
Table 5 Concentration range of calibration standards injected  
Compounds  Concentration range (µg/mL) 
Mangiferin 0.036 to 9.093 
Luteolin 0.001 to 0.350 
Eriocitrin 0.007 to 1.719 
Narirutin 0.003 to 0.6400 
Hesperidin 0.012 to 3.045 
Eriodictyol 0.003 to 0.713 
Narigenin 0.003 to 0.672 
Hesperetin  0.003 to 0.707 
 
Peaks were tentatively identified by comparing retention times and UV-Vis 
spectra from HPLC-DAD analysis with those of authentic standards.  Mangiferin, 
isomangiferin and luteolin were quantified at 320 nm, and eriocitrin, eriodictyol, 
naringinin, narirutin, hesperidin and hesperetin were quantified at 288 nm. 
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A calibration curve (seven dilution series) was set up for all the available 
authentic standards. Isomangiferin and iriflophenone-3-C-β-D-glucoside were 
quantified in mangiferin and hesperidin equivalence, respectively. Content was 
expressed as a 100 mg/ 100 g extract.  
 
4.3.5 Determination of antioxidant activity 
 
4.3.5.1 DPPH● scavenging assay 
 
The method of Rangkadilok et al. (2007) slightly modified by Arthur et al. 
(2011) was used for the free radical scavenging activity determination of C. 
maculata samples. DPPH● was prepared by dissolving 5 mg DPPH● in 100 mL 
methanol. The solution was covered with foil and sonicated for 5 minutes. The 
DPPH●-methanol solution was measured at 515 nm and then diluted to obtain an 
absorbance value between 0.68 - 0.71 for assay standardization purposes. 
Trolox was used to prepare a calibration curve ranging from 1 µg/mL to 10 µg/mL 
in the reaction volume. Stock solutions (1 mg/mL) of the samples were further 
diluted with deionized water (250 µL sample diluted to 1000 µL) to obtain 
absorbance values within the range of the calibration curve (between 40 and    
60 % radical scavenging). Thirty microliters each of the Trolox standards, 
samples and assay control (deionised water) were transferred in triplicate into a 
96 deep-well plate. The DPPH● solution diluted to ca 0.7 absorbance value was 
added (270 µL), followed by sealing of the deep-well plate with a silicone sealing 
mat to prevent evaporation of methanol. The contents in deep-well plate were 
then mixed using an Eppendorf MixMate micro-plate shaker for 30 seconds at 
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1650 rpm. The micro-plates were incubated in a dark cupboard at room 
temperature for two hours to allow scavenging of DPPH● by the antioxidants, 
leading to a decrease in absorbance of the free radical solution. Two hundred 
microliters of the reaction mixture was then transferred into corresponding wells 
of a 96-well polystyrene flat bottom micro-plate and the absorbance measured at 
515 nm. The radical scavenging ability was expressed as µmole Trolox/g extract, 
obtained from the calibration curve of the standard. The % inhibition caused by 
the Trolox standards and the sample extracts was calculated as follows:  
 
% inhibition = (AC-AS)/ AC *100, where  
AC = absorbance of control 
AS = absorbance of standards or samples. 
 
The % inhibition of the Trolox standard solutions was plotted against their 
concentration in the reaction mixture, giving a linear regression curve. The 
calibration curve was then used to calculate the total antioxidant capacity 
(TACDDPH) of a sample in terms of Trolox equivalents (µmoles Trolox/g extract). 
 
4.3.5.2 ABTS●+ decolourisation assay  
 
Radical scavenging capacity of C. maculata extracts was also determined using 
the ABTS●+ decolourisation assay as described by Re et al. (1999) and modified 
for micro-plate use by Venter (2013). An ABTS●+ stock solution (7 mM) was 
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prepared in deionized water (75 mg in 25 mL) and further diluted with 440 µL of 
140 mM potassium persulfate to generate the radical. The mixture was stored in 
a dark cupboard at room temperature for 16 hours to allow development of the 
radical (Re et al., 1999) prior to the reaction commencement. Trolox (dissolved in 
methanol) was used to prepare a standard curve, ranging from 50 µM to 300 µM 
in the final reaction mixture. Stock solutions of the samples (1 mg/mL) were 
further diluted to give between 40 % and 60 % bleaching of ABTS●+. Twenty 
microliters of each of the Trolox standards, samples and assay control (deionised 
water) were transferred in triplicate into a 96-well polystyrene micro-plate and 
180 µL of ABTS●+ reagent added. The contents in the 96-well polystyrene flat 
bottom micro-plate were mixed in the Biotek Synergy HT micro-plate reader. 
Following mixing, the reaction mixture was incubated at 30 °C and absorbance 
measured after 4 minutes at 734 nm. The percentage inhibition was calculated 
as described for the DPPH● assay. TAC ABTS was expressed as µmole Trolox 
equivalents/g extract. 
 
4.3.5.3 FRAP assay  
 
The assay by Benzie and Strain (1996) was used as adapted by Venter (2013) 
for use in the micro-plate format to evaluate the ferric reducing antioxidant               
power (FRAP) of C. maculata extracts. The FRAP reagent  was freshly prepared  
using 100 mL of 300 mM acetate buffer (pH 3.6), 10 mL of mM TPTZ in 40 mM 
HCl, and 10 mL of 20 mM iron (III) chloride (FeCl3). A Trolox stock solution of 
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1.25 mg/mL was prepared in ethanol and further diluted with deionised water to 
obtain a calibration curve between 50 µM - 500 µM. Sample stock 
solutions (1 mg/mL) were further diluted as required to obtain absorbance values 
within the range of the calibration curve. Twenty microliters of the blank 
(deionised water), standards and extract samples were added in triplicate in their 
allocated wells in a 96-well micro-plate, followed by the addition of the FRAP 
reagent. The increase in absorbance due to formation of a coloured TPTZ-Fe2+ 
complex was monitored spectrophotometrically at 593 nm, after a reaction time 
of 4 minutes at 37 °C. A linear regression plot, prepared for the calibration 
standard solutions was used to calculate the TACFRAP value of each sample, 
expressed as µmole Trolox equivalents/g extract.  
 
4.3.5.4 ORAC assay   
 
To determine oxygen radical absorbance capacity of C. maculata aqueous 
extracts, a method by Huang et al. (2002) was adapted as modified for use in 
micro-plate by Joubert and De Beer (2012) where 8 x 10-2 mM fluorescein 
disodium solution in 75 mM potassium-phosphate buffer (pH 7.4) was used. 
AAPH (153 mM) in potassium-phosphate buffer was used as a source of peroxyl 
radical (Werber et al., 2011). Trolox (0.125 mg/mL in methanol) was used to 
prepare a calibration curve ranging from 5 µM to 30 µM. The stock solutions 
(1 mg/mL) of the samples were further diluted with deionised water to a final 
soluble solid concentration of 0.6 - 0.8 µg/mL for optimum inhibition capacity of 
peroxyl-radical-induced oxidation within the range of the calibration curve. The 
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Trolox standards, samples and the assay control (deionised water) (25 µL) were 
each transferred in triplicate into a 96-well of a clear-bottom black micro-plate, 
and 150 µL of the fluorescein working solution was added to the reaction. The 
96-well micro-plate was then incubated in the Biotek Synergy HT micro-plate 
reader at 37 °C for 10 minutes, and 153 mM AAPH (25 µL) was added to the 
reaction mixture prior to measurement of fluorescence. The loss of fluorescent 
intensity was measured in the micro-plate reader over a period of 35 minutes. 
Excitation was performed at 485 nm with 20 nm band pass and emission was 
measured at 530 nm with 25 nm band pass. The fluorescence intensity was 
determined using Gen5™ Data Analysis Software to obtain area under the curve 
(AUC) and Net AUC (AUC samples – average AUC assay control). A calibration 
curve, where the Net AUC was plotted against the µmoles Trolox in the reaction 
volume, was used to quantify the activity of each extract. The activity was thus 
expressed as µmoles Trolox equivalents/100g soluble solids. 
 
4.3.6 Enzyme inhibition assays 
 
4.3.6.1 Lipase inhibition assay for anti-obesity activity  
 
4.3.6.1.1 Micro-plate colorimetric assay 
 
The method by Slanc et al. (2009), was adapted to evaluate pancreatic lipase 
inhibitory activity of C. maculata extracts in the micro-plate. A solution of 
3 mg/mL type II crude porcine pancreatic lipase was prepared by dissolving 75 
mg of the enzyme in 25 mL deionised water at 37 °C. The crude enzyme solution 
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was incubated at 37 °C for 30 minutes to extract the enzyme. Millipore Millex-HV 
syringe filters (0.45 µm pore size) with 4 mm diameter were used to filter the 
enzyme solution. The appropriate concentration for optimal activity was 
determined as an absorbance of 0.9 at 405 nm from a range of 
lipase concentrations (0.1 – 3 mg/mL) after incubation for 20 minutes. Thereafter, 
the lipase solution was diluted accordingly for the determination of inhibitory 
activity of the extracts. para-Nitrophenyl butyrate (pNPB)  (3.33 mM) (Kim et al., 
2012) was used as a substrate for this assay. A stock solution of 2 mg/mL 
Orlistat™ was prepared and used as positive control at a fixed concentration 
(25 µg/mL) per well. The composition of the reaction mixture per well (without the 
substrate) was: 20 µL of plant extract (200 µg/mL), 150 µL of 75 mM Tris-buffer 
(pH 8.5) and 65 µL of enzyme solution. The reaction mixture was incubated at 
37 °C for 15 minutes after which 15 µL of 3.33 mM pNPB was added by the 
dispenser at the Biotek Synergy HT micro-plate reader and the absorbance was 
read over 30 minutes at 405 nm. The difference in absorbance between start-
point and end-point (t0 and tmax, respectively) of the reaction was used as the 
measure of the reaction that has taken place.  Values for sample blanks, 
substituting water for the substrate, were subtracted to take absorbance of the 
sample into account. The Net absorbance and the % inhibition caused by 
Orlistat™ and the sample extracts were calculated as follows:  
 
Net Abs = Abstmax– Abst0 
% inhibition = (AC-AS)/ AC *100, where  
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AC = absorbance of control 
AS = absorbance of standards or samples 
Abstmax = Absorbance values at time of maximum  
Abst0 = Absorbance values at the start of reaction  
 
 
4.3.6.1.2 Micro-plate fluorimetric assay 
 
The methods by Andlauer et al. (2009) and Slanc et al. (2009) were adapted to 
micro-plate format. A substrate solution was prepared by dissolving 15 mg of      
4-methylumbelliferyl butyrate (MUB) in 10.125 mL DMSO. HPLC grade deionised 
water was added to the substrate solution to obtain a total volume of 15 mL. A 
solution of 3 mg/mL type II crude porcine pancreatic lipase, prepared as 
described in 4.3.6.1.1 was used. The appropriate concentration for optimal 
activity was determined from a dilution range of lipase concentrations (0.1 - 3 
mg/mL). The excitation wavelength was 360 nm with 40 nm band pass while 
emission was measured at 460 nm with 40 nm band pass. A fluorescence 
reading between 70000 to 80000 after 30 minutes was selected as optimal and 
the lipase solution was diluted accordingly for the determination of inhibitory 
activity of the extracts. The samples were analysed at a final concentration of 
480 µg/mL. The composition of the reaction mixture in a micro-well was: 20 µL of 
control, sample or standard, 125 µL potassium phosphate buffer (pH 7.4), 65 µL 
lipase solution, (replacing lipase with deionised water for blanks) and 40 µL MUB. 
Orlistat™ (25 µg/mL) was used as a positive control and to standardise activity 
between different plates and experimental days. The fluorescence emitted at 
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460 nm after excitation at 365 nm was recorded over 60 minutes. The values of 
initial fluorescence (t0) were subtracted from the values at the time of maximum 
fluorescence (tmax; 4min) to obtain the Net fluorescence and the % inhibition of 
each sample and control was calculated bellow:    
 
Net Fluorescence (Net FL) = Fluorescencetmax– Fluorescencet0 
 % inhibition = 100 x {1 – (Net FLsample – Net FLblank)/Net FLcontrol}  
% activity = 100 - % inhibition. 
 
4.3.6.2 Alpha-glucosidase inhibition for anti-diabetes 
 
4.3.6.2.1 Micro-plate colorimetric assay 
 
For the anti-diabetic potential of C. maculata, yeast α-glucosidase inhibitory 
activity of the extracts was investigated using a method adapted from Kim et al. 
(2010), as described by Muller et al. (2012), for micro-plate format. A stock 
solution of, approximately 2 U/mL α-glucosidase was prepared by using cold 
HPLC grade deionized water (ca. 4.4 mg in 100 mL). The enzyme solution was 
stored at 20 °C and defrosted in the refrigerator overnight prior to the 
experimental day. The substrate, 3 mM para-nitrophenyl α-D-glucopyranoside 
(pNPG), was prepared on the experimental day (18 mg substrate in 20 mL 
deionised water). +(-)Catechin (17 µg/mL per well) was used as a positive control 
(a stock solution prepared by dissolving 2.18 mg in 25 mL deionised water). The 
substrate was replaced with dH2O for the sample blanks and the sample was 
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replaced with deionised water for the assay control and reaction mixture. The 
activity of the enzyme was determined by preparing different dilutions of the 
stock solution with cold HPLC grade deionised water within activity range from 
0.25 to 2 U/mL. The absorbance at 405 nm was monitored during incubation at 
37 °C. The dilution that resulted in absorbance between 0.7 to 0.8 after 10 
minutes of incubation was selected for sample analysis. A mixture of 200 µg/mL 
sample, 200 mM potassium phosphate buffer and selected concentration of       
α-glucosidase, at 20 µL each, was incubated at 37 °C in the Biotek Synergy HT 
micro-plate reader. After 15 minutes incubation, 40 µL pNPG was added to the 
reaction mixture. For the assays, absorbance at 405 nm was monitored over 
30 minutes. To obtain the net absorbance values, the values of initial absorbance 
were subtracted from the values of absorbance at the end of the reaction (t0 and 
t10, respectively). The net absorbance values were used as measure of the 
reactions that took place during the time over which the assay was monitored. 
Values for sample blanks, substituting water for the substrate, were subtracted to 
take absorbance of the sample into account. The net absorbance and the 
percentage inhibition was calculated as follows:  
 
Net Abs = Abs t10- Abs t0 and  
% inhibition = (AC-AS)/ AC *100, where  
AC = Net absorbance of control 
AS = Net absorbance of standards or samples. 
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4.3.6.2.2 Micro-plate fluorimetric assay with yeast α-glucosidase 
 
The method by Azuma et al. (2011) was adapted with minor modifications to 
comply with micro-plates suitable for enzyme inhibition activity assays. A stock 
solution of 2 U/mL yeast α-glucosidase was prepared as described in section 
4.3.6.2.1. A substrate solution was prepared by dissolving 10.65 mg of                                         
4-methylumbelliferyl-α-D-glucopyranoside (4-MUG) in 2 mL dimethyl sulphoxide 
(DMSO). Potassium phosphate (200 mM; pH 6.8) was later added to the 
substrate solution adding up to a total volume of 25 mL. The activity of the 
enzyme was determined as described for the colorimetric assay. The appropriate 
concentration for optimal activity was determined based on the fluorescence 
emitted at 460 nm with 40 nm band pass after excitation at 360 nm with 40 nm 
band pass. A fluorescence reading between 70000 to 80000 after 60 minutes 
was selected as optimal activity and α-glucosidase solution was diluted 
accordingly for the determination of inhibitory activity of the extracts. The extracts 
were analysed at a final concentration of 500 µg/mL. Catechin (200 µg/mL) was 
used as a positive control and to standardise activity between different plates and 
experimental days. The composition of the reaction mixture in a 
micro-well was similar to that used for the colorimetric assay: 20 µL of 500 µg/mL
 sample/control/standard, 20 µL potassium phosphate buffer (pH 6.8), 20 µL 
α-glucosidase solution, (replaced with potassium phosphate for blanks). The 
micro-plate was incubated at 37 °C in the Biotek Synergy HT micro-plate reader. 
After 15 minutes incubation, 40 µL of the substrate (4-MUG) was added to each 
well. The fluorescence emitted was measured at 460 nm after excitation at 
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360 nm was recorded over 60 minutes. Percentage inhibition of each sample and 
control was calculated in the following way: 
 
Net Fluorescence (Net FL) = Fluorescencetmax– Fluorescencet0 
Where tmax = 50 min 
% inhibition = 100 x {1 – (Net FLsample – Net FLblank)/Net FLcontrol}  
% activity = 100 - % inhibition.  
 
4.3.6.2.3 Micro-plate fluorimetric assay with rat intestinal acetone powder  
 
The method by Sancheti et al. (2011) was adapted with minor modifications. 
The same experimental procedure, conditions and sample concentration as 
described in section 4.3.6.2.2 were used. However, a stock solution of enzyme 
was prepared by extracting 350 mg of rat intestinal acetone powder with 10 mL   
200 mM potassium phosphate (pH 6.8). The extraction process included a 
sonication sequence of 12 x 30 seconds with 1 minute resting intervals using the 
Ultrasonic processor. The solution was centrifuged at 10 000 x g for 30 minutes 
in a Hettich Universal 320R centrifuge (rotor 1615) at 4 °C. The supernatant was 
filtered with Durapore™ 0.45 µm pore size PVDF syringe filters and kept on ice 
until analysis.   Acarbose™ (200 µg/mL in a well) was used as a positive control 
and to standardise activity between different plates and experimental days. The 
reaction mixture per well consisted of 40 µL sample                 
(500 µg/mL)/control/ standard, 20 µL potassium-phosphate buffer (pH 6.8) and 
60 µL α-glucosidase solution, (replaced with potassium phosphate for blanks) 
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was incubated at 37 °C in the Biotek Synergy HT micro-plate reader before 80 µL 
of the substrate (3 mM 4-MUG) was added to the wells. The net fluorescence 
and percentage inhibition of extracts and standards were calculated in the 
following way: 
 
Net Fluorescence (Net FL) = Fluorescencetmax– Fluorescencet0 
Where tmax = 20 min 
% inhibition = 100 x {1 – (Net FLsample – Net FLblank)/Net FLcontrol}  
% activity = 100 - % inhibition.   
 
4.3.7 On-line BCD assays  
 
4.3.7.1 Antioxidant assays 
 
4.3.7.1.1 On-line HPLC (DPPH●, ABTS●+ and FRAP). 
 
The HPLC system used to identify active compounds responsible for antioxidant 
activity of C. maculata was described in section 4.2.1. Post-column mixing of the 
HPLC effluent and the radical solution (DPPH●, ABTS●+ or FRAP), at an 
additional flow rate of 0.5 mL/min, was achieved with a high pressure static 
mixing tee. The reaction coil was made of 15.24 m PEEK tubing (0.25 mm i.d.) 
resulting in a reaction time of ca. 0.6 minutes. 
 
 The DPPH● stock solution (58 mg/L) was prepared in acetonitrile on the day of 
analysis and kept in a flask protected from light. The working solution, containing 
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250 mL of a 0.068 mM citric acid phosphate buffer (6.8 mL of 0.01 M citric acid 
added to 93.2 mL of 0.02 M Na2HPO4 and made up to 1000 mL with deionized 
water) and 750 mL of DPPH in acetonitrile was filtered with Milipore 0.45 µm 
PVDF-filter by vacuum before use.  
 
The ABTS●+ stock solution (7 mM) was prepared as described by 
Pelligrini et al. (2003). A working solution was obtained by mixing 25 mL 7 mM 
ABTS●+ stock solution with 1000 mL of 75 mM potassium phosphate (pH 7.4). 
The 1 L solution was filtered with Milipore 0.45 µm PVDF-filter by vacuum before 
use.  
 
The FRAP reagent was prepared as described for the micro-plate FRAP assay 
(section 4.3.5.3), the mixture contained 100 mL of 300 mM acetate buffer 
(pH 3.6), 10 mL of mM TPTZ in 40 mM HCl, and 10 mL of 20 mM iron (III) 
chloride (FeCl3). However, the volumes were adjusted as required for a total 
volume of 1 L and filtered with Milipore 0.45 µm PVDF-filter by vacuum before 
use.   
 
 The reagents (DPPH●, ABTS●+ and FRAP) working solutions were kept in the 
thermostatically controlled cooling bath at 4 °C during analysis. The samples 
were injected in duplicate at 10 µL and a standard mix of mangiferin and 
isomangiferin was injected in triplicate at 10 µL. Trolox was used as an internal 
standard (0.25 mg/mL for DPPH●, 1.25 mg/mL for ABTS●+ and FRAP) to align the 
chromatograms and the biograms. Scavenging of DPPH●, ABTS●+ was detected 
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as negative peaks at 515 nm, 600 nm, respectively, whereas ferric reduction 
(FRAP) was detected as positive peaks at 593 nm.  
 
Quantitative on-line (ABTS●+ and DPPH●) analysis of selected samples was done 
by injecting 10 µL of the extract of each sample in triplicate. The response of 
mangiferin and isomangiferin over the expected concentration range was 
determined in triplicate. For ABTS●+ assay, the compounds were injected at a 
concentration range between 0.114 to 1.364 µg/µL mangiferin and 0.046 to  
0.554 µg/µL isomangiferin. In the DPPH● assay, the concentrations between 0.23 
to 4.09 µg/µL mangiferin and 0.09 to 1.66 µg/µL isomangiferin were injected. Due 
to equipment downtime the quantitative analysis of the later compounds could 
not be performed with the FRAP assay. The response of Trolox was also 
determined over a concentration range of 0.08 to 1.25 µg/µL for the ABTS●+ 
assay and 0.17 to 3.3 µg/µL for the DPPH●. This was not only used to align 
chromatograms and biograms but also to calculate TEAC values.  
 
4.3.7.2 Enzyme inhibition assays 
 
4.3.7.2.1 Lipase inhibition 
 
In the search of compounds with lipase inhibitory activity from C. maculata 
extracts, a method by C. J Malherbe, ARC Infruitec-Nietvoorbij, Stellenbosch 
(Figure 13; chapter 2) was employed. For the lipase inhibition assay, the HPLC 
system was coupled with on-line post-column detection of enzyme inhibitors 
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(Malherbe et al., 2012). A stock solution of 3 mg/mL type II crude porcine 
pancreatic lipase was prepared in 37 °C deionised water on the experimental day 
and 0.42 mg/mL MUB (in DMSO-water) as prepared in section 4.3.6.1.2 was 
used as substrate. The enzyme solution was kept at 4 °C during the experiment 
to prevent degradation (Granon and Semeriva, 1980). Fifty microliters of 
samples (6 mg/mL) was injected to the HPLC-BCD system. Orlistat™ was used 
as a positive control and to align chromatograms taking into account the delay in 
post-column reaction. HPLC effluant was combined with make-up buffer 
(potassium phosphate: 75 mM (pH 7.4) and 1.32 g/L Tween 20) in a 1:1 ratio 
using a high pressure mixing tee, Tween 20 was added to prevent secondary 
binding of enzyme to the reaction coil. The HPLC effluent-makeup buffer mixture 
was then split using a micro-splitter where 100 µL/minutes was diverted towards 
the (bio)chemical detection system. To this diverted flow, the enzyme solution 
was added using a mixing tee, by dual syringe pump at 50 µL/minute and the 
combination was pre-incubated through a 2 m pre-coil at 37 °C. Immediately after 
pre-incubation, the substrate solution was added using a mixing tee, by dual 
syringe pump at 50 µL/minute and the combined mixture passed through 4 m 
reaction coil at 37 °C. The fluorimetric reaction was recorded at 445 nm emission 
after excitation at 365 nm. Enzyme inhibition would be indicated as negative 
peaks.  
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4.3.7.2.2 α-Glucosidase inhibition  
 
To identify α-glucosidase inhibitors from C. maculata extracts, the same 
equipment and procedure as described in 4.3.7.2.1 was followed. However, 
2 U/mL yeast α-glucosidase prepared in 37 °C deionised water was used as 
enzyme and 0.9 mg/mL pNPG was used as a substrate. The enzyme and 
substrate solutions were kept at 4 °C during the experiment to prevent 
degradation (Unsworth et al., 2007). Extracts (6 mg/mL) were analyzed using 
50 µL injection volume. (+)-Catechin was used as a positive control and to align 
chromatograms taking into account the delay in post-column reaction. For the 
same reason as for lipase inhibition assay, the HPLC effluant was combined with 
make-up buffer (potassium phosphate: 200 mM (pH 6.8) and 1.32 g/L Tween 20) 
in a 1:1 ratio using a high pressure mixing tee. The colorimetric reaction was 
recorded by VWD at 405 nm and enzyme inhibitors would have been observed 
as negative peaks. 
 
4.4 Data and statistical analysis  
 
Data generated by Gen5 Secure software for micro-plates and Chemstation 
software for HPLC (DAD and BCD) was imported into Microsoft Excel (version 
2011) for analysis. Data are expressed as mean of triplicate experiments            
± standard deviation. Statistical significant differences between treatments 
(fermented and unfermented) and the correlation of HPLC with bioactivity data 
(antioxidant and anti-diabesity) were determined by subjecting the data to t-Test 
analysis of variance (ANOVA) using General Linear Models (GLM) of SAS® 
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software (Version 9.2, SAS institute Inc, Carry, USA). The correlations were 
conducted using Pearson methods. A p-value of less than 0.05 (P < 0.05) was 
considered to be statistically significant. A qualitative and quantitative 
assessment of active peaks on HPLC- DAD-BCD chromatograms were also 
performed. Principal component analysis (PCA), based on the correlation matrix, 
was conducted using XLStat (Version 7.5.2, Addinsoft, New York, USA) to 
determine correlations between attributes and to visualize and elucidate the 
relationships between the samples and their attributes.  
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Chapter 5 
Results 
 
 
5.1 Introduction  
 
Various micro-plate assays were employed to evaluate antioxidant and          
anti-diabesity potential of aqueous extracts of unfermented and fermented C. 
maculata. Several antioxidant assays were employed to quantify the total 
antioxidant capacity of the extracts, while anti-diabesity potential was assessed 
in terms of the inhibition of enzymes relevant to digestion. Characterisation of the 
phenolic composition of extract entailed quantification of total polyphenol content 
and the major individual phenolic constituents. On-line HPLC-(bio)chemical 
methods were employed to gain further insight into the activity of the extracts.    
 
5.2 Characterisation of the phenolic composition of C. maculata 
 
The hot water soluble solids content of unfermented and fermented shoots and 
leaves of C. maculata were 19 and 16 %, respectively. The soluble solids content 
of the plant material decreased on average by 16 %, but large variation, was 
observed for individual batches, ranging from 11 to 27 %   (Table 6). 
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Table 6.  Hot water soluble solids content (SSC) of unfermented and fermented C. 
maculata plant material.  
Sample coding Unfermented Fermented % decrease  
1 20.70 15.22 27 
2 18.40 16.38 11 
3 17.57 15.68 11 
4 19.62 16.72 15 
5 16.99 15.02 12 
6 19.16 16.23 15 
7 18.61 16.03 14 
8 19.51 14.27 27 
9 17.57 15.70 11 
Average 19 16 16 
SSC is expressed as g/100 g plant material. % Decrease: Reduction in soluble solid content of C. 
maculata extracts due to fermentation.   
 
 
The freeze-dried, hot water extracts were then analysed for their total phenolic 
content (TPC) at a concentration of 0.3 mg/mL. Gallic acid, most commonly used 
as standard (Prior et al., 2005), was also used as standard in this case to 
quantify the TPC of C. maculata extracts. A very good correlation between the 
gallic acid concentration and absorbance (R2 = 0.9997), measured at 765 nm, 
was observed when using the method of Singleton and Rossi (1965), adapted 
for use in micro-plate assay format (Addendum; Figure A1). The method was 
therefore deemed suitable to quantify the TPC of C. maculata extracts.  
 
The total polyphenol content values of unfermented extracts varied between 20.7
 and 26.0 g GAE/100 g extract, observed for sample 4 and sample 1, 
respectively. The TPC values of the fermented sampled ranged between 13.9 
and 16.7 g GAE/100 g extract (Figure 19), observed for sample 6 and sample 7, 
respectively. The average total polyphenol content was significantly lower after 
fermentation (P < 0.0001), decreasing from 23.5 to 15.3 g GAE/100 g extract 
(Table 7).  The percentage decrease in TPC of all individual batches exceeded 
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30 % (Table 8) due to fermentation, accompanied by a decrease in activity of the 
extracts observed in all measured parameters.  
 
 
 
 
 
 
Table 7. ANOVA of total polyphenol content (TPC) and antioxidant activities (DPPH, FRAP, 
ORAC and ABTS) of extracts of unfermented and fermented C. maculata.   
Assay Units Unfermenteda,b Fermenteda,b P value 
TPC g GAE/100 g 23.50 ± 1.49 15.28 ± 1.02 p < 0.0001 
DPPH  TAC (µmoles TE/g extract) 1632 ± 213 927 ± 142 p < 0.0001 
ABTS  TAC (µmoles TE/g extract) 2301 ± 120 1517 ± 126 p < 0.0001 
ORAC  TAC (µmoles TE/g extract) 6808 ± 597 4393 ± 215 p < 0.0001 
FRAP  TAC (µmoles TE/g extract) 1078 ± 61 612 ± 48 p < 0.0001 
aTotal antioxidant capacity expressed as µmoles Trolox equivalence/g extract and TPC as gallic acid equivalence/100 g 
extract; b Data are mean ± SD where n = 9.   
 
 
Figure 19. Total polyphenol content (TPC) of aqueous extracts unfermented and fermented C. 
maculata (n = 9) determined by the Folin–Ciocalteau Reagent (FCR) method. TPC is 
expressed in terms of gallic acid equivalents (GAE). 
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Table 8. Percentage change of parameters as measured for individual 
samples of C. maculata extracts as affected by fermentation.  
Batch TPC DPPH ABTS ORAC FRAP LPC LPF AGLC AGCF RATGL 
1 40 49 39 40 45 41 9 28 16 13 
2 30 28 41 37 36 -15 4 50 8 9 
3 35 60 37 38 49 5 19 14 18 16 
4 32 42 32 40 42 31 -9 -14 17 14 
5 36 42 26 41 45 14 5 58 7 11 
6 42 47 25 20 52 8 9 106 -6 14 
7 32 43 39 32 39 -3 14 83 34 9 
8 33 35 38 35 38 25 10 33 4 9 
9 34 35 30 32 42 0 24 74 30 12 
Average 35 43 34 35 43 12 9 48 14 12 
Abbreviations: TPC (total polyphenol content), DPPH, ABTS, ORAC, FRAP (antioxidant micro-plate assays), LPC 
(lipase inhibition with colorimetric probe), LPF (lipase inhibition with fluorimetric probe), AGLC (yeast α-glucosidase 
inhibition with colorimetric probe), AGCF (yeast α-glucosidase inhibition with fluorimetric probe), RATGL (rat α-
glucosidase inhibition with fluorimetric probe).  
 
HPLC analysis was also conducted to quantify individual phenolic compounds 
present in the extracts of unfermented and fermented C. maculata. The individual 
compounds were identified according to retention time and UV-Vis spectra, 
compared to those of authentic standards (Figure 20). Typical HPLC 
chromatograms of unfermented and fermented C. maculata extracts at 288 and 
320 nm are depicted in Figure 21a,b. Absorbance was measured at two 
wavelengths to take into account the different type of phenolic compounds, with 
flavanones and benzophenones giving higher absorbance at 288 nm, while  
xanthones (mangiferin and isomangiferin) have higher absorbance at 320 nm 
(De Beer and Joubert, 2010; Malherbe et al., 2014). The HPLC chromatographic 
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fingerprints of unfermented and fermented C. maculata were similar, except that 
peak areas were smaller for fermented C. maculata.  
 
Major phenolic compounds identified were iriflophenone-3-C-β-D-glucoside, 
mangiferin, isomangiferin, hesperidin and eriocitrin. The contents of these 
compounds in the respective samples are depicted in Figure 20. The xanthones, 
mangiferin and its regio-isomer, isomangiferin, were shown to be present at the 
highest quantities in both the aqueous extracts of unfermented and fermented C. 
maculata. The mangiferin levels varied from 4421 to 6357 mg/100 g extract 
(samples 4 and 3, respectively) in the unfermented batch of extracts and from 
740 to 1560 mg/100 g extract (samples 4 and 7) in the fermented batch of 
extracts. Isomangiferin levels were lower, i.e. in the unfermented extracts varying 
from 1363 to 1879 mg/100 g extract and 650 to 984 mg/100 g extract of the 
fermented extracts. 
 
Much lower quantities of iriflophenone-3-C-β-D-glucoside, eriocitrin and 
hesperidin (< 900 mg/100 g extract) were present in all extracts. Of these 
compounds, the eriocitrin and hesperidin contents were the lowest and highest, 
respectively. The unfermented extracts contained significantly more of the 
xanthones, benzophenone and flavonoids than the fermented extract               
(P < 0.0001; Table 9). Mangiferin and iriflophenone-3-C-β-D-glucoside contents 
decreased by more than 70 % due fermentation, while a decrease of ≥ 40 % was 
observed for isomangiferin, eriocitrin and hesperidin (Table 9). 
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For the wavelengths selected to quantify the major peaks, the HPLC 
chromatograms do not show the presence of new compounds such as polymers 
that could have formed during fermentation. Chromatograms at 420 and 450 nm 
were also used (Figure 21b) to detect brown polymers (Cilliers et al., 1990; 
Theron, 2012). The HPLC chromatogram at 450 nm showed no defined peaks, 
while the xanthones, benzophenone and flavanones, absorbing at 288 and 
320 nm, still gave detectable peaks at 420 nm, even at very low absorbance 
units. Interesting to note was that the “hump” starting to elute at 10 minutes also 
gave very low absorbance at 420 and 450 nm.  The “hump” considered to be 
brown polymeric compounds was estimated in both type of extracts on the basis 
of peak area at 450 nm for retention time window (RTW)  of 10 to 20 minutes. 
Absorbance at 450 nm was chosen as no peaks of the individual compounds 
(eriocitrin and hesperidin) that was visible at 420 nm, were observed 
(Figure 21b). 
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Figure 20. Levels of phenolic compounds present in aqueous extracts of unfermented and fermented 
C. maculata (n = 9) as quantified by HPLC at 288 and 320 nm. Data expressed in 
mg/100 g extract. 
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Figure 21a.  HPLC diode-array chromatogram of an unfermented (A) and fermented (B) C. 
maculata extract (sample 5) at 288 and 320 nm (1: iriflophenone-3-C-β-D-glucoside, 
2: mangiferin, 3: isomangiferin, 4: eriocitrin, 5: hesperidin). The chromatograms at 
320 nm are slight off-set for illustrative purposes. For both 10 µL of a 5.5 mg/mL 
stock solution of the extract was injected. 
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Table 9. ANOVA of individual phenolic compounds and polymers as 
quantified by HPLC-DAD, and changes in contents as affected by 
fermentation.  
 
Compound Unfermenteda
,b 
Fermenteda,b  % Change C P value 
Mangiferin 5374  ± 548 1202 ± 292 -77 p < 0.0001 
Isomangiferin 1608  ± 144 852  ± 113 -47 p < 0.0001 
Iriflophenone-3-C-β-D-glucoside 396  ± 37 114  ± 22 -71 p < 0.0001 
Eriocitrin 230  ± 30 124  ± 16 -46 p < 0.0156 
Hesperidin 903  ± 98 543  ± 51 -40 p < 0.0001 
Polymersd 284  ± 30 504 ± 36 78c p < 0.0001 
a Content expressed as mg/100 g extract, except for the polymers ; b Data are mean ± SD where n = 9. c Increase only 
observed for polymers. d Polymers indicate the fraction absorbing at 450 nm and eluting between retention times 10 and 
20 minutes. Content expressed as the peak area in mAU*s. The superscript +/- indicate the increase or decrease in levels 
of compounds.  
 
 
 
 
 
 
Figure 21b.  HPLC diode-array chromatogram of an extract of fermented C. maculata (sample 5) 
at 420 and 450 nm (1: iriflophenone-3-C-β-D-glucoside, 2: mangiferin, 3: 
isomangiferin, 4: eriocitrin, 5: hesperidin). For both 10 µL of a 5.5 mg/mL stock 
solution of the extract was injected. 
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5.3 Total antioxidant capacity of fermented and unfermented C. maculata 
 
The total antioxidant capacity (TAC) of C. maculata extracts was determined 
using multiple micro-plate methods to allow a more comprehensive evaluation as 
a single method cannot accurately reflect all the antioxidants in a complex 
mixture (Prior et al., 2005; Apak et al., 2007). For this reason methods 
measuring the scavenging of radicals (DPPH●, ABTS●+ and peroxyl) were 
employed. The FRAP assay was employed to measure ferric-to-ferrous 
reduction. All methods used Trolox as standard so that results could be directly 
compared (Zucca et al., 2013). 
 
5.3.1 DPPH● Assay 
 
Scavenging of DPPH● by Trolox as measured by a decrease in absorbance at 
515 nm, showed a good linear relationship (R2 = 0.9998; Addendum; Figure A2) 
over a concentration range of 5 to 40 µM in the reaction mixture. The samples 
were analyzed at final concentrations of 15 and 25 µg/mL for extracts of 
unfermented and fermented C. maculata, respectively. The DPPH● scavenging 
activity of individual C. maculata extracts is shown in Figure 22. Sample 5 
showed the highest TACDPPH values (1786 µmoles TE/g extract) from the 
unfermented group of extracts and sample 8 was the most active sample after 
fermentation (1117 µmoles TE/g extract). The lowest TACDPPH values were 
observed for sample 2 and 3 for unfermented and fermented extracts, 
respectively. The unfermented and fermented extracts showed average TACDPPH 
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values of 1632 and 927 µmoles TE/g extract, respectively (Table7), with an   
intra-batch variation (%RSD) of 12 and 14 %, respectively.  
 
 
 
The decrease in DPPH● scavenging with fermentation was highly significant 
(P < 0.0001; Table 7) with the percentage decrease observed for individual 
samples varying between 28 for sample 2 and 60 % for sample 3 (Table 8). 
 
5.3.2 ABTS●+ Assay 
 
Reaction of ABTS●+ with Trolox as measured by a decrease in absorbance at 
734 nm showed a good linear relationship (R2 = 0.9991; Addendum; Figure A3) 
over a concentration range of 50 to 300 µM in the reaction mixture. The samples 
Figure 22.  DPPH● scavenging activity of aqueous extracts of unfermented and fermented C. 
maculata (n = 9). Total antioxidant capacity (TAC) is expressed as µmoles Trolox 
equivalents (TE)/g extract.  
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were analysed at final concentrations of 80 and 100 µg/mL for extracts of 
unfermented and fermented C. maculata, respectively. As shown in Figure 23,  
significant ABTS●+ quenching activity was found for all samples, ranging from 
2488 to 2094 µmoles TE/g extract for unfermented samples and 1758 and 
1360 µmoles TE/g extract for fermented samples. Samples with the highest 
TACABTS values in the two respective groups were samples 2 and 5, while the 
samples with the lowest TACABTS values were 6 and 7, respectively. The average 
TACABTS values for extracts of unfermented and fermented C. maculata were 
2301 and 1517  µmoles TE/g extract (P < 0.0001; Table 7), respectively, with an 
intra-batch variation (%RSD) of 5 and 8 %, respectively. The TACABTS of 
individual batches decreased between 25 and 41 % (Table 8). 
 
 
 
Figure 23.  ABTS●+ scavenging activity of aqueous extracts of unfermented and fermented C. 
maculata (n = 9). Total antioxidant capacity (TAC) is expressed as µmoles Trolox 
equivalents (TE)/g extract.  
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5.3.3 ORAC Assay 
 
For the ORAC assay, the fluorescence intensity was measured at 530 nm after 
excitation at 485 nm. The net AUC versus Trolox concentration was linear over a 
concentration range of 3 to 30 µM (in a reaction mixture) with a R2 value of 
0.9992 (Addendum; Figure A4). In this case the analysis was performed at final 
soluble solid concentrations of 0.6 and 0.8 µg/mL for the unfermented and 
fermented extracts of C. maculata in the reaction mixtures, respectively. Data 
presented in Figure 24 showed that samples 3 and 8 showed the highest 
TACORAC values and samples 6 and 1 showed the lowest TACORAC values for the 
unfermented and fermented extracts, respectively. TACORAC values for 
unfermented C. maculata extract, ranged from 5349 to 7337 µmoles/g extract. 
Lowest and highest TACORAC values for fermented extract 
were 4075 and 4679 µmoles/g extract, respectively. The TACORAC values of 
different batches differed with an intra-batch variation (%RSD) of 9 % and 5 % for 
the unfermented and fermented batches, respectively. The average TACORAC 
values for unfermented C. maculata extracts were significantly (P < 0.0001) 
higher than that of the fermented C. maculata (Table 7), decreasing by 35 %, 
while TACORAC values of individual batches decreased between 20 and 41 % 
(Table 8). 
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5.3.4 FRAP Assay 
 
The calibration curve of Trolox with concentrations ranging from 50 to 500 µM (in 
the reaction mixture) versus absorbance measured at 593 nm showed a linear 
relationship for ferric reduction with increasing Trolox concentrations (R2 = 0.9998; 
Addendum; Figure A5). The FRAP assay was performed at concentrations of 
15 and 20 µg/mL of the unfermented and fermented extracts in the reaction 
mixture, respectively. As indicated in Figure 25, all the extracts (n = 18) showed 
substantial total antioxidant capacity with the FRAP assay. Samples 3 and 8 
showed the highest TACFRAP values and samples 4 and 6 showed the lowest 
TACFRAP values for the unfermented and fermented extracts, respectively. 
Figure 24. ORACscavenging activity of aqueous extracts of unfermented and fermented C. 
maculata (n = 9). Total antioxidant capacity (TAC) is expressed as µmoles Trolox 
equivalents (TE)/g extract.  
.  
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TACFRAP values for unfermented C. maculata extract, ranged from 1013 to 
1220 µmoles/g extract, and for fermented extracts from 520 to 677 µmoles/g 
extract. An intra-batch variation (%RSD) of 6 % was observed for the 
unfermented extracts, which increased to 8 % after fermentation. The average 
TACFRAP values were significantly higher (P < 0.0001) for unfermented extracts 
than that of fermented extracts.  Fermentation decreased the average TACFRAP 
value by 43 % (Table 8), with TACFRAP values of individual batches decreasing 
between 36 and 52 % (Table 8). 
 
 
 
 
 
 
 
 
 
Figure 25. Ferric reducing ability of aqueous extracts of unfermented and fermented C. 
maculata (n = 9) determined by FRAP method. Total antioxidant capacity (TAC) is 
expressed as µmoles Trolox equivalents (TE) /g extract.  
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5.3.5 Identification of antioxidants using on-line HPLC DPPH●, ABTS●+ 
and FRAP assays 
 
The on-line HPLC DPPH●, ABTS●+ and FRAP assays were used to identify major 
phenolic compounds with antioxidant activity (indicated by the biograms) without 
the need for isolation of compounds prior to the analysis. Based on the results 
obtained from the micro-plate antioxidant assays, the samples that showed the 
highest TAC values for these assays were selected to evaluate relative radical 
scavenging activity of individual compounds present in aqueous extracts of C. 
maculata. The same amount of extract was injected for the unfermented and 
fermented C. maculata extracts (10 µL of a 6 mg/mL stock solution) to allow 
direct comparison. In all of the on-line HPLC antioxidant assays except for FRAP, 
ascorbic acid were included in the reaction mixture for stability of the phenolic 
compounds during analysis, while Trolox™ was used in all cases for 
standardisation purposes. The selected samples for analysis (from the 
unfermented batch) included sample 5 (U5; DPPH●), sample 2 (U2; ABTS●+) and 
sample 3 (U3; FRAP). Results are depicted in Figures 26A, 27A and 28A. A 
number of peaks were observed on the UV-HPLC chromatograms of these 
samples. However, only the major compounds (mangiferin and isomangiferin) 
showed noticeable scavenging of DPPH●, ABTS●+, depicted by negative peaks 
as a result of decolourisation, and reduction of FRAP, depicted as positive peaks 
as a result of colour formation (as indicated on the biograms). Hesperidin 
(compound 5) and iriflophenone-3-C-β-D-glucoside (compound 1) showed no 
detectable antioxidant activity in all 3 assays used. It is clear from the biograms 
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for ABTS●+ scavenging and iron reduction that an ill-defined area for the retention 
time window (RTW) from ca 9 to 14 minutes (RTW9-14) is present. This activity 
peak on the biogram was more pronounced for the FRAP biogram than the 
ABTS●+ biogram. The DPPH● biogram showed very little scavenging activity for 
this retention time window. 
 
The counterpart samples (i.e. the fermented sample, F5, F2 and F3) were also 
subjected to HPLC-(bio)chemical detection (Figures 26B, 27B, and 28B) for 
qualitative comparison. The peak areas for active compounds on the biograms 
were lower than that observed for the unfermented samples, as could be 
expected from their lower content in the fermented samples. The peak area for 
RTW9-14min was also smaller for the fermented samples on both the ABTS●+ and 
FRAP biograms (Figure 29).  
 
Figures 26C, 27C and 28C show similar UV chromatograms and biograms for 
other samples, irrespective of relative sample activity (as per micro-plate assays) 
or fermentation state. No additional peaks or areas of antioxidant activity were 
observed. Given these observations further analysis of the data was carried out 
for all samples analysed by on-line HPLC-DAD-(bio)chemical detection to gain 
more insight.   
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Figure 26. Combined UV chromatograms and DPPH● on-line biograms of (A) the most active unfermented 
sample (i.e. U5), (B) its fermented counterpart (i.e. F5) and (C) the least active unfermented 
sample (U2) of aqueous extracts of C. maculata.  UV absorbance for detection of the major 
phenolic compounds was measured at 288 and 320 nm. Scavenging of DPPH● was measured 
at 515 nm, showing a negative peaks in the biogram. (0: ascorbic acid (antioxidant stabilizer in 
extract solution), 1: iriflophenone-3-C-β-D-glucoside, 2: mangiferin, 3: isomangiferin, 4: 
eriocitrin, 5: hesperidin, 6: Trolox (internal standard).  
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Figure 27. Combined UV chromatograms and ABTS●+ on-line biograms of (A) the most active 
unfermented sample (i.e. U2), (B) its fermented counterpart (i.e. F2) and (C) the most active 
fermented sample (F5) of aqueous extracts of C. maculata.  UV absorbance for detection of 
the major phenolic compounds was measured at 288 and 320 nm. Scavenging of ABTS●+ 
was measured at 600 nm, showing negative peaks in the biogram. (0: ascorbic acid 
(antioxidant stabilizer in extract solution), 1: iriflophenone-3-C- β-D-glucoside, 2: mangiferin, 
3: isomangiferin, 4: eriocitrin, 5: hesperidin, 6: Trolox (internal standard). 
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A 
Figure 28. Combined UV chromatograms and FRAP on-line biograms of (A) the most active 
unfermented sample (i.e. U3), (B) its fermented counterpart (i.e. F3) and (C) the most 
active fermented sample (F9) of aqueous extracts of C. maculata.  UV absorbance for 
detection of the major phenolic compounds was measured at 288 and 320 nm. 
Reduction of FRAP was measured at 593 nm, showing positive peaks as the UV 
chromatograms.  1: iriflophenone-3-C- β-D-glucoside, 2: mangiferin, 3: isomangiferin, 4: 
eriocitrin, 5: hesperidin, 6: Trolox (internal standard).  
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UV peak areas of the two most active compounds (mangiferin and isomangiferin) 
and their respective DPPH●, ABTS●+ and FRAP biogram peaks, given by the 
most active and least active samples (based on the antioxidant micro-plate 
assays) were determined and the ratio between the UV peak area and biogram 
Figure 29. Biograms showing the difference in peak areas of the most active samples per 
micro-plate assays  and the polymeric humps observed between RTW9-14min as 
detected with ABTS (A) and FRAP (B) on-line assays.  
 
 
 
 
 
 
 159 
peak area of the compound for each of the on-line antioxidant assays, calculated. 
The data are summarised in Tables 10, 11 and 12.  
 
The peak ratios for mangiferin, based on the on-line DPPH● assay, were higher 
for the unfermented samples, varying between 1.95 and 2.12. While the peak 
ratios for mangiferin given by the fermented samples were lower, varying from 
1.18 to 1.36. For the peak ratios of isomangiferin, the opposite trend in terms of 
effect of the fermentation state of the extract was observed. In the latter case the 
peak ratios for the unfermented samples varied between 1.45 to 1.56, while 
higher ratios, varying from 1.63 to 1.75, were observed for the fermented 
samples. In summary, the peak ratios of mangiferin, obtained for unfermented 
samples, were higher than that of isomangiferin (Rmangiferin> Risomangiferin), while the 
opposite was observed for the fermented samples (Risomangiferin> Rmangiferin)   
(Table 10).  
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Table 10.  Peak ratio of content and antioxidant activity of xanthones as 
determined by on-line HPLC DAD-DPPH● assay. 
Relative 
activity Treatment  Sample  Detection  
Mangiferin                 
Area [mAU*s]  
Isomangiferin           
Area [mAU*s] 
Most active  Unfermented  C. mac U5 UVa 5685.87 1951.35 
 Biogramb 2888.97 1251.07 
 Ratio 1.97 1.56 
   Fermented  
counterpart  
C. mac F5 UVa 1344.24 1104.36 
 Biogramb 1141.99 675.88 
 Ratio 1.18 1.63 
Most active  Fermented  C. mac F9 UVa 1842.08 1254.24 
 Biogramb 1352.30 728.91 
 Ratio 1.36 1.72 
   Unfermented  
counterpart 
C. mac U9 UVa 5719.83 2029.94 
 Biogramb 2937.74 1392.00 
 Ratio 1.95 1.46 
Least active  Unfermented  C. mac U2 UVa 5723.63 1974.77 
 Biogramb 2927.75 1358.70 
 Ratio 1.95 1.45 
   Fermented  
counterpart 
C. mac F2 UVa 1694.63 1247.23 
 Biogramb 1283.20 711.45 
 Ratio 1.32 1.75 
Least active  Fermented  C. mac F3 UVa 1212.73 1036.12 
 Biogramb 972.43 606.13 
 Ratio 1.25 1.71 
   Unfermented  
counterpart 
C. mac U3 UVa 7034.21 2458.94 
 Biogram
b 3312.74 1650.24 
 Ratio 2.12 1.49 
a Absorbance determined with diode array detector (DAD) at 320 nm. b Absorbance determined 
with variable wavelength detector at 515 nm  
 
 
The peak ratios for mangiferin and isomangiferin, based on the on-line ABTS●+ 
assay, were higher for the unfermented samples, varying between 1.21 and 1.27 
for mangiferin and 0.71 and 0.73 for isomangiferin. Their respective ratios for the 
fermented samples varied between 0.59 to 0.65 and 0.62 to 0.66. The 
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unfermented samples gave higher ratios for mangiferin than for isomangiferin, 
while for fermented samples similar ratios were observed (Table 11).  
 
Table 11.  Peak ratio of content and antioxidant activity of xanthones as 
determined by on-line HPLC DAD-ABTS●+ assay. 
 
Relative 
activity 
Treatment  Sample  Detection  Mangiferin  
Area [mAU*s]  
Isomangiferin 
Area [mAU*s]  
Most active  Unfermented  C. mac  U2 UVa 6270.98 2187.17 
 Biogramb 5027.94 3076.90 
 Ratio 1.25 0.71 
   Fermented 
counterpart  
C. mac  F2 UVa 1824.59 1333.39 
 Biogramb 2809.00 2023.48 
 Ratio 0.65 0.66 
Most active  Fermented  C. mac  F5 UVa 1432.44 1173.91 
 Biogramb 2415.81 1821.38 
 Ratio 0.59 0.64 
   Unfermented 
counterpart  
C. mac  U5 UVa 6105.71 2171.53 
 Biogramb 4817.32 2982.51 
 Ratio 1.27 0.73 
 Least active  Unfermented  C. mac  U8  No data 
available 
    
       
       
 Least active   Fermented 
counterpart 
C. mac  F8  No data 
available 
    
       
       
Least active  Fermented  C. mac  F7 UVa 1823.70 1232.71 
 Biogramb 2824.19 1985.60 
 Ratio 0.65 0.62 
   Unfermented 
counterpart  
C. mac  U7 UVa 5867.06 2094.83 
 Biogram
b 4837.94 2930.36 
 Ratio 1.21 0.71 
a Absorbance determined with diode array detector (DAD) at 320 nm. b Absorbance determined 
with variable wavelength detector at 600 nm  
 
 
The peak ratios for mangiferin obtained in the on-line FRAP assay ranged from 
1.27 to 1.45 for unfermented samples, while for fermented samples the ratios 
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varied from 1.30 to 1.38. The respective peak ratios for isomangiferin varied from 
2.13 to 2.34 and 2.07 to 2.31. It is clear that fermentation had little effect on the 
peak ratios of both compounds. Overall lower ratios were obtained for mangiferin 
than for isomangiferin (Table 12). 
 
Table 12.  Peak ratio of content and antioxidant activity of xanthones as 
determined by HPLC on-line DAD-BCD FRAP assay 
Relative 
activity Treatment  Sample  Detection  
Mangiferin                 
Area [mAU*s]  
Isomangiferin           
Area [mAU*s] 
Most active  Unfermented  C. mac U3 UVa 7777.92 2720.37 
 Biogramb 5853.40 1215.95 
 Ratio 1.33 2.24 
 Fermented  
counterpart 
C. mac F3 UVa 1489.73 1260.97 
 Biogramb 1107.10 547.05 
 Ratio 1.35 2.31 
Most active  Fermented  C. mac F9 UVa 2066.67 1396.62 
 Biogramb 1492.65 675.61 
 Ratio 1.38 2.07 
 Unfermented  
counterpart 
C. mac U9 UVa 6430.44 2245.52 
 Biogramb 5052.25 961.25 
 Ratio 1.27 2.34 
Least active  Unfermented  C. mac U4 UVa 5452.65 2031.94 
 Biogramb 4209.65 951.84 
 Ratio 1.30 2.13 
 Fermented  
counterpart 
C. mac F4 UVa 1031.37 967.80 
 Biogramb 768.50 439.42 
 Ratio 1.34 2.20 
Least active  Fermented  C. mac F6 UVa 1184.31 1043.48 
 Biogramb 913.73 472.25 
 Ratio 1.30 2.21 
 Unfermented  
counterpart 
C. mac U6 UVa 7184.45 2474.00 
 Biogram
b 4969.03 1087.00 
 Ratio 1.45 2.28 
a Absorbance determined with diode array detector (DAD) at 320 nm. b Absorbance determined 
with variable wavelength detector at 593 nm  
 
 
 
 
 
 163 
Given that the concentration of these compounds was much higher in the 
unfermented samples than fermented samples the linearity of the response of the 
on-line DPPH● and ABTS●+ assays was investigated by determining the 
response for a series of standards over their concentration ranges expected in 
the samples. Calibration curves, prepared for DPPH● and ABTS●+ scavenging 
activity versus mangiferin content, showed that while the UV response for 
content was linear in both cases the colorimetric response for radical scavenging 
(measured at 515 and 600 nm) was not linear (Figures 30 and 31), resulting in 
higher peak ratios at higher mangiferin contents (Table 13). In the case of 
isomangiferin the response to DPPH● (Figure 30) and ABTS●+ (Figure 31) was 
near linear with increasing concentration, resulting in little variation of the peak 
ratio for both assays (Table 13). 
 
 
 
Figure 30. Calibration curves of DPPH● scavenging activity versus mangiferin or isomangiferin 
content. A and B show linear regression fits of the UV response of the compounds as 
detected by diode-array-detector at 320 nm, while C and D show polynomial 
regression fits of the colorimetric response for radical scavenging measured by 
variable wavelength detector (VWD) at 515 nm.  
 
 
 
 
 
 164 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31. Calibration curves of ABTS●+ scavenging activity versus mangiferin or isomangiferin 
content. A and B show linear regression fits of the UV response of the compounds as 
detected by diode-array-detector at 320 nm, while C and D show polynomial 
regression fits of the colorimetric response for radical scavenging measured by 
variable wavelength detector at 600 nm.   
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Table 13. Peak ratio of content and antioxidant activity of pure compounds 
(standards) as determined by on-line HPLC-DAD DPPH● andABTS●+ 
assays 
 
Compound µg/µL Injected UV/Biogram ratio 
  DPPH● ABTS●+ 
Mangiferin 0.2273 1.66125 0.65288 
 0.4547 1.48965 0.71021 
 1.1367 1.37169 0.72270 
 2.2733 1.88966 0.80575 
 2.7280 2.01353 0.85407 
 3.4100 2.26432 0.92940 
Isomangiferin 0.0923 1.84950 0.69417 
 0.1847 1.71599 0.79461 
 0.4616 1.93946 0.71693 
 0.9233 1.63881 0.73532 
 1.1079 1.61349 0.89706 
 1.3849 1.64027 0.81886 
 
 
5.4 Correlation of phenolic composition and antioxidant activity as per 
micro-plate assay format 
 
The total polyphenol content (TPC) of freeze-dried aqueous C. maculata extracts 
correlated well with their antioxidant capacity measured with the synthetic radicals, 
(DPPH●, R2 = 0.824; P < 0.0001) and (ABTS●+, R2 = 0.8253; P < 0.0001). A very 
good correlation was also obtained for the antioxidant capacity measuring the 
ability of the extracts to reduce iron as measured in the FRAP 
assay (R2 = 0.9064; P < 0.0001). A weaker relationship was observed for the 
scavenging of the peroxyl radical as measured in the ORAC assay (R2 = 7952;  
P < 0.0001). Results are presented in Figure 32. The use of unfermented and 
fermented samples ensured variation in TPC values. This contributed to observing 
correlations between TPC and antioxidant capacity of the extracts.    
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The ill-defined polymeric compounds, presented by the “hump”, showed a 
negative, significant correlation (P < 0.0001) with the TAC as determined in the 
different assays (Figure 33). R2 values varied between 0.7052 and 0.9165, with a 
relative order of FRAP > ORAC > ABTS●+ > DPPH●.  
Figure 32. Correlation of the total polyphenols content with total antioxidant capacity of 
aqueous extracts of C. maculata evaluated by ABTS●+ (A), DPPH● (B), FRAP (C) 
and ORAC (D) assays.  
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A correlation analysis of individual phenolic compounds present in C. maculata 
extracts with antioxidant activity was also performed. In all four antioxidant 
assays used (ABTS●+, DPPH●, ORAC and FRAP), the individual compounds 
correlated positively and significantly (P < 0.0001) with the total antioxidant 
capacity (Figures 34 to 38). R2 values varied between 0.641 for eriocitrin in the 
DPPH● assay to 0.979 for hesperidin in the FRAP assay. The order of the R2 
values of the different assays were the same for mangiferin, isomangiferin and 
iriflophenone-3-C- β-D-glucoside (FRAP > ABTS●+ > ORAC > DPPH●). The order 
of R2 values for hesperidin was FRAP > ORAC > DPPH● > ABTS●+, while the 
Figure 33. Correlation of polymeric compounds with the total antioxidant capacity (TAC) as 
evaluated by ABTS●+ (A), DPPH● (B), ORAC (C) and FRAP (D) assays.  
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order for eriocitrin was ABTS●+ > FRAP > ORAC > DPPH●.    
 
 
 
Figure 34. Correlation of mangiferin with total antioxidant capacity (TAC) of the unfermented 
and fermented  extracts of C. maculata as evaluated by ABTS●+ (A), DPPH● (B), 
ORAC (C) and FRAP (D) assays.  
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Figure 35. Correlation of isomangiferin with total antioxidant capacity (TAC) of the unfermented 
and fermented  extracts of C. maculata as evaluated by ABTS●+ (A), DPPH● (B), 
ORAC (C) and FRAP (D) assays.  
 
 
 
 
 170 
 
 
 
 
 
 
 
 
Figure 36. Correlation of hesperidin with total antioxidant capacity (TAC) of the unfermented and 
fermented  extracts of C. maculata as evaluated by ABTS●+ (A), DPPH● (B), ORAC 
(C) and FRAP (D) assays.  
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Figure 37. Correlation of eriocitrin with total antioxidant capacity (TAC) of the unfermented and 
fermented extracts of C. maculata as evaluated by ABTS ●+ (A), DPPH● (B), ORAC 
(C) and FRAP (D) assays.  
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5.5 Anti-diabesity potential  
 
The anti-diabesity potential of C. maculata was investigated, using inhibition of 
digestive enzymes, α-glucosidase and pancreatic lipase that are respectively 
involved in absorption of glucose and triacylglycerols from the intestines. Type II 
crude porcine pancreatic lipase was selected to test for anti-obesity potential 
whereas α-glucosidase from Saccharomyces cerevisiae and α-glucosidase from 
rat intestinal acetone powder were used to evaluate anti-diabetic potential of the 
extracts. These activities were assessed in micro-plate assays. On-line HPLC-
Figure 38. Correlation of iriflophenone-3-C-β-D-glucoside with total antioxidant capacity (TAC) 
of the unfermented and fermented  extracts of C. maculata as evaluated by ABTS●+ 
(A), DPPH● (B), ORAC (C) and FRAP (D) assays.  
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enzyme inhibition assays were attempted in order to identify bioactives in the 
extracts responsible for enzyme inhibition.  
 
5.5.1 Anti-obesity assays  
 
The anti-obesity potential of C. maculata extracts were assessed in terms of their 
lipase inhibitory effects, using both a colorimetric and fluorimetric assay. 
Orlistat™, a well-known anti-obesity drug, was used as positive control in both 
assays. 
 
5.5.1.1 Lipase inhibition with colorimetric detection  
 
For the colorimetric assay (LPC), final concentrations of 200 µg/mL C. maculata 
extract and 25 µg/mL Orlistat™ were used. The activity shown by the extracts 
was significantly (P < 0.001) lower than that of Orlistat™ (60 %) (Figure 39), 
however, the reduction in lipase inhibition with fermentation was not significant 
(P > 0.0733) (Table 14) as the effect was not consistent. In the case of sample 2 
the fermented sample was more effective than its unfermented counterpart, while 
equivalent inhibition was observed for both treatments of sample 9 (Figure 39). 
The percentage decrease in lipase inhibition by the extracts after fermentation 
varied from -15 to 41 % (Table 8). As colour interference of the plant extracts 
with assay measurement was expected to be responsible for these inconsistent 
results with fermentation, the experiment was also performed using a fluorimetric 
probe. 
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Table 14. ANOVA of enzyme inhibition assays: Lipase inhibition (colorimetric and fluorescence 
probes) assays. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Probe Controlsa Unfermenteda,
b 
Fermenteda,b Pc value 
LPC pNPB 61.34d 41.87 ± 3.48 36.77 ± 7.14 p < 0.0733 
LPF  MUB 83.97d 56.57 ± 2.30 51.03 ± 3.78 p < 0.0177 
Figure 39. Lipase inhibitory activity of aqueous extracts of unfermented or fermented C. maculata 
(n = 9) at 200 µg/mL in the reaction mixture in comparison with Orlistat™ (control; 
25 µg/mL), using a colorimetric probe, para-nitrophenyl butyrate. 
 
a Values expressed as % inhibition of enzyme at final concentration (200 µg/mL: LPC and 
480 µg/mL: LPF) of extract; b Data are mean ± SD where n = 9. c P values indicate the significance 
between unfermented and fermented extracts (without considering the control) d Signifies that the 
control differ significantly (P < 0.005) from the extracts when considered.   
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5.5.1.2 Lipase inhibition with fluorimetric detection  
 
For this assay higher concentrations (480 µg/mL) of individual extracts were 
required to obtain measurable lipase inhibitory effects (Figure 40). The 
percentage inhibition given by Orlistat™ was 84 % at a final concentration 
25 µg/mL. This activity was significantly higher than those obtained for the 
extracts of unfermented and fermented plant material (57 and 51 %, respectively) 
(Table 14). The percentage inhibition ranged from 53 to 60 and 45 to 52 before 
and after fermentation, respectively. Even though the same concentration of the 
control (Orlistat™) was used in both lipase assays, Orlistat™ showed higher 
lipase inhibitory effect in the fluorimetric assay than with the colorimetric assay 
(84 % and 61 %, respectively) (Table 14).  
 
 
Figure 40. Lipase inhibitory activity of aqueous extracts ofunfermented or fermented C.  
maculata (n = 9) at 480 µg/mL in reaction mixture in comparison with Orlistat™ 
(25 µg/mL), using a fluorimetric probe, 4-methylumbelliferyl butyrate. 
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5.5.2 Anti-diabetic assays  
 
The anti-diabetic potential of C. maculata extracts was assessed in terms of 
ability to inhibit α-glucosidase. In this case colorimetric and fluorimetric assays, 
as well as two sources of the enzyme, i.e. yeast (S. cerevisiae) and mammalian 
(rat), were employed. The flavanol, (+)-catechin, and Acarbose™, a drug, were 
used as positive controls. 
 
5.5.2.1 α-Glucosidase inhibition with colorimetric detection  
 
For the colorimetric assay, unfermented and fermented extracts of C. maculata   
were analysed at a final concentration of 200 µg/mL and (+)-catechin (17 µg/mL) 
was used as a positive control. The unfermented extracts showed higher α-
glucosidase inhibition than the fermented extracts (37 % and 20 %, respectively) 
(Table 10). The most active of the individual extracts was sample 3, giving 54 
and 45 % inhibition before and after fermentation, respectively (Figure 41). The 
activity shown by the extracts was significantly (p < 0.0050) lower than that of 
(+)-catechin (87 %) (Table 15). Generally, fermentation reduced the                   
α-glucosidase inhibitory effect of the extracts, but individual extracts were not 
affected to the same degree by fermentation (Figure 41). In the case of sample 6, 
fermentation resulted in an apparent “increase” in the enzyme activity as 
indicated by the negative value, while for sample 4 fermentation increased 
inhibition of the enzyme. 
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Table 15. ANOVA of enzyme inhibition assays: α-Glucosidase inhibition 
(colorimetric, fluorimetric assays with yeast or rat intestine 
acetone powder enzymes) assays. 
 
 
 
 
 
 
 
 
 
The experiment was also performed using a fluorimetric probe to eliminate 
interference of colour in the extract.  
 Probe Controlsa Unfermenteda,b Fermenteda,b Pc value 
AGLC pNPG 87.23d 37.40 ± 8.55 20.10 ± 16.33 p < 0.0050 
AGCF  4-MUG 55.24d 34.31 ± 1.84 29.37 ± 4.53 p < 0.0078 
RATG 4-MUG 41.44d 60.00 ± 1.47 52.91 ± 1.89 p < 0.0001 
Figure 41. α-Glucosidase (yeast) inhibitory activity of aqueous extracts ofunfermented or 
fermented C. maculata (n = 9) at 200 µg/ml in reaction mixture in comparison with     
(+)-catechin (17 µg/ml), using a colorimetric probe, 4-nitrophenyl α-D-glucopyranoside. 
 
 
a Values expressed as % inhibition of enzyme at final concentration (200 µg/mL: AGCL and  500 µg/mL: AGCF and RATG) 
of extract; b Data are mean ± SD where n = 9. c P values indicate the significance between unfermented and fermented 
extracts of C. maculata  (without considering the controls: (+)-catechin or Acarbose™ ), dSignifies that the control differ 
significantly (P < 0.005) from the extracts when considered.  
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5.5.2.2  α-Glucosidase inhibition with fluorimetric detection  
 
The freeze-dried extracts were analyzed at a final concentration of 500 µg/mL, 
while 200 µg/mL was used for (+)-catechin (positive control). A significantly 
higher (P < 0.0078) α-glucosidase inhibitory activity was observed for extracts of 
unfermented C. maculata compared to the fermented batch (34 and 29 %, 
respectively). However, the activity shown by the extracts was 
significantly (P < 0.0050) lower than that of (+)-catechin (55 %). Unfermented 
sample 3 (38 %) and fermented sample 6 (36 %) showed the highest activity for 
α–glucosidase inhibition of these two batches of extracts, while samples 4 and 7 
(32 and 21 %) were the least active extracts of the unfermented and fermented 
batch of samples, respectively (Figure 42). In the case of sample 6 the 
unfermented and fermented extracts showed the same inhibitory activity.  
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5.5.2.3 Rat α-glucosidase inhibition with fluorimetric detection  
 
A mammalian enzyme (rat intestinal acetone powder) was also used to evaluate 
the anti-diabetes activity of aqueous extracts of C. maculata as the substrate 
specificity of α-glucosidase differs greatly depending on the source (Kimura et 
al., 2004). The same concentrations as used in the colorimetric assay were 
required to obtain a measurable inhibition of the enzyme. Acarbose™            
(202 µg/mL) was used as a positive control. Results are presented in Figure 43 
and Table 15. The inhibition of α-glucosidase by unfermented extracts (60 %) 
was significantly higher (P < 0.0001) than that of fermented extracts (53 %)         
Figure 42.  α-Glucosidase (yeast) inhibitory activity of aqueous extracts of unfermented or 
fermented C. maculata (n = 9) at 500 µg/ml in reaction mixture in comparison 
with (+)-catechin (200 µg/ml), using a fluorimetric probe, 4-methylumbelliferyl-
α-D-glucopyranoside. 
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(Table 15). An average of 12 % decrease in α-glucosidase inhibition was 
observed after fermentation (Table 8). Sample 8 was deemed the most active in 
case of both unfermented and fermented extracts (62 and 58 %, respectively), 
whereas lowest inhibition was observed for sample 4 of the unfermented and 
fermented extracts (58 and 50 %, respectively). An intra-batch variation (%RSD) 
of 3 % was observed for the unfermented extracts, which increased to 4 % after 
fermentation. All plant extracts, at the concentration tested (500 µg/mL) showed 
a significantly higher inhibitory activity than Acarbose™ (41 %).  
 
 
 
 
 
 
 
 
Figure 43. α-Glucosidase inhibitory activity of aqueous extracts of C. maculata (n = 9 
fermented or unfermented samples fermented and unfermented samples) at 
500 µg/ml in reaction mixture, in comparison with Acarbose™ (202 µg/ml), 
using a fluorimetric probe (4-methylumbelliferyl-α-D-glucopyranoside) and rat 
intestinal acetone powder (source of enzyme). 
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5.5.3 Identification of bioactives (on-line HPLC lipase and α-glucosidase 
inhibition) 
 
In the attempt to identify enzyme inhibitors from the C. maculata extracts, the  
on-line HPLC-lipase and α-glucosidase inhibition assays were performed. The 
most active samples (as per micro-plate assay results) were selected for these 
analyses, however, no detectable activity was obtained from the extracts for both 
enzyme assays. A typical on-line HPLC-lipase inhibition biogram of unfermented 
C. maculata extract, together with the UV-Vis chromatogram used for detection 
of the compounds, is depicted in Figure 44. The 320 nm chromatogram is slightly 
off-set for illustration purposes. The lipase inhibition biogram, determined with 
fluorescence detection, showed no activity (depicted as a flat line). Similar results 
were obtained with the HPLC-α-glucosidase inhibition assay (data not shown).   
 
 
 
 
 
 
Figure 44. Combined UV chromatograms and lipase on-line biogram of the most active 
unfermented sample (i.e. U5) of aqueous extracts of C. maculata. UV absorbance 
for detection of the major phenolic compounds was measured at 288 and 320 nm. 
Inhibition of lipase was measured with a fluorescence detector after excitation at 
365 nm and emission at 445 nm. The biogram shows no negative peaks to 
identify activity. The UV peaks are: 1: iriflophenone-3-C- β-D-glucoside, 2: 
mangiferin, 3: isomangiferin, 4: eriocitrin, 5: hesperidin.  
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5.6 Correlation of phenolic composition and anti-diabesity activity  
 
The correlation between phenolic composition (TPC, individual phenolic 
compounds and polymers) and enzyme inhibition was investigated and the results 
are depicted in Figures 45 to 48. Significant, positive correlations were obtained 
between the enzyme inhibition parameters and composition (P < 0.001), except for 
the polymers, showing a significant, negative correlation (P < 0.001). Based on the 
categories of Taylor (1990) the correlation coefficients (r = R2) varied from low or 
weak to very high (Table 16).  Lipase inhibition correlated the best with the 
hesperidin content of the extracts (R2 = 0.5432), in comparison with eriocitrin gave 
the weakest correlation   (R2 = 0.4245). The correlation thus varied from moderate 
to high according to the categories of Taylor (1990). Inhibition of yeast                 
α-glucosidase correlated the best with the polymers (R2 = 0.4420) and the 
weakest in comparison with eriocitrin (R2 = 0.2157). In the case of rat                   
α-glucosidase generally higher correlations (R2 > 0.6047), were observed than for 
yeast α-glucosidase. Isomangiferin and eriocitrin gave the best (R2 = 0.9048) and 
weakest (R2 = 0.6047) correlation with the inhibition of rat α-glucosidase, 
respectively, thus varying from moderate to strong. 
Table 16. Correlation between phenolic constituents and enzyme inhibition 
parameters  
 
Variables LPF AGCF RATG P values  
TPC 0.4644 0.2877 0.8400 P < 0.001 
Eriocitrin 0.4238 0.2157 0.6047 P < 0.001 
Mangiferin 0.4722 0.3892 0.8972 P < 0.001 
Isomangiferin 0.6600 0.4112 0.9048 P < 0.001 
Hesperidin 0.4356 0.2981 0.6394 P < 0.001 
Iriflophenone-3-C- β-Dglucoside 0.4530 0.4286 0.8733 P < 0.001 
Polymers 0.4545 0.4420 0.9006 P < 0.001 
R2 values for individual variables versus inhibition of obesity and diabetes enzyme(s) 
 and significance of the correlation.  
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Figure 45. Correlation of TPC and individual compounds with lipase inhibitory activity of 
unfermented and fermented C. maculata extracts (480 µg/mL), determined using 
fluorimetric probe, 4-Methylumbelliferyl butyrate.  
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Figure 46. Correlation of TPC and individual compounds with yeastα-glucosidase inhibitory 
activity of unfermented and fermented C. maculata extracts (500 µg/mL), 
determined using fluorimetric probe.  
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Figure 47.  Correlation of TPC and individual compounds with α-glucosidase inhibitory activity of 
unfermented and fermented C. maculata extracts (500 µg/mL), determined using 
fluorimetric probe and rat intestinal acetone powder α-glucosidase.  
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5.7 Principal component analysis (PCA) of freeze-dried aqueous extracts 
of unfermented and fermented C. maculata 
 
PCA was performed to obtain the association between the samples and various 
parameters (composition and activity), depicted by the scores and loading plots 
(Figures 49 to 51). The score plot shows how samples relate to each other based 
on their phenolic composition and bio(activities). Samples with similar profiles lie 
close to each other in the map while samples with different profiles lie far apart. 
The information on the reason for samples clustering together is reveald by the 
loading plot. In this manner it is possible to visually assess similarities and 
differences between samples and determine whether samples can be grouped, 
based on all parameters (Ringner, 2008). Figure 49 clearly shows a separation 
Figure 48. Correlation of polymeric compounds with the anti-diabesity activity as evaluated 
by lipase (LPF), α-glucosidase (AGCF and RATGL) inhibition assays.  
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between unfermented and fermented samples with PC1 and PC2 explaining 
83.70 and 5.01 % of the variation, respectively. The polymer content associated 
with the fermented samples, while all other parameters associated with 
unfermented samples. PCA was also performed on the two groups of samples, 
i.e. unfermented (Figure 50) and fermented (Figure 51), to again, identify the 
most “bioactive” sample(s) of each group. Sample 3 of the unfermented extracts 
best associated with α-glucosidase inhibition (yeast) as depicted in the biplot 
(Figure 50). Furthermore, the best association was observed between sample 3 
and FRAP, isomangiferin, mangiferin and iriflophenone-3-C-β-D-glucoside values. 
For lipase inhibition the best association with samples 8 and 9 were observed 
(Figure 50). When the fermented samples are considered, sample 8 with high 
TPC and mangiferin content is identified as being the most “bioactive” in terms of 
rat α-glucosidase inhibition. Fermented sample 8 showed good association with 
FRAP and ORAC values and sample 7 best associated with the ORAC values 
(Figure 51). It should be noted that not all the variance are explained by PC1 and 
PC2 as combined they explain only ca. 60 % of the variance.  
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5.8 Effect of fermentation on soluble solids content and phenolic 
composition 
 
Two matrices, illustrating unfermented and fermented samples with the highest 
and lowest soluble solids content, TPC and contents of individual compounds, 
were compiled to give an overview of sample variability (Figure 52). From these 
matrices it is clear that no single sample had the highest or lowest content of all 
parameters. Furthermore, unfermented samples with highest content of a 
parameter did not give the fermented counterparts with highest parameters. The 
same observation is true for samples with the lowest activity. The extent to which 
fermentation decreased the soluble solids and phenolic content was thus not the 
same for all samples. 
 
Figure 52. Matrices showing samples with the highest (A) and lowest (B) values for 
soluble   solids, TPC (total polyphenol content), mangiferin, isomangiferin,         
 iriflophenone-3-C-β-D-glucoside, eriocitrin and hesperidin.  
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Chapter 6 
Discussion and Conclusions  
 
Several Cyclopia species have been used traditionally for the preparation of the 
herbal tea known as honeybush tea (Joubert et al., 2008a). Its re-discovery in 
the 1990s partly as result of consumer interest in herbal teas and antioxidants 
lead to commercialisation of several species, namely C. intermedia, C. 
subternata and C. genistoides (Joubert et al., 2011). Due to its health benefiting 
properties and its peculiar growth requirements, the demand of honeybush tea 
exceeds production, thus raising interest in commercial development of other 
species such as C. maculata. Although the unfermented (green) tea has also 
entered the herbal tea market (Joubert et al., 2008b), the success of this herbal 
tea still relies on the fermented form, because of its unique sweet flavour and 
taste (Joubert et al., 2011).       
 
The current study follows investigations undertaken by a small number of 
researchers studying the potential health properties of C. maculata (Hubbe, 
2000; Dudhia et al., 2013; Pheiffer et al., 2013; Schulze, 2013; Chellan et al., 
2014). Hubbe (2000) evaluated the antioxidant potential of aqueous extracts of 
several Cyclopia spp., including C. maculata for future development of an 
antioxidant nutraceutical product. Dudhia et al. (2013) and Pheiffer et al. (2013) 
showed that C. maculata has potential as an anti-obesity nutraceutical, while the 
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ability of C. maculata to attenuate streptozotocin-induced diabetes and β-cell 
toxicity was demonstrated by Chellan et al. (2014).   
 
Analysis of the aqueous extracts of C. maculata showed the presence of high 
levels of mangiferin, a xanthone known for its antioxidant properties (Dar et al., 
2005), glucose-lowering effects (Muruganandan et al., 2005) and the ability to 
inhibit α-glucosidase (Phoboo et al., 2012) and pancreatic lipase (Moreno et al., 
2006), two intestinal enzymes relevant to carbohydrate and lipid metabolism 
(Hanhineva et al., 2012; Birari and Bhutani, 2007).  
 
Within this context, further investigation of the antioxidant and anti-diabesity 
potential of C. maculata was deemed relevant. The present study focused on the 
effect of fermentation on the antioxidant and anti-diabesity potential of C. 
maculata as assessed in non-cell based assays. Hot water extracts, prepared 
according to a simulated industrial process, was used, considering its relevance 
for the food and supplement industries (De Beer et al., 2012). Additionally, 
traditional consumption of honeybush is in the form of a cup of tea, prepared by 
brewing the fermented plant material for extended periods at low heat (Du Toit et 
al., 1998). Modern preparation of a cup of tea entails infusing one teabag for 5 
min in freshly boiled water (Joubert et al., 2008a). As part of the evaluation of C. 
maculata as a potential raw material for the production of a standardized 
antioxidant nutraceutical with anti-diabesity properties, several batches of the 
plant material were harvested to gain insight into the variation in composition and 
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bioactivity of the different batches, as well as their behaviour during fermentation.  
The plant material was expected to vary as it represents wild genotypes, even 
though all the batches were harvested from a single population in the wild due to 
limited availability.    
 
In the current study, fermentation decreased the extract yield, total polyphenols 
content (TPC) and individual polyphenol contents of the extracts, while the 
polymer content increased. Previous studies on Cyclopia species have also 
shown that fermentation decreased extract yield (Joubert et al., 2008b) and the 
soluble solids content of the extracts (Hubbe, 2000) and infusion is also affected 
by the process (Du Toit and Joubert, 1999; Theron, 2012).The soluble fraction 
is represented by the dried extract (after filtration to remove plant material). The 
polymers were present at low concentrations, given the low absorbance values 
observed (Figure 3b). The low polymer values could be a result of low solubility. 
Du Toit et al. (1998) showed that fermentation was accompanied by changes in 
CIELab colour parameters of the plant material, indicative of browning that was 
attributed to formation of brown polymers. They also found that as fermentation 
progressed, the infusion colour became lighter, postulated to be the result of the 
formation of less soluble polymers. The present study demonstrated that the total 
polyphenol content of the hot water extract decreased by 35 % with fermentation, 
while Hubbe (2000) reported a decrease of 47 %, which could be explained by 
the different fermentation conditions used (90 °C/16 h vs 70 °C/60 h, 
respectively). 
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Generally, depending on processing conditions and the type of plant material, 
different mechanisms are proposed to explain the reduction of TPC and 
individual polyphenol content observed (Maillard and Berset, 1995). Enzymatic 
oxidation is initiated when the cellular structure of plant material is damaged. 
However, high temperatures employed in the present study should inactivate the 
enzymes as demonstrated for green tea (Camellia sinensis) production 
(Tounekti et al., 2013). In the presence of oxygen, chemical oxidation and other 
degradation reactions will take place (Shingai et al., 2011). The high 
temperatures used during fermentation of C. maculata would facilitate these 
changes, i.e. during fermentation it could be expected that polyphenols are 
subjected to chemical modifications. These could include polymerisation and 
complexation with other molecules leading to decreased solubility (Bonvehi and 
Coll, 1997; Aikpokpodion and Dongo, 2010). Moreover, Maillard and Berset 
(1995) proposed three hypotheses when investigating kilning of barley that could 
also explain the changes caused by honeybush fermentation: release of bound 
phenolic compounds; partial degradation of lignin which could lead to the release 
of phenolic acid derivatives; and/or the thermal degradation of the phenolic 
compounds. Other investigations on the effect of heat on polyphenols showed 
that the type of compounds and temperature plays an important role in the extent 
of change (Nwanguma and Eze, 1996; Larrauri et al., 1997; Ebun and 
Santosh, 2011). 
 
 
 
 
 
 198 
Joubert et al. (2008b), using the same fermentation conditions as Hubbe 
(2000), found that fermentation reduced the TPC of hot water extracts of C. 
intermedia, C. subternata, C. sessiliflora and C. genistoides between 23 % and 
46 % with C. genistoides being the least affected. This indicates that Cyclopia 
species are not affected to the same degree by fermentation. Furthermore, it is 
noteworthy that Hubbe (2000) observed a 33 % reduction of TPC of C. 
genistoides using the same fermentation conditions as Joubert et al. (2008b). 
These findings suggest that other factors apart from fermentation conditions 
could play a role. This could also be associated with the varying contents of 
individual phenolic compounds present in the different Cyclopia species (Joubert 
et al., 2008b) or within a specific species and their susceptibility to thermal 
degradation. Both the present study and Joubert et al. (2008b) showed that 
individual phenolic compounds are also not affected to the same extent by 
fermentation, i.e. mangiferin was shown to be highly susceptible to thermal 
degradation, while hesperidin was less affected. A study by Neelakandan and 
Kyu (2009) showed that mangiferin (in a dry form) is stable, as a significant 
weight loss was only observed at temperatures above 250 °C. However, Chen et 
al. (2008) reported that mangiferin in aqueous solution is unstable at T > 100 °C 
over time. The fermentation temperature used in this study was 90 °C and the 
plant material was kept moist (>60 % moisture content) throughout the 
fermentation period of 16 h. These conditions would thus be conducive to 
thermal degradation of mangiferin as observed for C. maculata. It is noteworthy 
that isomangiferin, regardless of its  structural similarity with mangiferin, was 
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more resistant to thermal degradation, showing 47 % degradation compared to 
77 % of mangiferin. Both compounds have the same aglycone, i.e. 1,3,6,7-
tetrahydroxy xanthone, but differ in the position of the sugar. Isomangiferin is the 
4-C-glucoside regio-isomer of mangiferin. One could speculate that the position 
of sugar play a protective role against oxidation under these conditions and that 
their behaviour under oxidative conditions, such as during antioxidant activity 
determination, would provide some insight. However, Hubbe (2000) reported 
similar DPPH● scavenging activity for mangiferin and isomangiferin, while 
Malherbe et al. (2014) found isomangiferin to be slightly less reactive towards 
DPPH● in an on-line HPLC-BCD assay. However, in the on-line ABTS●+ and 
ORAC assays, the reverse were found (Malherbe et al., 2014). Given these 
findings, the relative antioxidant activity of mangiferin and isomangiferin does not 
explain their susceptibility to degradation under oxidative conditions. This 
conclusion is supported by the behaviour of the benzophenone, iriflophenone-3-
C-β-D-glucoside, given its high level of thermal degradation (71 %) and relative 
weak antioxidant activity in the on-line assays (Malherbe et al., 2014). No data 
on the thermal stability of iriflophenone-3-C- β-D-glucoside could be found in 
literature, but benzophenone decomposes on heating to produce toxic agents to 
react with strong oxidants (No and No, herbpedia.wdfiles.com). From these 
results it is evident that the antioxidant activity of a compound does not give an 
indication of its susceptibility to thermal degradation under oxidative conditions. 
 
Antioxidant activity of the extracts as affected by fermentation was investigated, 
using a battery of assays to take into account the overall concentrations and 
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compositions of diverse antioxidants (Tabart et al., 2009). A reduction in total 
antioxidant capacity (TAC) values for all assays employed was detected with 
fermentation. This is not surprising, as previously discussed, fermentation 
caused a significant reduction in TPC of the extracts as well as the individual 
polyphenols. Good correlations between TPC, contents of individual compounds 
and the different antioxidant assays were observed. The decrease in content, 
chemical modifications such as polymerisation and oxidative degradation would 
explain the reduction in TAC. Polymerisation of polyphenols entails formation of 
bonds at phenolic hydroxyl groups, which would be accompanied by loss of 
antioxidant activity. The negative correlation between polymer content and TAC 
values supports this. Chemical modification of flavonoids which take place during 
fermentation in the presence of oxygen would also include oxidation of the 
hydroxyl groups on the A-ring or the breaking of the C2=C3 bond on the B-ring of 
flavonoids, structural features for antioxidant activity (Nijveldt et al., 2001; 
Woodman et al., 2005; Xiao et al., 2013a, b). The flavanones, hesperidin and 
eriocitrin, have also been shown to be less affected by fermentation than 
mangiferin. Therefore, the type of compound could also influence the 
susceptibility of the compound to thermal degradation. 
 
The decrease in antioxidant capacity of the extracts with fermentation as shown 
with the DPPH●, ABTS●+, ORAC and FRAP assays was in agreement with trends 
observed in previous studies (Hubbe, 2000; Joubert et al., 2008b). Hubbe 
(2000) employed the DPPH and superoxide anion radical scavenging assays, 
while Joubert et al. (2008b) employed the FRAP and ABTS●+ scavenging 
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assays.  In the present study the same reference antioxidant, Trolox, was used 
for all assays so that TAC values could be compared. TAC values of the different 
assays increased in the order FRAP < DPPH● < ABTS●+ < ORAC for both the 
unfermented and fermented extracts. From the on-line biograms it is clear that 
constituents are present in the extracts that reacted in the FRAP assay, but not in 
the other assays. The difference between the TAC values of the different assays 
is explained by their mechanisms of action (Prior et al., 2005). The FRAP assay 
gives an indication of the ability of the extracts to reduce iron, whereas DPPH● 
and ABTS●+ assays measure hydrogen donating ability. The ORAC is based on 
the inhibition of peroxyl-radical-induced-oxidation (Ou et al., 2001). Other factors 
that would affect radical scavenging are the solvent and pH (Sharma and Bhat, 
2009). Solvent polarity significantly influences the antioxidant activity. Alcoholic 
solvents have been reported to have a great effect on the methods that involve 
hydrogen transfer mechanism and polar antioxidants such as polyphenols 
(Litescu et al., 2014). 
 
Considering the antioxidant activity of individual compounds, previous studies 
have shown that their reactivity depends on the radical. The flavanone, 
hesperidin, showed low to no antioxidant activity in comparison to mangiferin 
when evaluated in DPPH●, ABTS●+ and FRAPassays (Hubbe, 2000; Joubert et 
al., 2008b). However, this compound behaved as a better antioxidant in the 
FRAP assay than it did in the ABTS●+ assay (Joubert et al., 2008b). Tabart et 
al. (2009) also showed that hesperidin had no activity in the DPPH● and little 
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activity in ABTS●+ assays, but high activity in the ORAC assay. Eriocitrin showed 
similar antioxidant capacity in the ABTS●+ and FRAP assays and was more 
active than hesperidin in both assays, and more active than mangiferin in the 
FRAP assay (Joubert et al., 2008b). The low antioxidant activity observed for 
hesperidin could be attributed to glycosylation of the compound, as this has been 
reported to decrease antioxidant activity (Williamson et al., 1999; Londono-
Londono et al., 2010).  Malherbe et al. (2014) showed that the benzophenone, 
iriflophenone-3-C-β-D-glucoside, presented no scavenging ability against DPPH●, 
but scavenged ABTS●+ and peroxyl radicals generated in the ORAC assay. In the 
ABTS●+ assay, iriflophenone-3-C-β-D-glucoside was a weaker antioxidant than 
mangiferin and isomangiferin (TEACABTS of 1.04, 1.67 and 1.82, respectively). 
Similarly, it was a weaker antioxidant than isomangiferin in the ORAC assay 
(TEACORAC of 3.61 and 4.14, respectively). However, the antioxidant capacity of 
iriflophenone-3-C-β-D-glucoside was equivalent to that of mangiferin (TEACORAC 
3.69). Moreover, isomangiferin showed a slightly lower antioxidant capacity than 
mangiferin against DPPH●, but higher capacity against ABTS●+ and ORAC.  
 
In the present study the antioxidant capacity of the individual compounds was not 
determined, but the analysis of the extracts by the on-line HPLC assays (FRAP, 
DPPH● and ABTS●+) provide some indication of the activity of the compounds. 
Hesperidin showed no detectable activity (unlike the xanthones). This apparent 
lack of activity is partially attributed to the difference in reaction times between 
the micro-plate and on-line HPLC assays, as times vary from as short as          
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0.6 minutes in the on-line assays to 120 minutes in the micro-plate DPPH● assay. 
The short reaction time of the on-line assays thus limits the time for the potential 
antioxidant (i.e hesperidin) to react with the radical, as on-line antioxidant assays 
are suitable for quick reacting antioxidants (Malherbe et al., 2012). Schulze 
(2013) using another approach, investigated the use of advanced 
chromatographic fingerprint analysis to identify compounds that contributed to 
the prediction of TACDPPH as determined by micro-plate assay. Compounds 
identified in this manner were iriflophenone-di-O,C-hexoside,              
iriflophenone-3-C- β-D-glucoside, mangiferin, isomangiferin, vicenin-2, 3-hydroxy 
phloretin-3ɂ,5ɂ-di-C-hexoside,  eriocitrin, scolymoside a 7-O-rutinoside of luteolin,  
phloretin-3ɂ,5ɂ-di-C-β-D-glucoside and hesperidin. Dudhia et al. (2013) analysed 
hot water extracts of unfermented C. maculata and showed that it contained 
traces of scolymoside and low levels of phloretin-3ɂ,5ɂ-di-C-β-D-glucoside       
(170 mg/100 g extract). As discussed some of these compounds have been 
shown to be antioxidants. By comparison, radical scavenging activity of 
scolymoside was found to be better than that of chlorogenic acid (Wang et al., 
2003). Vicenin-2 has been reported to have moderate radical scavenging ability 
against DPPH● (IC50 of 90.5 µM), but a significantly weaker antioxidant capacity 
than quercetin (IC50 of 7.2 µM) (Velezo et al., 2009).The dihydrochalcone, 
phloretin-3',5'-di-C-β-D-glucoside, due to the similarity in structure to nothofagin, 
a compound present in rooibos and reported as a potent antioxidant               
(IC50 = 4.04 µM) (Snijman et al., 2009), could also be expected to contribute to 
the antioxidant activity of Cyclopia  extracts. The results of the present study 
 
 
 
 
 204 
suggest that TAC values would be more suitable as quality control parameters 
than individual compound contents. If standardization of extracts needs to be 
performed, a large number of samples would be recommended to gain insight 
into the extent of expected variation. When interpreting TAC values, the 
antioxidant assay used must be taken into account as different values are 
obtained with different assays (Prior et al., 2005). A contributing factor to this is 
the lack of validated protocols and methods dedicated to antioxidant assessment 
of either, food, beverages biological samples or pharmaceutical formulas. 
Sample handling is another contributing factor to the variation between these 
assays (Litescu et al., 2014).   
 
The anti-diabesity potential of C. maculata extracts was assessed using inhibition 
of two enzymes important in digestion; α-glucosidase and pancreatic lipase as 
indication of anti-diabetic and anti-obesity potential, respectively. Micro-plate 
assays were used in both cases. Inhibition was obtained against the enzymes 
used in the study, suggesting the use of unfermented C. maculata extracts as 
potential anti-diabesity nutraceuticals. Generally, fermentation reduced the 
enzyme inhibitory activity of the extracts. Again, samples were not affected to the 
same degree by fermentation. Colour interference of the fermented extracts (as a 
result of polymers, known to absorb at 405 nm) (Cilliers et al., 1990; Theron, 
2012) was encountered with the colorimetric assays, thus necessitating the use 
of fluorescence detection. However, higher concentrations of the extracts were 
required to obtain a measureable activity when using fluorimetry rather than 
 
 
 
 
 205 
colorimetry. It is noteworthy that the increase in sample concentration did not 
affect the activity of the extract but only increased the accuracy of the results as 
the fluorimetric assay is reported to be more sensitive than colorimetric assay 
(Margesin et al., 2002). This obeserevation could result from molecular 
interactions between particular compounds as antagonistic and synergistic 
effects have been demonstrated for phenolic compounds in complex mixtures 
(Palafox-Carlos et al., 2012).   
 
Mimicking the method used by Muller et al. (2012) for α-glucosidase inhibitory 
effects of rooibos extracts, the unfermented and fermented extracts of C. 
maculata were firstly screened for their α-glucosidase inhibitory effects in the 
micro-plate assay format using yeast α-glucosidase as it is readily available in a 
pure form (Hogan et al., 2010). The extracts were further evaluated using the 
mammalian enzyme (from rat) for physiological relevance of the analysis (Hu et 
al., 2013; Misbah et al., 2013) and different results were obtained. At 
500 μg/mL, using the yeast and rat α-glucosidase fluorimetric assays, an 
increase in enzyme inhibitory activity was observed (unfermented: 43 % and 
fermented: 52 % increase) when analysis was performed using rat                     
α-glucosidase. However, the α-glucosidase inhibitory activity of the extracts was 
significantly weaker than that of the controls (55 % and 41 % inhibition for         
(+)-catechin and Acarbose™, respectively, both evaluated at a final 
concentration of 200 μg/mL). These findings suggest distinct differences in 
inhibitory potency of active compounds in the extracts towards α-glucosidase 
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from different sources. This difference in activity by plants extracts have also 
been observed by other researchers, for example, Hogan et al. (2010), observed 
lower activity for pomace extracts when using rat α-glucosidase than yeast        
α-glucosidase. Differences in substrate specificity of the different enzyme 
sources used (Kimura et al., 2004) could also play a role. These were also in 
agreement with the findings of Kim et al. (2008a), in which they investigated the 
inhibitory effects of 2,4,6-tribromophenol against two enzymes of different 
sources (Saccharomyces cerevisiae and Bacillus. stearothermophilus) and 
obtained IC50 values of 60.3 and 110.4 µM, respectively. In addition to that, 
Uddin et al. (2012) also obtained significantly different results                     
(IC50 = 89 and 63 µM, respectively) when investigating the α-glucosidase 
inhibitory activity of pistagremic acid (PA) against yeast and mammalian (rat 
intestinal) enzymes. They explained this in terms of the molecular binding mode, 
which revealed hydrogen bonding interactions between PA and amino acids 
surrounding the catalytic site of the enzymes. This enzyme specificity also 
contribute to the necessity of using different positive controls (such as              
(+)-catechin for yeast and Acarbose™ for rat intestinal enzyme) for a valid and 
accurate comparison (Uddin et al., 2012).  
 
In an attempt to identify compounds responsible for the activity of the extracts, 
the on-line HPLC-BCD assay, as employed by Muller et al. (2012), was also 
used in the present study. Compounds present in the aqueous extracts of C. 
maculata, however, did not show any detectable activity. Pure mangiferin (major 
 
 
 
 
 207 
compound), tested in the micro-plate assay, was shown to inhibit rat                   
α-glucosidase, but it had substantially lower activity than AcarboseTM             
(IC50 = 52 mM and 1.8 mM, respectively) (Phoboo et al., 2012), which could 
explain the undetectable activity shown by the mangiferin containing extracts of 
C. maculata as per on-line HPLC assays. The relative concentrations of 
compounds should be considered. The stock solution injected (10 µL) had a very 
low mangiferin concentration (360 µg/mL = 0.85 μM). On the other hand,         
(+)-catechin, added to the extract before injection, also did not show inhibitory 
activity, whereas Muller et al. (2012) demonstrated a negative peak for           
(+)-catechin, i.e. inhibitory activity. Mangiferin was also shown to inhibit the 
digestive enzymes sucrase and isomaltase (from rat) (Yoshikawa et al., 2001). 
Its derivative, isomangiferin, is also reported to be “potent” α-glucosidase inhibitor 
at high concentration (Sellamuthu et al., 2009; Girones-Vilaplana et al., 2014). 
The inhibitory effect of these xanthones was supported by a strong correlation 
between their content in the C. maculata extracts and the inhibition of rat α-
glucosidase (R2 values 0.9472 and 0.9512, respectively) observed in this study. 
Shivaprasad et al. (2014) showed yeast α-glucosidase inhibitory activity of 
mangiferin to be similar to that of Acarbose™ (IC50 = 69.04 µg/mL and 74.95 
µg/mL, respectively), while Dineshkhumar et al. (2010) had previously shown 
this compound to be 50 % more effective (IC50 = 41.88 µg/mL) than the standard 
Acarbose™ (IC50 = 83.33 µg/mL) using the same source of enzyme. It is 
however, noteworthy that this drug has been reported to be a weak inhibitor of 
yeastα-glucosidase (Uddin et al., 2012). Hesperidin, a major compound in the C. 
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maculata extracts was shown to have weak α-glucosidase inhibitory activity 
(Shen et al., 2012), which would explain the moderate correlation (R2 = 0.7996) 
obtained in this study. One of the phenolic compounds detected in the extracts, 
but not quantified due to very low levels, is the flavone aglycone, luteolin. Potent 
α-glucosidase inhibitory activity has been reported for this compound at 5 mg/mL 
(17 μM) (Kim et al., 2000; Nicolle et al., 2011). Vicenin-2 (apigenin-6,8-di-C-β-
D-glucoside) has also been reported to inhibit not only yeast α-glucosidase but 
also protein tyrosine phosphatase 1B and rat lens aldose reductase (Islam et al., 
2014). These findings suggest this compound to have multiple target-oriented 
therapeutic qualities for the treatment of diabetes and diabetes-associated 
complications, such as inflammation and oxidative stress. Kim et al. (2008) 
suggested that the potential of α-glucosidase inhibitors is related to their ability to 
mimick the pyranosyl moiety of glucose (α-D-glucose). Moreover, the presence of 
these compounds in C. maculata extracts could explain the α-glucosidase 
inhibition observed in this study using the micro-plate assays. The difference in 
anti-diabetic properties of compounds is owed to the structure-activity 
relationship with the enzyme due to enzyme specificity.  
 
Structural configurations of the phenolic compounds have been reported to play 
a major role in binding of the compound to the active site of α-glucosidase. Many 
of the structural features necessary for antioxidant activity were also shown to be 
important for enzyme inhibition. Hydroxylation has a major impact on                  
α-glucosidase inhibitory activity. On the other hand, hydrogenation of C2-C3 
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double bond and glycosylation as observed for hesperidin may result in weak 
activity (Xiao et al., 2013 a, b). Slight modifications in the chemical structures 
may have an impact on the activity, for example, Chen et al. (2013), 
demonstrated different IC50 values (244 and 266 µM) for α-glucosidase inhibitory 
activity of vitexin and its regio-isomer isovitexin, respectively. The difference in 
position of the sugars could be responsible for the lower α-glucosidase inhibitory 
activity of isovitexin. This could also be explanatory to the reported difference in 
α-glucosidase inhibitory potency of mangiferin and isomangiferin.  
 
As observed for all other parameters measured in the current study, fermentation 
resulted in a significant decrease in lipase inhibitory activity of C. maculata 
extracts. Due to thermal susceptibility or resistance of individual compounds 
present in the extracts, variability in the lipase inhibitory effect of individual 
extracts was observed. Both unfermented and fermented extracts showed 
inhibition of lipase when assessed using the colorimetric or fluorimetric probes. In 
an attempt to identify active lipase inhibitors on the on-line HPLC-BCD assay, no 
detectable activity was observed from the compounds. As the method was still in 
development when applied other factors than inability of the individual 
compounds to inhibit the enzyme could have contributed to this apparent 
inactivity. A number of the phenolic compounds in C. maculata extract have been 
shown to have lipase inhibitory effects in microplate assays by other researchers. 
Hesperidin showed an IC50 value of 32 µg/mL when evaluated for lipase inhibition 
activity by Kawaguchi et al. (1997). Yoshikawa et al. (2002) showed weak 
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activity against lipase for a mangiferin concentrated hot water extract of Salacia 
reticulata. Moreover, IC50 values of 1750 and 1 µg/mL were reported for lipase 
inhibition of mangiferin and Orlistat™, respectively (Shivaprasad et al., 2014). 
Zheng et al. (2010) demonstrated that luteolin exhibited weaker lipase inhibition 
activity (17 % inhibition) than OrlistatTM (87 % inhibition) at the same 
concentration (25 µg/mL).  
 
Therefore, the presence of mangiferin and hesperidin as major compounds in the 
extracts of C. maculata could explain the significant lipase inhibitory activity 
observed as per micro-plate assays. As for α-glucosidase inhibition, the presence 
and position of the sugar moiety affects lipase activity of the compounds. For 
example, Lee et al. (2010) demonstrated that the inhibitory activity of luteolin 
which does not have a C-glycosyl group on the A-ring of its flavonoid moiety, 
against pancreatic lipase was much weaker than those of C-glycosylated 
derivatives on their A-ring.  
 
Previous research showed that crude extracts could be more potent lipase 
inhibitors than their isolated compounds. For instance, Bustanji et al. (2010) 
demonstrated that a methanolic extract from Rosmarinus officinalis (rosemary) 
showed higher lipase inhibitory activity than its phenolic acids, chlorogenic acid 
and caffeic acid (IC50 values of 13.8, 96.5 and 32.6 µg/mL, respectively).  
No detailed literature could be found on anti-obesity potential of the newly 
identified compounds of C. maculata (i.e.  iriflophenone-di-O,C-hexoside,           
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3-hydroxyphloretin-3ɂ,5ɂ-di-C-hexoside, scolymoside,  vicenin-2, and phloretin-
3ɂ,5ɂ-di-C-β-D-glucoside) of C. maculata (Schulze, 2013) as determined by the 
ability to inhibit lipase. In the present study iriflophenone-3-C-β-D-glucoside and 
eriocitrin showed moderate correlation (R2 values of 0.6731 and 0.7370, 
respectively) with lipase inhibition activity of the extracts. Lipase inhibitory 
activities of the pure compounds has not yet been evaluated, however, extracts 
of C. maculata and C. subternata in which these compounds are present in 
relatively high levels, have been shown to inhibit adipogenesis in 3T3-L1 pre-
adipocytes, suggesting the extracts to possess anti-obesity properties (Dudhia et 
al., 2013).  Zhang et al. (2013) showed that iriflophenone-3-C-β-D-glucoside 
regulates lipid homeostasis.  
 
A factor that cannot be ruled out when considering the contribution of individual 
compounds to the activity of a complex mixture such as a plant extract is 
synergism and antagonism. The effectiveness of inhibition by different individual 
phenolic components depends on their site of action, their mechanism and their 
binding affinities, which may either elevate or reduce therapeutic potencies of the 
active compounds (Boath et al., 2012; Qin et al., 2012). Therefore, the 
mechanism of action of active constituents should be well established before 
making conclusions about the potency of the extracts. Mixtures of phenolic acids 
were shown to be more effective inhibitors of lipase than single compounds (Cai 
et al., 2012). Boath et al. (2012) demonstrated that polyphenol-rich berry 
extracts potentiated the inhibition caused by the drug, AcarboseTM. Low doses of 
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the drugs in combination with phenolic compounds could thus reduce the 
reported side effects of the commercial anti-diabesity drugs. 
 
In summary, the presence of several compounds in the unfermented extracts of 
C. maculatacould explain to some extent the observed lipase and α-glucosidase 
inhibitory activity of these extracts as per micro-plate assays. The polymers 
present in the extracts might also contribute to the observed activity as a good 
correlation was obtained between polymer content and ratα-glucosidase 
inhibition (R2 = 0.9049) and a moderate correlation for lipase (R2 = 0.6742), 
suggesting the polymers to also exhibit anti-diabesity potential. This finding is in 
agreement with that of Nakai et al. (2005), showing that polymerisation of tea 
polyphenols enhances pancreatic lipase inhibition. This could be related to the 
affinity of polyphenols, especially oligomeric polymers to bind proteins (Kawai et 
al., 2003). 
 
Although varying concentrations of individual compounds were detected in 
different extracts and the effect of fermentation on the composition of the extract 
varied, small inter-batch variation (RSD < 5 %) was observed for the enzyme 
inhibition assays and antioxidant assays. By using principal component analysis 
(PCA) the most “active” extract(s) as determined by one or more parameters 
could be identified. Unfermented sample 3 gave the highest association with both 
α-glucosidase inhibition and the FRAP assay. However, unfermented samples 8 
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and 9 showed great association with lipase inhibition. Both extracts also showed 
the best association with DPPH● scavenging activity.  
 
The original plant material used in the current study comprised leaves and stems 
of C. maculata, harvested from different bushes to assess inter-batch variation. 
The individual compound concentrations as determined in the present study were 
similar to that determined by Schulze (2013), who analysed a large sample set 
of C. maculata seedling plants raised in pots (n = 40) and plants collected in the 
wild (n = 10). Interestingly, Schulze (2013) also showed that the inter-sample 
%RSD for individual compound content values were much higher for C. 
subternata samples (from seedling plants) than for C. maculata samples.  
 
The phenolic content of aqueous extracts from C. maculata was comparable to 
that of previous studies (Dudhia et al., 2013; Schulze, 2013) with regards to the 
individual compounds identified in the current study. The total polyphenol content 
of the extracts had a mean value (24 %), similar to those observed by Dudhia et 
al. (2013) (22 %). The highest mean values of the extracts in the present study 
were observed for mangiferin (5.4 %), isomangiferin (1.6 %) and hesperidin     
(0.9 %). Lower mean values were observed for iriflophenone-3-C-β-D-glucoside 
(0.4 %) and eriocitrin (0.2 %). These results were similar to that of Schulze 
(2013), observing mean values of 5.1, 1.5 and 0.9 % for mangiferin, 
isomangiferin and hesperidin, respectively for hot water extracts of C. maculata 
leaves and stems. Similarly, low mean values were also observed for 
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iriflophenone-3-C-β-D-glucoside (0.5 %) and eriocitrin (0.3 %) (Schulze, 2013). 
Compared to hot water extracts of C. subternata (De Beer et al., 2012) C. 
maculata extracts contains much higher levels of mangiferin, isomangiferin and 
hesperidin, but lower levels of iriflophenone-3-C-β-D-glucoside and eriocitrin.     
De Beer et al. (2012), analysing C. subternata and Du Preez (2014), analysing 
C. maculata, showed that hesperidin occurs predominantly in the stems, while 
mangiferin, isomangiferin and eriocitrin are predominant in the leaves.              
De Beer et al. (2012) also analysed for iriflophenone-3-C-β-D-glucoside, showing 
higher levels in the leaves than the stems. This indicates that the ratio of leaves 
to stems will affect the composition of the extract. Cyclopia maculata, when not 
harvested frequently, forms thick stems (Joubert et al., 2011). It is noteworthy 
that, although C. maculata extracts contain higher levels of the major 
antioxidants (i.e. xanthones) than C. subternata, it showed low TAC values than 
the latter species as evaluated by DPPH, ORAC and FRAP assays (De Beer et 
al., 2012). The lower TPC values of the unfermented C. maculata extracts 
compared to those of C. subternata extracts would support this in view of the 
correlation between TAC and TPC, demonstrated in the present study.  
 
Irrespective of these quantitative differences in composition and antioxidant 
activity between C. maculata and C. subternata, Dudhia et al. (2013) reported 
similar anti-obesity properties as assessed in 3T3-L1 pre-adipocytes for hot 
water extracts of these species. In their study, both unfermented andfermented 
C. maculata displayed anti-adipogenic properties, suggesting that fermentation 
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does not affect the ability to inhibit fat and tryglyceride accumulation. These 
findings thus suggest that C. maculata is a promising anti-diabesity nutraceutical 
sincefermented plant extracts are preferred due to their sensory properties. 
Moreover, this potential should be evaluated in a complex physiological system 
before a conclusion can be made with regards to the relative potency of the 
extracts.In comparison with other species, less variation in the individual phenolic 
content of C. maculata extracts has been demonstrated in the current study. This 
could be advantageous with regard to the production of a standardised 
honeybush extract by industry.  
 
Recommendations  
 
The overall aim of the study was to evaluate antioxidant and anti-diabesity 
potential of C. maculata using in vitro non-cell based screening assays.  
 
From the results obtained in this study, the following conclusions may be drawn:  
· Cyclopia maculata, like other commercial Cyclopia species, is rich in 
polyphenols, some of which possess a number health benefiting properties, 
thus supporting its potential as a health beverage or nutraceutical.  
· Based on multiple biological activities of compounds, such asvicenin 2, 
mangiferin, isomangiferin, hesperidin and iriflophenone-3-C-β-D-glucoside, 
present in C. maculata, this plant might be a useful source of compounds that 
could provide a lead compound for the development of multiple target-
oriented therapeutic modalities for the treatment of diabetes and diabetes-
associated complications.  
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· Fermentation resulted in a significant reduction of the phenolic content of the 
extracts, as well as a significant reduction of activity in all parameters 
evaluated in this study. This is mainly due to the decrease in content of 
individual phenolic constituents. Structural modification of active compounds 
as a result of oxidation may also have affected activity. Therefore, 
unfermented plant material should preferentially be used for preparation of 
extracts.  
· Different TAC values were obtained for different antioxidant assays. These 
relate to the different mechanisms of the assays and solvent mediums. 
Overall the FRAP assay would be the recommended assay for investigation 
on antioxidant capacity of plant extracts as is showed the best correlation with 
all quantified phenolic compounds including total polyphenol and polymeric 
compound contents. However, no single assay can accurately reflect all 
radical sources or all antioxidants in a mixed or complex system (Prior et al., 
2005). Therefore, considering the physiologically relevant radical of the 
ORAC assay, this assay should preferably be included as one of the 
biological non-cell based assays when evaluating the nutraceutical potential 
of C. maculata.   
· The major compounds in C. maculata extracts, i.e. mangiferin, isomangiferin 
and iriflophenone-3-C-β-D-glucoside, could be used as chemical markers to 
obtain a standardized antioxidant nutraceutical. Their anti-diabesity activity, 
however, needs to be further explored before they can be used as chemical 
markers for a nutraceutical product aimed at the anti-diabesity market.  
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· A combination of the measured parameters could be useful in product 
standardisation by providing a basis for specifying minimum levels. 
· Total polyphenols and total antioxidant activities are generally used by 
industry to standardise honeybush extracts (Joubert et al., 2011), however, 
complex physiological systems are also to be considered in future to account 
for synergistic and antagonistic effects of these complex mixtures.  
· Orlistat™ and Acarbose™ (the only clinically available anti-diabesity drugs) 
have been associated with adverse gastrointestinal side effects. Plant 
extracts such as C. maculata extracts are a promising solution to this 
problem. However, toxicology studies are recommended.  
 
Based on these conclusions, the following recommendations can be made:  
· The use of selected plants, propagated on large scale, will aid product 
standardisation. 
· A larger number of samples should in future be analysed for lipase or α-
glusosidase inhibitroty potential to set representative baseline data for 
selected parameters used for standardization of a C. maculata nutraceutical.  
· For future research, an improved HPLC method such as that recently 
developed by Schulze (2014) should be employed for better separation of the 
phenolic constituents of the extracts and to gain greater insight into the 
phenolic composition of C. maculata. This could also facilitate improved      
on-line monitoring of biological activities.  
· Further research on the anti-diabesity potential of C. maculata is 
recommended, with special focus on the combination of the clinical anti-
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diabesity drugs and bioactive compounds, tested in appropriate complex 
physiological systems.  
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Addendum 
 
 
 
 
 
 
 
 
 
Figure A1. Standard curve of gallic acid concentration (µg/mL) in reaction mixture versus 
absorbance at 765 nm in theFolin–Ciocalteau Reagent (FCR) method. 
 
Figure A2. Standard curve of Trolox concentration (µM) in reaction mixture versuspercentage 
scavenging of DPPH● measured at 515 nm in the DPPH● scavenging method. 
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Figure A3. Standard curve of Trolox concentration (µM) in reaction mixture   versuspercentage 
scavenging of ABTS●+measured at 734 nm in the ABTS●+method. 
 
 
Figure A4. Standard curve of Trolox concentration (µM) in reaction mixture versus fluorescence 
intensity (Net AUC) measured at 485/20 nm Excitation and 530/25 nm emissionin the 
ORAC method. 
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Figure A5. Standard curve of Trolox concentration (µM) in reaction mixture versusdecrease in 
absorbance at 593 nm in the FRAP method. 
 
 
 
 
 
